Deal Oct 9, 2026
GE HealthCare will pay $945 million in cash to Trilantic North America for a U.S. PET tracer manufacturer with 15 sites and 21 cyclotrons plus U.S. rights to Phase III tracer FAPI-74, with closing expected in the first half of 2027.
Why it matters PET scans depend on short-lived isotopes made close to the scanner, and this deal puts a large share of that U.S. supply chain under an imaging equipment maker. Watch whether supply terms change.
Report Oct 9, 2026
After CMS posted 2027 Medicare Advantage Star Ratings, Humana's share of members in plans rated four stars or higher rose from 41 percent to 93 percent while Alignment's fell from 98 percent to 25 percent, and Alignment's California HMO contract dropped from 4.0 to 3.5 stars with litigation expected.
Why it matters Star ratings set quality bonus money two years out, so a rating posted this week decides 2028 revenue for insurers and shapes the plan choices seniors see. Watch Alignment's appeals and any lawsuit over the measures.
Deal Oct 9, 2026
CD&R would hold about 51 percent and McKesson would invest about $1.4 billion for about 49 percent at $32.05 a share, a roughly 37 percent premium, with closing expected in the first half of 2027.
Why it matters A drug wholesaler with a path to full ownership now sits behind a major home-infusion provider. Watch the stockholder vote and regulatory review.
Deal Oct 9, 2026
Japan's Shionogi agreed October 5 to pay $2 billion upfront for Texas-based IntraBio, maker of FDA-approved Niemann-Pick disease type C treatment Aqneursa, with closing expected by the end of this year.
Why it matters Another ultra-rare-disease drug is moving under a larger commercial parent. Watch what the new owner does with pricing and access for Aqneursa.
Record Sep 21, 2026
Advocate Health announced September 20, 2026 that it is canceling all real estate liens filed against patients before its 2022 no-lien collections policy, more than 11,500 in total and some over 20 years old, coordinating court by court to release them.
Why it matters The third-largest nonprofit system is canceling more than 11,500 real estate liens tied to old patient medical debt, some more than 20 years old, putting numbers behind an industry retreat from aggressive collections. The cancellation will take time to complete court by court.
Earnings Sep 21, 2026
Ascension reported September 16, 2026 that fiscal 2026 net income reached 1.5 billion dollars and its operating loss narrowed to 120 million dollars from 491 million dollars, with recurring operating EBITDA positive at 1.2 billion dollars, the same week Kaufman Hall flagged weak sector-wide hospital margins.
Why it matters One of the largest nonprofit systems posted 1.5 billion dollars in net income in its first full turnaround year, even as a national benchmark flagged weak hospital margins the same week. Watch whether the gains hold.
Alert · now Sep 21, 2026
A direct review of CMS, HHS-OIG, DOJ, FDA, the Federal Register and SEC EDGAR found no rule, enforcement action or 8-K filing dated September 19 or 20, 2026, leaving two FDA food recalls, for undeclared wheat in GF Blends products and possible Listeria in an Elegant Foods Pecorino Toscano cheese lot, as the only confirmed events in that window.
Why it matters This is a housekeeping catch-up confirming a quiet regulatory weekend; the only real news is two small FDA food recalls, so there is little here to act on.
Enforcement Sep 21, 2026
A Texas bankruptcy judge confirmed CVS-owned Omnicare's Chapter 11 plan on September 17, 2026, closing a 440 million dollar settlement that resolves a 948.8 million dollar False Claims Act judgment over 3.3 million improper prescription claims; the plan pays creditors in full and takes effect in October.
Why it matters A Texas judge confirmed CVS-owned Omnicare's bankruptcy plan, closing one of the largest pharmacy fraud cases in memory: a 440 million dollar settlement resolving a 948.8 million dollar False Claims Act judgment over 3.3 million improper prescription claims. The plan pays creditors in full and takes effect in October.
Deal Sep 21, 2026
HCA Healthcare completed its acquisition of The College of Health Care Professions on September 15, 2026, a deal first agreed May 27, adding an 8,000-student, 10-campus Texas training school to a workforce pipeline that already includes three nursing colleges and 365-plus graduate medical education programs.
Why it matters The largest for-profit hospital operator bought an 8,000-student training college, a sign systems increasingly build their own workforce pipeline rather than compete for scarce staff. Terms were not disclosed.
Deal Sep 21, 2026
Telix Pharmaceuticals agreed September 20, 2026 to acquire ITM Isotope Technologies Munich for about 1.65 billion dollars upfront plus up to 700 million dollars in milestones, six weeks after the FDA rejected ITM's lead cancer drug over manufacturing, not the clinical data.
Why it matters A cancer radiopharmaceutical maker turned an FDA rejection into one of the largest deals nuclear medicine has seen, paying up to 2.35 billion dollars for its isotope supplier. Watch whether Telix shareholders approve the dilution in November and whether ITM-11 clears its manufacturing issues.
Funding Sep 12, 2026
The ADVOCATE program aims to develop a clinical AI system capable of assessing symptom severity, prescribing medications and ordering labs that ARPA-H wants the FDA to eventually authorize as a partially autonomous member of the care team.
Why it matters The federal government is funding AI that could one day prescribe drugs and order labs for heart failure patients with less doctor involvement in every step, a meaningful test case for how far regulators will let autonomous AI go in direct patient care.
Deal Sep 12, 2026
The private equity firms bought out prior owners HGGC and Snapdragon Capital Partners in a deal announced September 10, 2026, days after wearable partner Oura filed for a Nasdaq IPO seeking a valuation above 16 billion dollars.
Why it matters A fast-growing health platform just changed hands for an undisclosed sum, and its growth case leans on Oura's wearable data pipeline into clinician workflows, which looks more valuable now that Oura itself is going public. Watch whether the deal price ever surfaces once Oura's IPO prices.
Report Sep 12, 2026
The University of Minnesota Rural Health Research Center found 57 percent of rural hospitals lacked a birthing unit as of 2024 and tied the closures to Medicaid, which finances about 41 percent of U.S. births and faces further cuts under last year's One Big Beautiful Bill Act.
Why it matters Nearly 36,000 births in 2024 happened at a hospital that would close its maternity ward the following year, and the program paying for more than four in ten U.S. births is about to get cut, a combination that points toward fewer birthing options in more places.
Record Sep 12, 2026
At a September 8, 2026 investor conference, UHS CFO Steve Filton said the unfavorable earnings impact from lost ACA exchange coverage widened to 85 million dollars for 2026, and the company cut its full-year admissions and behavioral health patient-day growth guidance.
Why it matters One of the country's largest hospital and behavioral health operators just told investors that people losing ACA marketplace coverage aren't finding other insurance, they're becoming unpaid patients instead, a warning sign for how the broader ACA subsidy cliff is playing out in hospital finances.
Record Sep 12, 2026
The Department of Veterans Affairs named Amwell to help power a digital health infrastructure modernization potentially covering more than 9 million veterans, though the letter of intent is not yet a signed contract.
Why it matters A struggling publicly traded telehealth company just got a potential government lifeline. Watch whether the letter of intent converts into a signed VA contract, since that step is not guaranteed.
Deal Sep 11, 2026
Axogen announced September 10, 2026 that it will acquire BioCircuit Technologies for $200 million in cash to add NerveTape, the first FDA-cleared sutureless device for peripheral nerve repair, in a deal expected to close in the fourth quarter of 2026 and funded in part by a same-day $208.7 million stock offering.
Why it matters A nerve-repair device maker is paying $200 million to lock up the only sutureless technology of its kind before a competitor can build one, a bet on consolidating a niche surgical device market.
Deal Sep 11, 2026
Holders of Definitive Healthcare's tax receivable agreement waived their early-termination payment right if the company signs a merger agreement by December 31, 2026, clearing a cost hurdle days after Advent International's September 1, 2026 non-binding proposal to take the healthcare-data company private at $1.02 per share, a 36 percent premium.
Why it matters A healthcare data company used by drugmakers and hospitals cleared a legal obstacle to a possible sale, a sign the private equity buyout process is moving forward even though no deal is final.
Record Sep 11, 2026
Elevance Health's CFO told the Wells Fargo healthcare conference on September 10, 2026 that third-quarter earnings are tracking ahead of plan and reaffirmed 2026 guidance of at least $27.00 adjusted EPS, sending shares up about 5 percent the same week UnitedHealth fell 3 percent on separate news.
Why it matters Two big insurers gave similar reassurances at the same investor conference this week and got opposite stock reactions, a sign investors are judging turnaround credibility as much as the numbers.
Deal Sep 11, 2026
S&P Global Ratings downgraded Norman Regional Health System to D, its lowest rating, after the Oklahoma hospital system missed a $7.1 million principal and $4.9 million interest payment due September 1, 2026, on $247.45 million in outstanding revenue bonds, triggering a technical default now awaiting a $40 million rescue financing expected to close by September 15, 2026.
Why it matters An Oklahoma hospital system's bond troubles just became an actual credit default, a warning sign for how much financial stress is building in nonprofit hospital debt this year.
Deal Sep 11, 2026
UnitedHealth disclosed on September 8, 2026 that it sold private equity firm TPG an undisclosed-value interest in part of Optum Health's WellMed primary care clinic network in Florida, the same value-based care business whose 2025 cost overruns drove UnitedHealth's leadership shakeup.
Why it matters UnitedHealth brought in a private equity partner for the exact Florida clinic business that hurt its earnings last year, and investors read that as a mixed signal about how fixed the turnaround really is.
Record Sep 10, 2026
CVS Health raised its full-year 2026 adjusted EPS guidance to 7.90 to 8.10 dollars in its August earnings release, and at the September 9 Wells Fargo conference Aetna's president said the insurer is running about 2,000 cost-control initiatives but is not assuming meaningful improvement in elevated Medicare Advantage cost trend.
Why it matters CVS is telling investors its 2026 turnaround plan is working even as its own executives admit Medicare Advantage medical costs remain stubbornly elevated, a split worth watching heading into 2027.
Record Sep 10, 2026
At the same Wells Fargo healthcare investor conference, HCA reported a 6 percent drop in first-half 2026 elective surgical volumes tied to ACA coverage losses, Tenet raised its full-year guidance on its ambulatory-surgery-center mix, and Community Health Systems cut its outlook citing uninsured visits and slower payer payments.
Why it matters This shows how differently exposed hospital systems are handling the ACA coverage losses running through 2026: the same trend produced a guidance raise at one chain and a guidance cut at another. Watch which model, inpatient-heavy versus ASC-heavy, better weathers uninsured growth.
Deal Sep 10, 2026
Lincoln Property Company and PGIM Real Estate announced on September 10, 2026 the acquisition of the 13,957-square-foot, five-operating-room Surgery Center of Gilbert in Mesa, Arizona, leased to Banner Health, Atlas Healthcare Partners and physician partners, on undisclosed terms.
Why it matters A real estate investor's bet that ambulatory surgery keeps growing lines up with hospital executives' own accounts of patients and procedures moving to outpatient settings, reinforcing that the shift toward lower-cost outpatient care is a durable trend, not a one-quarter blip.
Record Sep 10, 2026
The Seattle-area Catholic nonprofit system filed a WARN notice on September 9, 2026 eliminating 24 virtual-care positions effective November 10, its second telehealth layoff round after cutting 116 jobs in June, with leadership citing Washington state budget cuts and tax increases.
Why it matters A second round of telehealth layoffs at the same system in three months shows how state budget and tax pressure, not just national telehealth demand, can drive virtual-care retrenchment at an individual health system.
Deal Sep 8, 2026
Black Pearl Equities completed a tender offer paying $5.75 per share after roughly 90.93% of Selectis Health shareholders tendered their stock, taking the eight-property Arkansas and Oklahoma post-acute operator private on September 1, 2026.
Why it matters A small, publicly traded nursing-home operator just went private, another sign that small post-acute companies are choosing to exit public markets rather than navigate a difficult reimbursement environment as a standalone public company.
Deadline Sep 8, 2026
Humana, UnitedHealth, Elevance Health and Centene disclosed Medicare Advantage plan exits affecting well over 2 million members on earnings calls months before CMS's October 2 deadline for insurers to send members their own non-renewal notices.
Why it matters The insurers already told Wall Street which Medicare Advantage plans are ending in 2027; if you or a family member is on one of these plans, you likely will not find out from your insurer until October 2, leaving 66 days before Open Enrollment closes.
Deal Sep 8, 2026
Tarsus Pharmaceuticals closed its purchase of Alkeus Pharmaceuticals on September 4, 2026, paying $450 million upfront plus up to $350 million in milestones for gildeuretinol, an oral therapy for the untreatable inherited blindness Stargardt disease.
Why it matters A drugmaker just paid up to $800 million for the leading treatment candidate for Stargardt disease, an inherited blindness with no approved treatment today, which matters most to patients and families watching for a first approved therapy.
Report Sep 8, 2026
At least 37 states carry federal Medicaid state directed payments to hospitals exceeding the new 2025 reconciliation law caps by a combined $60 billion, with Texas hospitals already losing $27 million a day after CMS withheld $9.8 billion in payments.
Why it matters This is about whether the federal government follows through on a scheduled cut to hospital Medicaid funding, and Texas shows what happens when it does: real, immediate revenue loss and rural hospital closures. Watch whether other high-exposure states follow the Texas trajectory.
Rule Sep 7, 2026
CMS's proposed Calendar Year 2027 Medicare Physician Fee Schedule would cut the conversion factor by up to 1.68 percent because a one-year 2.50 percent statutory boost to 2026 payments is not being renewed, and the public comment period closes September 14, 2026.
Why it matters If this rule finalizes as proposed, some Medicare-participating physicians would see lower per-service payments starting January 2027; the comment window to weigh in closes September 14.
Rule Sep 7, 2026
Representative Greg Landsman and three bipartisan cosponsors introduced H.R. 10210 on September 1, 2026 to require a licensed clinician to independently review every medical-necessity denial and force insurers to disclose when AI played a role.
Why it matters A bill like this could change how insurance denials work by requiring a human clinician's sign-off, but it is an early-stage bill referred to committee, not law.
Rule Sep 7, 2026
The FDA issued final guidance effective September 4, 2026 letting more pharmacies compound standardized starter parenteral nutrition for newborns without full outsourcing-facility registration after the two main suppliers announced permanent closure.
Why it matters Explains why hospitals may have easier access to newborn IV nutrition without a supply gap; watch whether more pharmacies actually step up to compound it.
Report Sep 7, 2026
A federal judge granted a preliminary injunction August 19, 2026 blocking HHS from cutting 53 of 66 Teen Pregnancy Prevention Program grants worth roughly $67 million after finding the agency's justification cited studies that do not appear to exist.
Why it matters If a federal program you rely on gets defunded, this case shows courts can block agency cuts when the stated justification does not hold up, here because cited research appears fabricated.
Deadline Sep 7, 2026
Governor Josh Stein and NCDHHS launched a public-information campaign warning that federal rules effective October 1, 2026 will end full Medicaid coverage for refugees, asylum recipients, trafficking survivors and other lawfully present immigrants among the state's roughly 740,000 Medicaid expansion enrollees.
Why it matters If you or someone you know is a refugee, asylee, or trafficking survivor on Medicaid, coverage could end October 1; watch for state notices about redetermination.
Deadline Sep 6, 2026
Twelve congressional Democrats gave the Consumer Product Safety Commission until September 18 to answer eleven questions and explain why its NEISS-R program still collects identifiable emergency-department records from up to 100 hospitals through contractor Konza Health.
Why it matters Congress is pressing federal regulators to explain why a data-collection program is still gathering identifiable emergency-room records, including names and diagnoses, from hospitals, even after admitting participation is voluntary. Watch for CPSC's response by the September 18 deadline.
Enforcement Sep 6, 2026
Kenneth Kessler and Michael Gomez were sentenced to 33 and 24 months in federal prison for running DME companies that billed Medicare $34.8 million for unnecessary orthotic braces obtained through illegal kickbacks and continued billing through shell companies after payment suspension.
Why it matters This is a reminder that Medicare fraud involving unnecessary medical equipment gets prosecuted and can result in years of federal prison time, not just fines. Watch for related civil recoveries or additional defendants tied to the same scheme.
Enforcement Sep 6, 2026
Louisiana's attorney general alleged Express Scripts and Prime Therapeutics coordinated pharmacy reimbursement rates under a 2019 agreement, following a similar suit Florida filed against the same two companies a week earlier.
Why it matters Two state attorneys general have now accused the same two pharmacy benefit managers of colluding to fix reimbursement rates, signaling a broadening multistate legal campaign against PBM practices that could affect drug costs and independent pharmacy survival nationwide. Watch for additional states joining or a consolidated response from Express Scripts and Prime Therapeutics.
Approval Sep 6, 2026
The FDA granted accelerated approval to AstraZeneca's camizestrant for ESR1-mutated metastatic breast cancer, its first cancer approval guided by a liquid-biopsy blood test rather than a tissue biopsy.
Why it matters This is the first cancer drug approved based on a blood test rather than a tissue biopsy, which could make it faster for patients with this drug-resistant breast cancer subtype to start treatment. Watch for pricing news and whether liquid-biopsy testing spreads to other cancer approvals.
Approval Sep 6, 2026
The FDA approved Ionis Pharmaceuticals' zilganersen, an intrathecal injection given every three months, as the first drug ever cleared for Alexander disease, a rare and often fatal neurological disorder mostly striking infants and young children.
Why it matters This is the first-ever approved treatment for Alexander disease, an ultra-rare and often fatal childhood neurological disorder, giving affected families a treatment option where none existed before. Watch for pricing, which hasn't been disclosed yet.
Deal Sep 6, 2026
Norman Regional Health System missed a September 1 bond payment, secured a bondholder waiver, and is seeking about 40 million dollars in interim financing by September 15 after S&P downgraded it to CC.
Why it matters A financially distressed Oklahoma hospital system narrowly avoided bond default and is now racing to secure emergency financing, a warning sign for other stretched rural and safety-net hospitals. Watch whether it closes financing by September 15 or slides toward a sale.
Rule Sep 6, 2026
New York approved 2027 individual and small-group ACA rates well below what insurers requested, saving an estimated $1.6 billion, while Delaware approved smaller-than-requested increases for Highmark and AmeriHealth Caritas the same day.
Why it matters If you buy your own health insurance in New York or Delaware, this is why your 2027 premium won't rise as much as insurers wanted, though regulators still approved real increases tied to expiring federal subsidies. Watch whether other states follow the same pattern before November 1 open enrollment.
Deal Sep 6, 2026
Sanford Health finalized its merger with North Memorial on September 1, 2026, forming a 61,000-employee, 60-hospital system and committing more than 600 million dollars to Minnesota facilities under a 10-year state oversight agreement.
Why it matters A major nonprofit hospital system just entered the Twin Cities market for the first time, backed by a large capital commitment and a decade of state oversight designed to protect jobs and services. Watch how Sanford executes on its Robbinsdale and Maple Grove investment promises.
Rule Sep 6, 2026
Texas hospitals began losing an estimated 27 million dollars a day in Medicaid funding after CMS withheld approval of three directed payment programs, including CHIRP, for the state's 2027 fiscal year.
Why it matters This is a funding standoff between Texas and the federal government that could force real cuts to hospital services if it drags on, especially at safety-net hospitals. Watch whether CMS approves the programs before hospitals start cutting services.
Rule Sep 6, 2026
Wisconsin began issuing new APRN licenses on September 1 that let nurse practitioners with 7,680 supervised clinical hours practice independently without a physician collaborative agreement.
Why it matters If you live in Wisconsin, this means nurse practitioners with enough clinical experience can now treat you without a supervising physician's sign-off, part of a broader trend of states easing scope-of-practice rules to fight provider shortages.
Funding Sep 5, 2026
Between September 1 and 4, 2026, CMS's Rural Health Transformation Program awarded $76 million to New York, $120 million to Indiana, $149.3 million to Arkansas, $25 million to Michigan, and $5.48 million to Rhode Island for rural care coordination, maternal health, telehealth, and workforce projects.
Why it matters This is real money starting to flow from last year's $50 billion rural health law, and it shows CMS prioritizing maternal health and telehealth access in the first wave. Watch which states get funded next and how transparently they report use of funds.
Enforcement Sep 5, 2026
A federal grand jury indicted Erekle Gugava on one count of money laundering conspiracy for allegedly using a Pennsylvania durable medical equipment company to move insurer payouts from Operation Gold Rush, a scheme that billed roughly $1.3 billion in fraudulent claims using stolen identities of elderly and disabled Americans.
Why it matters This is the largest health care fraud case DOJ has ever prosecuted, and it shows how fraud networks use shell companies to launder proceeds even when insurers ultimately pay out a small fraction of what's billed. Watch for additional indictments as DOJ works through the network.
Alert · now Sep 5, 2026
FDA posted warning letters dated August 24 to five companies selling unapproved compounded semaglutide, tirzepatide, and other peptide products online, as agency data shows 990 adverse-event reports tied to compounded semaglutide alone and more than 730 for compounded tirzepatide.
Why it matters This shows the scale of harm from unregulated online peptide sellers, nearly 1,000 adverse-event reports tied to one drug alone, and that FDA considers these products illegal to sell regardless of how they're advertised. Watch for state actions or further FDA enforcement following these letters.
Deal Sep 5, 2026
The FTC's Bureau of Competition found OhioHealth's bid for Fairfield Medical Center risked raising costs and cutting care quality, prompting Fairfield to run a wider sale process that ended with Adena Health acquiring the hospital around September 1, 2026.
Why it matters This shows federal regulators actively blocking hospital mergers even without formal enforcement action, just by pressuring a target to find another buyer. Watch whether this signals more aggressive FTC involvement in rural hospital deals.
Deal Sep 5, 2026
Morgan Stanley Real Estate Investing acquired the 193-unit Sonata Lake Mary for about $60 million and the 106-unit Preserve at Dunedin for $31.1 million, pricing the combined 299 units at roughly $305,000 per unit, nearly double Florida's average.
Why it matters Institutional capital is paying well above the state average for senior housing, a sign investors see steady demand in Sun Belt markets even as broader real estate cools.
Record Sep 5, 2026
Regional One Health filed a WARN notice closing its 30-bed Extended Care Hospital effective September 1, 2026 and laying off 103 workers, while financing for the rest of its $1.2 to $1.5 billion replacement campus, beyond Shelby County's $500 million commitment, remains unresolved.
Why it matters A safety-net hospital system is cutting services now while betting its future on a billion-dollar campus it hasn't fully financed; watch whether the funding gap closes or forces further cuts.
Record Sep 5, 2026
Bradley Radoff and Michael Torok, who own about 7.7 percent of Seer, called on director Meeta Gulyani to resign after the company's stock fell more than 90 percent and the board rejected three take-private offers, most recently a $2.40 per share bid plus a contingent value right.
Why it matters This is a fight over whether a struggling diagnostics company gets sold or keeps operating independently; watch whether the board caves to the activists or the proxy fight goes to a vote.
Deal Sep 4, 2026
The FTC found OhioHealth's proposed purchase of financially distressed Fairfield Medical Center risked raising costs and reducing care quality, prompting a broader sale process that closed with Adena Health on September 1, 2026.
Why it matters FTC intervention rerouted a struggling hospital's sale, showing regulators actively steering hospital deals rather than just blocking them. Watch whether the FTC repeats this playbook nationally.
Deal Sep 4, 2026
The 867-unit portfolio spans six Northeastern states and is the REIT's second nine-figure senior housing purchase in three days, pushing 2026 investment past $2 billion.
Why it matters A REIT just spent over 1.2 billion dollars in three days buying senior housing, a sign investors see supply-constrained Northeast markets as a durable opportunity. Watch whether the pace of senior housing consolidation continues.
Rule Sep 4, 2026
A federal judge dismissed AstraZeneca's lawsuit against Colorado's law requiring manufacturers to honor 340B discounts at contract pharmacies, and AstraZeneca said it will appeal.
Why it matters Courts keep siding with states on 340B contract pharmacy laws, so drugmakers are running out of legal room to resist state-level discount pricing rules.
Funding Sep 4, 2026
CMS's Innovation Center began funding up to 30 cooperative agreements worth as much as $3.3 million each over three years for organizations building nutrition, exercise, and sleep coaching programs for traditional Medicare beneficiaries.
Why it matters Medicare is now funding lifestyle and functional-medicine programs, nutrition, exercise, sleep, alongside standard medical care, a notable shift for a program historically focused on treating illness rather than preventing it.
Rule Sep 4, 2026
The DEA's temporary order placing three synthetic kratom-derived chemicals into Schedule I took effect August 26, 2026 and can run up to two years, while a separate comment period on scheduling concentrated 7-hydroxymitragynine itself closes September 10.
Why it matters The DEA has locked three synthetic kratom-derived chemicals into its strictest drug category, and a decision on the compound found in over-the-counter kratom shots sold nationwide is due within days.
Deal Sep 4, 2026
The oversubscribed round, which drew a fourth publicly traded medtech strategic investor, brings Elucid's total funding to about $185 million to commercialize Plaque-IQ and advance FFR-CT through FDA review.
Why it matters A cardiovascular AI diagnostics company raised 55 million dollars from its fourth publicly traded medtech strategic investor, signaling device makers are betting on AI plaque-detection software. Watch whether BioIntegrated FFR-CT clears FDA review.
Record Sep 4, 2026
Louisiana's Medicaid agency said Healthy Blue's managed care contract ends December 31, 2026, moving 290,000 members to one of four remaining plans on January 1, 2027.
Why it matters A major insurer is walking away from a state Medicaid program entirely, and it says more state exits are coming within the next year and a half.
Report Sep 4, 2026
The steepest projected increase since 2003 comes even after planned cost-cutting steps like higher deductibles, more premium cost-shifting, and tighter GLP-1 coverage.
Why it matters Employers expect the steepest jump in health benefit costs since 2003 and plan to push more of that cost onto workers through higher deductibles and premium shifts. Watch what employers finalize during 2027 open enrollment.
Record Sep 4, 2026
A bankruptcy court hearing put administrative and professional costs for North Star Health Alliance's Chapter 11 case at $6 million since its February 2026 filing, with New York providing bridge financing as the system cuts jobs and moves to close a maternity unit.
Why it matters A rural hospital system's bankruptcy is burning through millions in legal and administrative costs, money that isn't going to patient care, while the state props it up and services get cut.
Rule Sep 3, 2026
Wyoming went live August 31 and Tennessee went live September 1, letting licensed counselors in either state practice across all nine compact states, in person or by telehealth, without a second license.
Why it matters Licensed counselors in nine states can now cross state lines to see patients without extra licensing paperwork, part of a broader trend of interstate compacts easing workforce shortages. Watch which states join next.
Rule Sep 3, 2026
The court reversed a 2024 ruling that had declared the False Claims Act's whistleblower mechanism unconstitutional, reviving a fraud suit against three Florida Medicare Advantage companies.
Why it matters A federal appeals court kept alive the legal tool that drives billions of dollars in Medicare and Medicaid fraud recoveries each year. Watch whether the Supreme Court takes up the underlying constitutional question.
Funding Sep 3, 2026
The award splits $45 million for a University of Hawaii rural physician workforce program and $13 million for new ambulances and emergency communications upgrades in every county, under the federal Rural Health Transformation Program.
Why it matters Hawaii is getting a real infusion of federal money aimed at rural ambulance coverage and physician training, part of a much larger $50 billion national program other states are also drawing on. Watch which other states get funded next and how the money is spent.
Deadline Sep 3, 2026
The state Medicaid agency began mailing, emailing and texting notices this week that a new federal work requirement takes effect January 1, 2027, and it is also shortening recertification from annual to every six months.
Why it matters Hundreds of thousands of Colorado Medicaid enrollees now have a hard deadline to prove they meet new work requirements or lose coverage. Watch for confusion and coverage gaps as recertification also moves to twice a year.
Enforcement Sep 3, 2026
Poul Thorsen admitted to diverting more than $1 million from an $11 million-plus CDC grant using forged invoices, ending 14 years as a fugitive, and faces sentencing December 1 plus full restitution.
Why it matters A 14-year fugitive case tied to research long cited in vaccine misinformation has ended in a guilty plea, closing a chapter that fueled public distrust. Watch the December 1 sentencing for the restitution outcome.
Deal Sep 2, 2026
American Healthcare REIT closed the first six of an eight-community, 745-unit Kensington Senior Living portfolio worth roughly 873 million dollars total, with Kensington staying on as manager and the remaining two properties expected to close in Q4 2026.
Why it matters A large healthcare REIT just paid over half a billion dollars for senior living communities, a sign investors still see steady demand in senior housing even as some hospital real estate lags.
Rule Sep 2, 2026
The House passed a continuing resolution 370-48 funding the government through December 11 while blocking OMB from finalizing a rewrite of the Uniform Guidance rules that govern federal grant administration.
Why it matters This averts an imminent government shutdown and buys time before a grants-rule rewrite that worried grant recipients. Watch for the rule to resurface after the December 11 funding deadline.
Funding Sep 2, 2026
SAMHSA distributed the funds across community and tribal prevention partnerships, state-level partnerships, and long-term recovery support, timed to Overdose Awareness Day.
Why it matters This signals continued federal investment in addiction and mental health services. Watch which states and organizations receive the awards.
Deadline Sep 2, 2026
42 states plus DC had to warn ACA expansion enrollees by August 31 about new 80-hour-a-month work requirements taking effect January 1, 2027, with Washington state alone projecting 250,000 could lose coverage.
Why it matters This signals a major coverage disruption coming in 2027 as work requirements take effect. Watch state-by-state enrollment and disenrollment data as implementation proceeds.
Rule Sep 2, 2026
First Coast Service Options and Novitas Solutions finalized updated local coverage rules effective September 6 limiting billing to one code per patient per day and requiring stricter medical-necessity documentation across Florida, Texas, and more than a dozen other jurisdictions.
Why it matters This signals CMS scrutiny of a commonly billed pain procedure. Watch for denial rates in the affected states after the effective date.
Earnings Sep 2, 2026
Medtronic reported 9.8 billion dollars in fiscal first-quarter revenue, up 13.7 percent, beat Wall Street's EPS estimate, and raised its fiscal 2027 organic revenue and EPS guidance.
Why it matters Medtronic's device sales are booming, meaning the products in your hospital's cath lab and pharmacy are increasingly likely to be Medtronic's, and their prices probably are not falling.
Record Sep 2, 2026
Prime Healthcare is ending labor and delivery at Saint Joseph, Mercy, and Resurrection Medical Centers, three of the eight Ascension Illinois hospitals it bought for more than 370 million dollars in 2025, affecting about 75 nurses.
Why it matters Three Chicago-area hospitals bought in a 2025 acquisition are now cutting labor and delivery, a reminder that hospital deals can be followed by service closures once the ink dries.
Rule Sep 2, 2026
The manufacturers pledged $19.6 billion in US manufacturing investment and extended most-favored-nation pricing to every state Medicaid program, bringing the total to 26 companies covering 89 percent of the branded drug market.
Why it matters This significantly widens a federal drug pricing program tying US prices to the lowest price paid in other wealthy countries. Watch whether the projected $600 billion in savings, an administration estimate rather than an independent one, actually materializes.
Rule Sep 2, 2026
UnitedHealthcare will remove prior authorization requirements from 1,700 outpatient procedure codes across commercial, Medicare Advantage, exchange, and Medicaid plans starting October 1, 2026, alongside a new Gold Card notification program.
Why it matters The country's largest insurer is dropping prior authorization on 1,700 procedure codes starting October 1, cutting paperwork for common outpatient procedures like colonoscopies and hernia repairs, though most imaging and specialty drugs are untouched.
Rule Sep 1, 2026
The American College of Cardiology filed comments on CMS's CY2027 OPPS/ASC proposed rule ahead of the August 31 deadline, backing higher cardiac PET/CT reimbursement and opposing a proposed site-neutral cut to off-campus cardiac imaging.
Why it matters This is a comment letter, not a final rule, so nothing changes yet, but it shows what cardiology's largest physician group is fighting for as CMS finalizes 2027 outpatient payment rates by November.
Rule Sep 1, 2026
CMS published its final list of 2,600 general cardiologists required to join the mandatory Ambulatory Specialty Model for heart failure launching January 1, 2027, and the American College of Cardiology says about 500 were added in error.
Why it matters This is a mandatory Medicare payment model, not optional, so the roster determines who is on the hook for future performance-based pay swings. Watch whether CMS corrects the misclassified names before the list locks.
Deal Sep 1, 2026
Aon plc agreed August 31, 2026 to buy USI Insurance Services from KKR and other shareholders for 17 billion dollars in cash, its second major brokerage acquisition after the 2024 purchase of NFP.
Why it matters Two of the largest U.S. insurance brokers are combining, concentrating employer health benefits shopping into fewer, larger platforms. Watch the regulatory review process ahead of the expected fourth-quarter close.
Record Sep 1, 2026
Once performance-based scoring begins in 2029, cardiologists correctly included in CMS's mandatory heart-failure Ambulatory Specialty Model face a payment adjustment ranging from negative 9 percent to positive 9 percent on all their Medicare Part B claims, not just heart-failure care.
Why it matters This single number, a swing of up to 9 percent on all Medicare Part B billing, turns a reporting requirement into a practice-economics question for roughly 2,100 cardiologists once corrections are made. Watch how practices use 2026 to build the quality-reporting workflow before scoring starts.
Deal Sep 1, 2026
EIT Pharma closed an oversubscribed 35 million dollar Series A round led by Propel Bio Partners on August 31, 2026 to fund FDA review and commercial readiness for lonafarnib, an oral treatment for hepatitis delta virus.
Why it matters Early-stage funding is going toward a rare, aggressive liver co-infection with no approved cure today. Watch the FDA review, which the company itself flags as still uncertain.
Deal Sep 1, 2026
Medtronic completed its purchase of CathWorks, maker of the FFRangio system that computes fractional flow reserve from standard angiogram images instead of a pressure wire, folding it into its coronary and renal denervation business.
Why it matters This shows device makers now buying the software that interprets cath lab images, a fourth consolidation path in cardiology alongside private equity practice roll-ups, hospital employment, and payer partnerships. Watch whether other device makers follow with similar AI acquisitions.
Rule Sep 1, 2026
The White House announced August 31, 2026 that Alcon, Astellas, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva, and UCB signed most favored nation pricing deals, bringing the program to 26 manufacturers covering 89 percent of the branded drug market.
Why it matters This expands a voluntary drug pricing program that now touches most branded drugs sold to Medicaid. Watch whether the administration's self-reported savings figures hold up to independent scrutiny.
Report Sep 1, 2026
In a 262-patient randomized trial presented at ESC Congress and published in The Lancet, ablation cut AFib recurrence to 73 percent versus 52 percent for a sham procedure but produced nearly identical quality-of-life gains in both arms.
Why it matters This is the first sham-controlled trial to test whether AFib ablation's benefits go beyond keeping the heart rhythm steady, and it suggests some of what patients feel better from may be placebo. Watch whether the finding changes how doctors talk about the procedure, not whether it's still offered.
Deal Sep 1, 2026
The merger took effect September 1, 2026 after Minnesota's Attorney General secured a 10-year binding oversight agreement requiring Sanford to invest 600 million dollars and preserve Robbinsdale Hospital's trauma center, union contracts, and reproductive and gender-affirming care.
Why it matters A hospital merger closed alongside an unusually binding decade-long state oversight agreement, a model other states may look to replicate. Watch the required quarterly meetings and annual compliance reports over the next 10 years.
Deal Aug 31, 2026
Arintra, whose AI platform audits hospital and clinic billing and now drives 5 billion dollars in annual claim value, raised a Series B led by Define Ventures to expand into more health systems.
Why it matters An AI platform that catches missed hospital billing revenue raised new funding, part of a broader wave of AI tools aimed at revenue-cycle efficiency in health systems.
Deal Aug 31, 2026
BioXcel entered a stalking horse asset purchase agreement for Teva to buy its assets for up to 145 million dollars while the company proceeds through bankruptcy court in Delaware.
Why it matters A once-promising drugmaker ran out of cash and its only approved product is now headed to Teva; watch the November 14 FDA decision on expanded at-home use for the deal's final size.
Deal Aug 31, 2026
Bloom Healthcare acquired Christian Care House Calls on August 31, with undisclosed terms, even as broader private equity investment in physician practices contracts sharply.
Why it matters One in-home primary care organization for homebound seniors kept acquiring practices even as the broader physician-practice deal market froze. Watch whether more home-based primary care consolidation follows.
Enforcement Aug 31, 2026
CMS credits AI-driven program integrity analytics with revoking 157 fraudulent lab providers, suspending 185 more among roughly 600 flagged, and blocking or identifying $1.6 billion in payments since January 2025.
Why it matters This is CMS touting its ability to catch fraud before it drains Medicare, and it's worth watching whether the AI tools flag legitimate labs by mistake.
Rule Aug 31, 2026
Attorney General William Tong filed objections to proposed 2027 rate increases from Anthem, ConnectiCare, and UnitedHealthcare covering about 220,000 Connecticut residents, ahead of a final Insurance Department decision.
Why it matters If regulators side with the insurers, 220,000 Connecticut residents could see premiums jump by double digits next year; watch the Insurance Department's decision in the coming weeks.
Rule Aug 31, 2026
Acting CPSC Chairman Peter Feldman said hospital participation in the NEISS-R emergency department data collection effort with contractor Konza Health remains voluntary, walking back outreach materials that told hospitals it was required.
Why it matters A federal agency told hospitals nationwide their ER records were mandatory to hand over, then admitted that was wrong, worth watching for how much identifiable patient data ends up flowing to a private contractor anyway.
Rule Aug 31, 2026
CMS's proposed CY2027 physician fee schedule sets a 1.19 percent cut for clinicians in advanced alternative payment models versus a 1.68 percent cut for everyone else, with comments due September 14, 2026.
Why it matters Medicare's proposed 2027 payment rates cut fee-for-service doctors more than doctors in value-based arrangements, a financial nudge toward joining an ACO. Watch the September 14, 2026 comment deadline and whether the final rule keeps the gap.
Deal Aug 31, 2026
Faro AI, whose platform is used by six of the world's ten largest pharmaceutical companies, closed a Series B round co-led by Merck's venture arm and S32 to expand its agentic AI tools for clinical development.
Why it matters A clinical-trials AI vendor already used by major pharma companies raised fresh capital, a sign investors see room to expand AI's role in running drug trials.
Approval Aug 31, 2026
The FDA approved Takeda's Mimrylo (rusfertide) for adults with polycythemia vera after a pivotal trial found 76.9 percent of patients avoided therapeutic phlebotomy versus 32.9 percent on placebo.
Why it matters This is a new treatment option for a rare blood cancer that could reduce the need for frequent therapeutic blood draws; watch for uptake and pricing once it reaches the market.
Rule Aug 31, 2026
A unanimous three-judge panel affirmed a Texas district court ruling against PhRMA, the National Infusion Center Association, and the Global Colon Cancer Association, holding that manufacturers have no protected property interest in Medicare drug pricing because program participation is voluntary.
Why it matters This is the 25th consecutive court loss for the drug industry's legal campaign against Medicare price negotiation, reinforcing that the program is likely here to stay.
Record Aug 31, 2026
HMSA is shifting independent primary care doctors off fixed monthly transformation payments back to fee-for-service starting September 1, 2026, with a final deadline of January 1, 2027, alongside new patient-attribution rules.
Why it matters A major insurer's payment model reversal is already forcing at least one independent practice to close, showing how a single payer's policy can determine whether a local doctor's office stays open.
Enforcement Aug 31, 2026
The Department of Justice said Monogram Health agreed to pay $2.4 million to resolve False Claims Act allegations that it submitted unsupported diagnosis codes to Medicare Advantage plans from 2021 through 2023, based on a former staff physician's whistleblower complaint.
Why it matters This is another Medicare Advantage upcoding settlement driven by a physician whistleblower, a reminder that inflated diagnosis codes carry real financial and legal risk.
Rule Aug 31, 2026
NAACOS wants CMS to extend ACO REACH through 2027 because the LEAD Model's January 1, 2027 start does not give the program's roughly 115 current participants enough time to plan their transition.
Why it matters Medicare's accountable care system is mid-transition, and the trade group representing most ACOs says the timeline is too tight. Watch for a CMS response before the September 15 Implementation Period begins.
Report Aug 31, 2026
Physician practice management deal volume dropped from 851 transactions in 2021 to 105 in the first half of 2026 as at least 25 states restrict private equity control of medical practices.
Why it matters Fewer private equity buyers are competing to acquire physician practices, which affects who owns your doctor's practice and how it's run. Watch whether state restrictions expand to more specialties and states.
Report Aug 31, 2026
Federally designated primary care shortage areas covering more than 92 million Americans meet only about 48 percent of documented need, and just 9.3 percent of physicians practice in rural areas.
Why it matters The government has mapped where primary care doctors are most scarce, and the shortfall is large and getting worse in rural areas even as policy tries to steer more care toward primary care and value-based models. Watch whether this workforce gap becomes a policy priority alongside payment reform.
Deal Aug 31, 2026
Radiology Partners agreed to buy Everlight Radiology, adding more than 800 radiologists across over 40 countries in a deal trade press estimates near 1 billion dollars though neither company confirmed a price.
Why it matters The deal consolidates teleradiology capacity across multiple countries under one US-based physician group, a sign of continuing scale consolidation in radiology reading services.
Rule Aug 31, 2026
CMS is proceeding with quarterly risk-adjustment audits across all 550-plus eligible Medicare Advantage contracts while its Fifth Circuit appeal of a ruling that vacated its extrapolation authority remains unresolved.
Why it matters The government is auditing Medicare Advantage plans for billing accuracy while a court fight over how those audits are calculated remains unresolved. Watch the Fifth Circuit's ruling in case 25-11293.
Deal Aug 28, 2026
AusperBio Therapeutics closed a $120 million Series C round to push its antisense drug AHB-137 into a Phase 3 program for chronic hepatitis B.
Why it matters A biotech just raised $120 million to push an experimental hepatitis B drug toward a pivotal trial, a reminder of how much capital it now takes to reach late-stage testing for a disease with no approved cure.
Record Aug 28, 2026
DaVita and Humana struck a partnership to pay DaVita for delaying or preventing dialysis among more than 10,000 Humana Medicare Advantage members with chronic kidney disease.
Why it matters DaVita, which normally gets paid every time a patient goes on dialysis, just agreed to get paid instead for keeping over 10,000 Humana Medicare Advantage members with kidney disease off dialysis altogether, a bet that managing the disease upstream can be more profitable than treating it.
Report Aug 28, 2026
The Florida Policy Institute estimated that expanding the state's homestead tax exemption through Amendment 3 would cut public hospital districts' property tax revenue by $323 million over three years, with Jackson Health System alone losing $63.7 million.
Why it matters This is a ballot-measure story with direct stakes for anyone who relies on Florida's public safety-net hospitals; a November vote could cut hundreds of millions from the property tax revenue that funds care for uninsured and low-income residents.
Funding Aug 28, 2026
CMS announced August 27, 2026 that 87 rural Georgia hospitals will split $93.3 million in Rural Health Transformation Program funding for surgical robots, telehealth, cybersecurity, and paramedic training, bringing Georgia's first-year program total to more than $218 million.
Why it matters This is new federal money flowing to rural hospitals under a $50 billion, five-year program, worth watching for whether it stabilizes struggling rural facilities or just funds equipment purchases without addressing underlying financial pressure.
Report Aug 28, 2026
STAT News found that reviewers flagged 66 percent, or $5.4 million, of the $8.1 million in Louisiana sheriff's office opioid settlement spending they could assess as inappropriate under the settlements' allowable use guidelines, while $10.7 million more went undisclosed.
Why it matters This is a public-accountability story about whether opioid settlement money, meant to fund addiction treatment, is instead going to law enforcement equipment like license-plate readers and body cameras. Watch whether other states with sheriff carve-outs face similar scrutiny.
Deal Aug 28, 2026
Sword Health agreed to buy Headspace in an all-cash deal disclosed in a Massachusetts regulatory filing, expected to close September 14, 2026.
Why it matters A virtual care company just agreed to pay up to $300 million for a mental-health app once valued near $3 billion, a steep markdown that shows how far 2021-era digital health valuations have fallen and how the sector is consolidating around fewer, broader platforms.
Enforcement Aug 28, 2026
The Villages Health System LLC agreed to pay $541.5 million to resolve False Claims Act allegations that it submitted invalid Medicare Advantage diagnosis codes from 2020 through 2024, with Humana, UnitedHealthcare and GuideWell (Florida Blue) separately returning the resulting overpayments to CMS.
Why it matters This is the largest healthcare fraud settlement in Florida history and shows federal enforcers can still recover big money from Medicare Advantage coding schemes even after a company files for bankruptcy. Watch whether other physician groups facing similar coding scrutiny follow TVH's self-disclosure playbook.
Deal Aug 28, 2026
Yardstik raised a $30 million Series B to expand continuous post-hire monitoring, including checks against the federal Medicare and Medicaid exclusion list.
Why it matters A workforce-screening startup raised $30 million to build tools that keep monitoring employees after they're hired, not just before, a category of demand fueled by employers, including healthcare organizations, that got burned by staff who went wrong post-hire.
Funding Aug 27, 2026
CMS awarded Alaska $160 million across 142 projects under the Rural Health Transformation Program, funding drone pharmacy delivery, AI stroke detection, robotic surgery, and addiction treatment infrastructure.
Why it matters It shows how a federal rural health fund is translating into concrete, often unusual tech, like prescription delivery drones, in a state where distance itself is the biggest barrier to care.
Report Aug 27, 2026
Two of three Arizona Medicaid managed care insurers reviewed could not produce reliable data showing they apply the same prior authorization rules to mental health and substance use claims as medical ones, making Arizona the third state to fail this federal audit.
Why it matters It shows that mental health parity, a law on the books for over a decade, is still not verifiably enforced in some of the biggest state Medicaid programs.
Alert · now Aug 27, 2026
Baxter International recalled two lots of 500 milliliter Viaflex saline bags shipped between July 31 and August 3, 2026 after finding fiberglass particulate matter, though it has not received any reports of patient harm.
Why it matters Contaminated IV fluid is a basic hospital supply used constantly, so a recall like this forces facilities to check inventory fast even without confirmed injuries yet.
Enforcement Aug 27, 2026
CMS has withheld the funding while more than 1,000 California hospices have lost Medicare billing privileges since early 2025 amid an escalating federal-state fraud fight.
Why it matters This shows how deep hospice fraud has spread in California and why patients caught up in it can lose access to normal medical care for months while providers get sorted out.
Record Aug 27, 2026
The fund, targeting a $125 million total, will back Series A and B device, diagnostics, and AI-enabled digital health companies addressing conditions that disproportionately affect women and children, with a final close expected in 2027.
Why it matters This is a signal of where specialist venture capital is positioning in women's and children's health technology, not a transaction that changes care delivery yet.
Report Aug 27, 2026
A June 2026 report from the Center for Healthcare Quality and Payment Reform found only 41 percent of rural hospitals still offer labor and delivery, with fewer than a third doing so in 12 states.
Why it matters This is the sector's most-cited tracker on rural maternity access, and the standby-payment fix it proposes is the policy idea to watch if Congress or CMS moves on rural OB funding.
Rule Aug 27, 2026
CMS's CY2027 Physician Fee Schedule proposed rule would let insurers keep using bundled global maternity G-codes alongside new unbundled per-visit codes, and ACOG warns that would split patients into two billing tracks.
Why it matters The choice CMS makes by early November decides whether obstetric billing gets simpler or more fragmented starting in 2027, and the comment window to weigh in closes September 14.
Enforcement Aug 27, 2026
The Justice Department said DermTech, now in bankruptcy liquidation as DTech Liquidating, billed Medicare for melanoma tests run on an unvalidated marker range from October 2022 through March 2023 without disclosing or refunding the results.
Why it matters It's a reminder that a lab's internal quality control failure, if hidden rather than disclosed, can turn into a federal fraud case even after the company is gone.
Approval Aug 27, 2026
The FDA approved daraxonrasib (Rasonque) for adults with metastatic pancreatic adenocarcinoma after one prior treatment, based on a trial showing median survival of 13 months versus 6.7 months on standard chemotherapy.
Why it matters This is the first clinical proof that directly blocking the RAS protein family, a mutation behind 90 percent of pancreatic cancers, meaningfully extends life in one of the deadliest common cancers.
Deal Aug 27, 2026
The FTC approved a final consent order letting Ascension Health Alliance close its purchase of AmSurg LLC only after Ascension agreed to divest seven ambulatory surgery centers in five metro areas to rival operators.
Why it matters This is a case study in how antitrust regulators police hospital consolidation of outpatient surgery, requiring specific market fixes rather than blocking a deal outright. Watch whether the divested centers keep prices and access stable under new owners.
Record Aug 27, 2026
Henderson Hospital in suburban Las Vegas will stop delivering babies and close its NICU around September 30, 2026, converting the space into 64 medical-surgical beds by the end of 2027.
Why it matters Watch whether other suburban, well-resourced hospitals start making the same maternity-to-medsurg trade UHS just made in Henderson, since it signals volume and geography are no longer the only variables driving closures.
Deal Aug 27, 2026
Hike Medical raised a combined $22.5 million seed and Series A round led by Saga Ventures to expand an AI platform that handles insurance prior authorization, digitizes clinical evaluations and 3D-prints custom orthotics, prosthetics and durable medical equipment.
Why it matters This funding targets a real friction point, the long wait for custom orthotic and prosthetic devices, though the company's claimed reductions in wait times and remake rates are not independently quantified.
Deal Aug 27, 2026
MiiHealth AI closed a seed funding round led by former Headspace CEO Russell Glass for its AI assistant DAINA, which calls patients before appointments and writes clinical intake notes into the electronic health record, though reported funding amounts conflict across outlets.
Why it matters The core claim, that this tool gives doctors back two hours a day, rests on a single reported clinical validation at Mayo Clinic that was not independently reviewed this run, and even the round's size is disputed between sources.
Enforcement Aug 27, 2026
Minnesota's Attorney General settled with Stevens Community Medical Center after finding it overbilled uninsured patients by up to 20.5 percent above the state-mandated discount, making roughly 3,500 patients eligible for refunds or debt cancellation totaling up to $1,412,776.25.
Why it matters It's a concrete example of a state enforcing its own uninsured-discount law against a hospital, with real refunds going to thousands of specific patients rather than just a policy change.
Report Aug 27, 2026
The same national survey found neuraxial labor analgesia use rose from 61 percent of deliveries in 2015 to 84 percent in 2025, but smaller hospitals still lean more on general anesthesia, a gap tracking with race, insurance status, and geography.
Why it matters US hospitals offering obstetric services have been cut in half over four decades even as pain-relief access improved on average, and the gap that remains tracks with race, insurance status, and geography.
Report Aug 27, 2026
A national survey of 1,180 hospitals found that just 27 percent provide a financial stipend for continuous in-house obstetric anesthesia coverage, leaving most hospitals to expect the coverage without funding it as a distinct cost center.
Why it matters The staffing cost nobody's pricing into 2027 maternity budgets is anesthesia call coverage, since only 27 percent of hospitals actually pay for it.
Report Aug 27, 2026
An HHS OIG audit of Centene, Elevance, and UnitedHealthcare Medicaid plans covering over 29 million enrollees found about 25 percent of listed maternal health providers were not actually in-network and nearly half were missing from the plans' own directories.
Why it matters A federal audit found that a quarter of the maternity providers Medicaid plans claim are in-network aren't, which matters directly if you or someone you know is trying to find a Medicaid OB provider.
Deal Aug 27, 2026
Onos Health, whose AI platform analyzes claims and clinical data to flag gaps in behavioral health care for insurers, closed a $17 million Series A led by Costanoa Ventures with CVS Health Ventures and Flare Capital Partners participating.
Why it matters This is a bet by a major insurer's venture arm that AI can catch bad behavioral health care before it becomes expensive, and the outcome metrics cited come from the company's own customers rather than an independent study.
Deal Aug 27, 2026
Oregon's attorney general approved Salem Health's merger with financially strained Santiam Hospital, under which Salem Health commits at least $61 million including $35 million in capital investment over 10 years and assumes about $22 million of Santiam's debt, with closing expected by August 31, 2026.
Why it matters This is a case of a larger nonprofit system stepping in to keep a financially strained rural hospital open, a pattern worth watching as more small community hospitals face closure pressure.
Record Aug 27, 2026
Vandalia Health will permanently close SurgiCare, a three-suite outpatient surgery center at CAMC Memorial Hospital in Charleston, West Virginia, effective August 28, 2026, citing operating room utilization and efficiency.
Why it matters This is the sixth service line Vandalia Health has closed in 2026, a pattern worth watching for what it signals about financial pressure on West Virginia's largest hospital system.
Funding Aug 25, 2026
The state distributed the first round of ARHTP funding to 138 projects in every county, covering rural workforce, mental health, and digital obstetric care initiatives.
Why it matters This is the first real money moving from a new $50 billion federal program meant to shore up rural health care access, so watch how the money actually gets spent and whether it improves care where you live.
Deal Aug 25, 2026
ArtesRx, a specialty pharmacy platform serving patients with serious mental illness and substance use disorders, grew from 3 pharmacies in one state to 16 across 15 states since 2023 before Flexpoint Ford sold it to Linden Capital Partners for an undisclosed price.
Why it matters A private-equity backed pharmacy chain serving people with serious mental illness and substance use disorders just changed owners, a sign investors see steady demand in complex-medication management for vulnerable populations.
Deal Aug 25, 2026
Union Community Care's board approved a merger with three-site Berks Community Health Center by August 24, 2026, extending the Lancaster County nonprofit's federally qualified health center network into a fourth Pennsylvania county pending regulatory approval.
Why it matters Two Pennsylvania nonprofit clinics serving low-income patients are combining to share resources and administrative capacity, a common survival strategy for small community health centers facing rising costs.
Deal Aug 25, 2026
Cityblock Health signed an all-stock deal to acquire rural Medicare Advantage company Homeward Health and closed a $116 million Series E led by General Catalyst, combining to serve nearly 250,000 Medicaid, dual-eligible and Medicare Advantage members.
Why it matters Two value-based care companies are combining to chase government health spending across both urban Medicaid and rural Medicare populations, a bet that scale and capability, not cuts, is the way to manage cost pressure in government programs.
Deal Aug 25, 2026
Concentra completed its acquisition of four independently owned Minnesota Occupational Health medical centers in the Twin Cities on August 17, 2026, doubling its state footprint to eight centers since entering Minnesota in 2018.
Why it matters A national occupational health chain absorbed four independent Twin Cities clinics, continuing steady consolidation in workplace injury and employer health services.
Enforcement Aug 25, 2026
The center is a prosecutor-led, multi-agency data-analytics team under DOJ's National Fraud Enforcement Division, which has grown to about 500 attorneys and staff since its April 2026 creation.
Why it matters This signals faster, data-driven detection of suspicious healthcare billing before losses pile up, so providers should expect scrutiny to move earlier in the billing cycle rather than after the fact.
Report Aug 25, 2026
OASAS's new report details how New York has allocated its multi-billion-dollar opioid litigation settlement funds as oversight of settlement spending remains inconsistent nationally.
Why it matters This shows how much of a multi-year opioid settlement windfall is actually reaching communities versus sitting unspent, a question watchdogs are raising in multiple states.
Enforcement Aug 25, 2026
Stephanie Mobley was sentenced to 17 months to 10 years in prison and ordered to pay $1.76 million in restitution for billing Medicaid for caregivers who never existed at ComfortZone Home Health Care LLC.
Why it matters This is a reminder that Medicaid home care fraud enforcement is active and can result in real prison time, not just fines.
Deal Aug 25, 2026
R1 agreed to acquire Humata Health, whose AI prior-authorization technology drives up to a 96 percent first-pass approval rate, folding it into R1's Phare OS platform with a close expected by the end of the third quarter of 2026.
Why it matters A major hospital revenue-cycle company is betting AI can meaningfully cut the friction and delay of prior authorization, a process patients and providers have long complained about.
Deal Aug 25, 2026
Radial, a General Catalyst-backed neuromodulation psychiatry platform, acquired TMS Health Partners, the MSO behind 21-clinic Spravato provider Mindful Health Solutions, expanding its combined network to 27 clinics with more than 100 clinicians.
Why it matters A psychiatry platform focused on TMS, Spravato and ketamine treatments just roughly doubled its footprint, reflecting investor appetite for scaling access to newer depression and treatment-resistant mental illness therapies.
Deal Aug 24, 2026
Bon Secours Mercy Health signed an asset purchase agreement to acquire the 97-bed Fauquier Health hospital in Warrenton, Virginia from LifePoint Health, converting it from for-profit to nonprofit in a deal expected to close this fall.
Why it matters This is another example of a financially stretched or non-core hospital moving from a private equity-backed chain to a larger nonprofit system; watch how the conversion affects local services and pricing.
Rule Aug 24, 2026
CMS's CY2027 ESRD PPS proposed rule would raise the per treatment dialysis base rate to $299.55, of which $15.96 reflects folding phosphate binder drug costs into the bundled payment for the first time, with the public comment period closing August 24, 2026.
Why it matters This determines how much Medicare pays dialysis facilities per treatment next year, and a chunk of the increase is really a drug cost accounting shift rather than new money. Watch whether the $15.96 phosphate binder add on survives to the final rule expected around late October or November.
Rule Aug 24, 2026
CMS's CY2027 Physician Fee Schedule proposed rule would require RPM and RTM monitoring staff to be direct employees of the billing practice, add a face to face initiation visit requirement, and cut several code payments, with comments due September 14, 2026.
Why it matters This could reshape how conditions like chronic kidney disease are remotely monitored, since programs built on outsourced monitoring vendors may have to restructure or shut down. Watch whether the direct employment mandate survives to the final rule.
Earnings Aug 24, 2026
DaVita reported that its Integrated Kidney Care division generated $40 million in adjusted operating income in Q2 2026, up from a $19 million loss in Q1, while managing about $5.8 billion in annualized risk-based medical spend across roughly 64,900 patients as of June 30, 2026.
Why it matters The country's largest dialysis chain is turning a profit on managing kidney patients under risk based contracts, meaning it is now competing more directly with outside companies for the same value based kidney care deals.
Report Aug 24, 2026
On its Q2 2026 earnings call, DaVita said full year treatment volume growth is tracking to the high end of guidance mainly because of lower patient mortality after moving phosphate binders into the Medicare payment bundle, even as revenue per treatment fell about $2 sequentially.
Why it matters A dialysis chain is crediting a drug bundling change with keeping more patients alive and in treatment, which is a nearer term volume driver than the open question of whether GLP-1 drugs will eventually shrink the dialysis population.
Rule Aug 24, 2026
A federal appeals court upheld the core of Medicare's drug price negotiation program against Teva's challenge, rejecting its constitutional claims while reviving a narrower fight over how generics count against a brand drug's eligibility.
Why it matters The ruling keeps the second round of Medicare's Inflation Reduction Act drug price negotiations intact while manufacturers keep fighting the program in multiple circuits.
Record Aug 24, 2026
President Trump will nominate Dr. Heidi Overton, a White House Domestic Policy Council deputy director, to lead the FDA, the agency that decides which drugs, vaccines and devices reach the market and when.
Why it matters The FDA has been without a permanent commissioner since May, and Overton is the third physician approached for the job after two others declined.
Deal Aug 24, 2026
Genentech agreed to pay Hanmi Pharmaceutical 190 million dollars upfront and up to 2.3 billion dollars total in milestones and royalties to license HM17321, an obesity drug that has not yet entered Phase 2 trials.
Why it matters This is a record-setting bet on an obesity drug candidate that has not started Phase 2 testing; watch whether it can actually avoid the muscle-loss side effect drawing scrutiny to current GLP-1 drugs.
Enforcement Aug 24, 2026
Federal prosecutors charged Rodney Greer in a four-count indictment, alleging he called about 261 pharmacies roughly 3,329 times using real physicians' identities to fraudulently authorize GLP-1 and other prescriptions for paying customers.
Why it matters A case that exposes a pharmacy-verification gap driving GLP-1 fraud, as demand and prices for the weight-loss drugs climb.
Record Aug 24, 2026
Mount Carmel Health System permanently closed its freestanding Franklinton emergency department in Columbus, Ohio on August 22, 2026 and opened a walk-in care center without emergency-level acuity in its place two days later.
Why it matters A hospital permanently closing an ED in a low-income neighborhood signals ongoing consolidation of emergency capacity into fewer facilities, worth watching for similar closures elsewhere.
Report Aug 24, 2026
The American Society of Nephrology's first look at the AY2026 fellowship Match found only 333 candidates matched, down 8 percent year over year, with just 89 of 186 training tracks, or 48 percent, filling completely and 66 percent of the 501 offered positions claimed.
Why it matters The pipeline of new nephrologists is shrinking even as positions offered rose slightly, meaning the competition for existing kidney specialists across practices, MSOs, and value based care companies will keep intensifying.
Enforcement Aug 24, 2026
Three Buffalo-area skilled nursing facilities agreed to pay $9 million over two separate schemes, billing for rehab therapy that was not medically necessary or never provided, and submitting false data to inflate Medicaid reimbursement rates.
Why it matters A rare double settlement resolving two distinct fraud schemes at once, phantom therapy billing and inflated Medicaid rate data, across three Erie County facilities.
Rule Aug 24, 2026
Oregon regulators finalized 2027 health insurance rates with a 21.6 percent average increase in the individual market and 15.5 percent in small group, blaming the loss of enhanced ACA subsidies and rising costs.
Why it matters One of the first states to finalize 2027 rates, Oregon shows what premium season looks like as enhanced federal ACA subsidies lapse.
Report Aug 24, 2026
Premier Medical Distribution LLC filed for Chapter 11 bankruptcy protection on August 21, 2026 with 10 million to 50 million dollars in liabilities against 1 million to 10 million dollars in assets, and the filing states unsecured creditors will receive nothing.
Why it matters This shows how thin margins have gotten for mid-sized medical-supply distributors squeezed between manufacturer pricing and health-system purchasing power, and it could disrupt supply relationships for facilities that used this vendor.
Report Aug 24, 2026
KFF analyzed the first federal data set that lets patients compare prior authorization denial rates insurer by insurer, covering 14 major insurers and roughly 71 million enrollees, and found denial rates ranging from 2 percent to 25 percent.
Why it matters The first federal data set that lets patients compare prior authorization denial rates insurer by insurer, forced into the open by a 2024 CMS transparency rule.
Deal Aug 24, 2026
SuperiorMed Holdings Limited, a Cayman Islands holding company for a Dubai-based longevity medicine and health-tourism platform, signed a merger agreement with Nasdaq-listed Starry Sea Acquisition Corp without disclosing a deal valuation.
Why it matters A Dubai-based health-tourism and longevity-medicine company going public in the U.S. through a SPAC signals investor interest in cross-border wellness business models, though the deal still needs shareholder approval and no valuation was disclosed.
Deal Aug 23, 2026
BioMarin will pay $275 million upfront plus up to $215 million in milestones for Alesta's early-stage oral candidate ALE1, a potential first oral therapy for the rare bone disease hypophosphatasia.
Why it matters This is a bet on a still-unproven pill years from approval; watch Phase 1/2a data before assuming hypophosphatasia patients will have an oral option anytime soon.
Alert · now Aug 23, 2026
FDA classified its highest-risk recall for more than 165,000 Enroute Transcarotid Neuroprotection System units after reports that the device's arterial sheath tip can separate inside a patient's artery during the procedure meant to prevent stroke.
Why it matters This is FDA's most serious recall category for a device meant to prevent stroke during carotid artery procedures, worth watching for how many of the 165,000 distributed units are still in active use.
Record Aug 23, 2026
Glenview Capital CEO Larry Robbins departed CVS's board effective August 13, 2026, two years after his fund's roughly $700 million stake won him a seat, and will be replaced in November by JPMorgan's chief data and analytics officer Teresa Heitsenrether.
Why it matters This is a signal on how CVS's activist-driven shakeup, which already replaced the CEO and launched a $2 billion cost-cutting plan, may be entering a new phase; watch whether Glenview keeps pushing or has moved on.
Enforcement Aug 23, 2026
Federal prosecutors unsealed a nine-count indictment alleging the men used GPS spoofing to fake non-emergency medical transportation rides, paid patient kickbacks, laundered proceeds through a sham charity, and carried out an armed home invasion against a rival fraud ring.
Why it matters This shows Medicaid fraud enforcement now reaching into RICO and violent-crime territory, not just billing audits, a sign prosecutors are treating organized fraud rings more aggressively.
Deadline Aug 23, 2026
Commissioners are set to adopt a 23.7-cent no-new-revenue tax rate and FY2027 budget for University Medical Center of El Paso on August 24 even as the CEO projects $277 million in uninsured patient care costs next year.
Why it matters This is a local funding story, not a federal policy shift; watch whether UMC has to return for a tax increase if uninsured costs keep rising.
Report Aug 23, 2026
Fitch Ratings found the median operating margin for 222 rated nonprofit hospitals rose to 1.5 percent in 2025 from 1.1 percent in 2024, but warned Medicaid cuts starting in 2027 could end the recovery.
Why it matters Hospital finances just had their best year in decades, but Fitch itself says 2025 could be the peak before Medicaid funding cuts squeeze providers starting in 2027; watch 2026 margin trends as an early signal.
Rule Aug 23, 2026
HHS posted a Request for Information asking whether the Routine, Risk-Based, and Shared Clinical Decision-Making vaccine categories should change, with comments due September 20, 2026.
Why it matters The category a vaccine sits in determines whether your insurer must cover it free; watch whether HHS narrows the Routine label since that could shift shots from free to cost-sharing.
Deadline Aug 23, 2026
HRSA's revived 340B Rebate Model Pilot Program requires manufacturers of drugs in the Medicare Drug Price Negotiation Program to submit participation plans by August 24, with approved switches to after-sale rebates taking effect January 1, 2027.
Why it matters This changes how safety-net hospitals get paid for discounted drugs, from an upfront price cut to a rebate paid after the fact, which can strain their cash flow.
Record Aug 23, 2026
The insurer will wind down all Medicare Advantage, Medicaid, and commercial coverage by the end of 2026 after talks to hand its Medicare Advantage business to a national insurer fell through.
Why it matters If you're a Providence Health Plan member, you'll need to find new coverage before the end of 2026; watch for your enrollment window and any state guidance on your options.
Enforcement Aug 23, 2026
Steven Richardson was sentenced to two years in prison after his companies paid telemarketers to generate leads and doctors to sign unexamined orders for durable medical equipment like back and knee braces from 2016 to 2023, with $15.7 million subject to forfeiture.
Why it matters This is a real-world example of the telemarketing-to-DME fraud pattern regulators have been warning is still outrunning Medicare's safeguards, worth watching for further prosecutions of the same playbook.
Deal Aug 23, 2026
Universal Health Services paid $5.25 per share in debt-financed cash to acquire the virtual therapy platform, aiming to link it with its inpatient and outpatient behavioral health facilities.
Why it matters A hospital operator now owns a virtual therapy network reaching 200 million-plus Americans; watch whether UHS actually integrates referrals between virtual and in-person care or keeps Talkspace as a standalone unit.
Deal Aug 21, 2026
The round, led by InnovaHealth Partners, follows what the company calls a successful commercial relaunch of Cerene, its cryotherapy device for heavy menstrual bleeding.
Why it matters A women's health device that struggled commercially has found its footing enough to raise a fresh round, worth watching for whether non-surgical alternatives to endometrial ablation are gaining real traction.
Deal Aug 21, 2026
CHG did not disclose the purchase price for KREWE, a firm founded in 2022 that provides locum tenens staffing and coverage solutions for certified registered nurse anesthetists.
Why it matters A major staffing company buying a firm dedicated to anesthesia providers is a direct response to how hard it has become for hospitals and surgery centers to keep that specialty staffed.
Alert · now Aug 21, 2026
The agencies raised Medusa's confirmed victim count to more than 500 organizations and added HHS as a co-sealing agency for the first time to detail healthcare-sector impact.
Why it matters This is a reminder that ransomware groups continue to target hospitals specifically; watch whether your own health system or provider has applied the recommended patching and MFA controls.
Deadline Aug 21, 2026
The FDA's PDUFA target action date on Capricor Therapeutics' deramiocel arrives August 22, three weeks after the agency's advisory committee voted 9 to 3 that the evidence did not support approval.
Why it matters Watch whether the FDA follows its advisory committee's negative vote; a rejection would delay the first approved treatment for a fatal complication of Duchenne muscular dystrophy.
Deal Aug 21, 2026
The Sunnyvale startup is developing a single-procedure platform that combines ultrasound imaging with tissue-selective therapy to treat the prostate through the urethra.
Why it matters A well-funded new device platform for a common condition is being built by a startup you'll likely not interact with directly yet, but watch whether it reaches later-stage trials and eventual market entry, since a major device maker rarely backs a company without confidence in the science.
Report Aug 21, 2026
HHS's inspector general published a white paper flagging that fraud schemes exploiting supplier enrollment, physician orders, and beneficiary ID numbers continue to outpace CMS's efforts to stop them, even as CMS stands up a new Fraud Defense Operations Center.
Why it matters This is a reminder that a chunk of Medicare spending on wheelchairs, braces, and similar equipment still leaks to fraud; watch whether CMS's new fraud center actually slows the schemes down.
Deadline Aug 21, 2026
Pennsylvania's public comment period on proposed 2027 individual and small-group health insurance rates, including a 40.9 percent increase requested by Ambetter Health, closes August 22.
Why it matters These filings hint at what individual and small-group premiums could look like in Pennsylvania next year; watch the state's final decisions this fall.
Deal Aug 21, 2026
Rockbridge Growth Equity is exiting its stake in the waiting-room health education and pharma advertising platform on undisclosed terms, with the deal expected to close in the third quarter of 2026.
Why it matters A private equity firm buying majority control of a point-of-care advertising and education platform is a reminder of how much healthcare marketing infrastructure sits inside waiting rooms and exam rooms, largely invisible to patients.
Alert · now Aug 21, 2026
The FDA classified the July 29 recall of GreenWise Organic frozen blueberries and mixed berries as its most serious risk category after confirming Escherichia coli O145:H28 contamination tied to 12 illnesses and 4 hospitalizations in Florida and Georgia.
Why it matters If you bought GreenWise Organic frozen blueberries or mixed berries from Publix, discard them or return them for a refund; watch for updates if the illness count grows.
Rule Aug 20, 2026
CMS published a new Privacy Act System of Records Notice for its Nurses for Nursing Homes Program, the records backend for an $80 million initiative paying nurses' loan repayment and stipends to work in nursing homes, with public comment open through September 21, 2026.
Why it matters This is the administrative paperwork behind an $80 million push to draw nurses into nursing home jobs, worth watching if you want a say in how CMS handles nurses' personal data under the program.
Rule Aug 20, 2026
HRSA republished its 340B Rebate Model Pilot Program in the Federal Register, giving drug manufacturers until August 24, 2026 to opt in ahead of a January 1, 2027 launch, with no exemption this time for critical access or children's hospitals.
Why it matters This revives a rebate scheme a federal court already blocked once, and this version removes exemptions that protected the most financially vulnerable hospitals, so watch whether Congress's SUSTAIN 340B Act overtakes it before launch.
Enforcement Aug 20, 2026
Federal and Illinois prosecutors allege Foot & Ankle Health Care Center and related entities kept billing Medicaid and Medicare for podiatry services performed by Dr. Vadim Goshko after Illinois Medicaid had already terminated him, by listing other physicians as the treating provider.
Why it matters This case shows how a terminated provider allegedly kept billing government programs by hiding behind other physicians' names, and it started from a whistleblower tip, so watch for the case's outcome under the False Claims Act.
Enforcement Aug 20, 2026
David Morens pleaded guilty August 18, 2026 to conspiring to evade FOIA requests and violate federal records law regarding COVID-19 research grant communications, and faces sentencing November 12, 2026.
Why it matters This is a criminal accountability case over how a top federal science official handled records tied to pandemic origins research, not a new rule, so watch the November 12 sentencing for how seriously courts treat records violations.
Report Aug 20, 2026
New CMS data shows nearly 1.4 million No Surprises Act arbitration disputes were initiated in the second half of 2025 alone, with providers winning about 85 percent of decided cases and 87 percent of awards exceeding insurers' benchmark rate.
Why it matters This shows the arbitration system meant to protect patients from surprise bills is increasingly a provider-favorable revenue fight behind the scenes, with disputes still growing 16 percent, so watch whether Congress or courts move to recalibrate the benchmark rate.
Funding Aug 20, 2026
CMS is distributing $90 million of its Rural Health Transformation Program allocation to 82 rural hospitals and clinics in South Dakota, though 144 organizations applied for a combined $336 million.
Why it matters This funding round shows how a $50 billion federal rural health fund is starting to reach providers, but most applicants in this state went unfunded, so watch how other states ration their own allocations this fall.
Deal Aug 19, 2026
The dental support organization behind Affordable Dentures & Implants completed an August 13, 2026 recapitalization that cut its debt by roughly 65 percent and handed ownership to lenders led by Blackstone and KKR, effectively wiping out Harvest Partners' 2021 equity stake.
Why it matters This shows private credit lenders increasingly taking ownership of healthcare roll-ups when leveraged buyouts sour, converting paper losses into real control changes. Watch whether other heavily levered PE-backed dental and physician groups follow the same path.
Rule Aug 19, 2026
CMS's CY2027 Home Health PPS proposed rule pairs a net 2.4 percent, $420 million payment increase with a temporary 3.0 percent clawback of PDGM overpayments and $82 million in annual program-integrity savings, with comments due August 31.
Why it matters This is the annual Medicare payment update for home health agencies, and it keeps clawing back billions in prior overpayments while raising base rates; watch the August 31 comment deadline and the final rule this fall.
Rule · now Aug 19, 2026
CMS finalized a rule barring federal Medicaid and CHIP dollars from paying for puberty blockers, hormones, or surgery for gender dysphoria in minors starting October 13, with a six-month taper for patients already on hormone therapy.
Why it matters This cuts off federal funding for a category of care in roughly 17 states that currently cover it, though states can still pay with state-only dollars; watch for expected legal challenges.
Deal Aug 19, 2026
The deal gives Curium global rights to develop and commercialize ABS-011, an investigational gallium-68 PET tracer targeting HER2, a marker found in some breast and gastric cancers, with no purchase price disclosed.
Why it matters A global radiopharmaceutical maker is expanding its oncology imaging pipeline with an investigational HER2-targeted PET tracer, part of a broader wave of radiopharmaceutical dealmaking this month. Watch for clinical trial progress on ABS-011 and further consolidation in the radiopharma space.
Rule Aug 19, 2026
DEA issued a two-year temporary order placing O-desmethyltramadol, a potent opioid metabolite of tramadol increasingly sold on its own, into Schedule I effective August 12, 2026, despite only 148 documented law enforcement encounters since 2011.
Why it matters This restricts a little-encountered but potent opioid substance for two years while DEA considers permanent scheduling; watch for harm-reduction pushback on the sparse data behind the imminent-threat designation.
Deal Aug 19, 2026
The merged organization will treat about 3 million patients annually across 12 states, with DermCare's Jeffrey Schillinger becoming executive chair and USDP's Paul Singh becoming president and CEO of the combined company.
Why it matters Two of the largest dermatology practice platforms are merging into a single group treating roughly 3 million patients a year, continuing the trend of physician-specialty consolidation. Watch whether the combined scale changes payer negotiating leverage or referral patterns in dermatology markets.
Deal Aug 19, 2026
DocGo will pay Hicuity's Series F preferred stockholder in DocGo stock plus a market-cap-linked earnout and assume approximately $52 million of Hicuity's term loans, while Perceptive Credit separately commits up to $50 million in new financing to DocGo.
Why it matters A mobile health and ambulance operator is expanding into tele-ICU and virtual nursing, another sign that ambulance and urgent-care companies are building toward integrated virtual-to-in-home care platforms. Watch whether DocGo can integrate Hicuity's hospital and health-system contracts profitably.
Rule Aug 19, 2026
The full Fifth Circuit ruled en banc that HHS, Labor, and Treasury violated the No Surprises Act by letting insurers use ghost rates and exclude bonus payments when calculating the qualifying payment amount that anchors out-of-network arbitration.
Why it matters This forces federal agencies to rewrite the pricing benchmark behind surprise medical bill arbitration, though the current formula stays in place until a replacement is issued.
Report Aug 19, 2026
HHS's Inspector General reviewed 100 denied prior-authorization requests from Health Share of Oregon and found 21 violated federal or state rules, extrapolating to roughly 5,677 improper denials in 2023.
Why it matters This shows how little routine scrutiny Medicaid managed-care denials get nationwide; watch whether other coordinated care organizations face similar audits.
Funding Aug 19, 2026
HRSA awarded $102 million in New Access Points grants to 158 community health centers to open 415 new sites, extending primary care to nearly 1 million more Americans in the program's largest expansion since 2019.
Why it matters This expands access to primary care through the federal health center program's biggest growth since 2019, reaching nearly 1 million more people; watch for the new sites standing up over the coming months.
Deal Aug 19, 2026
The private equity firm will pay $7.40 per share in cash, a roughly 34 percent premium to Weave's unaffected price, in a deal the board approved unanimously and expects to close in the fourth quarter of 2026.
Why it matters A private equity firm is paying a 34 percent premium to take a healthcare patient-engagement software vendor private, signaling continued PE appetite for healthcare-adjacent software with recurring revenue. Watch for how the ownership change affects product pricing and roadmap for practices that rely on Weave.
Deal Aug 18, 2026
The unit, which generated 645 million dollars in 2025 revenue making antimicrobial susceptibility testing and culture media products, now operates independently under chief executive Dirk Bontridder and will launch under a new brand later in 2026.
Why it matters A diagnostics maker's antimicrobial-resistance testing unit changing owners does not change how tests are run, but it is worth watching whether new ownership shifts pricing or investment in the space.
Rule Aug 18, 2026
Public comments closed August 17 on CMS's proposal to make the Medicare Drug Price Negotiation Program permanent, aggregate reformulated drugs with their originals for pricing, and end the small-biotech exception after 2028, with CMS aiming to finalize the rule this fall.
Why it matters A rule meant to stop drugmakers from dodging Medicare's drug price negotiation program through reformulation is headed toward finalization this fall.
Alert · now Aug 18, 2026
CDC has tracked more than 24,000 domestically acquired cyclosporiasis illnesses since May 1 across at least 17 states, with Michigan alone logging nearly 14,000 cases and both US deaths, after FDA traced the outbreak to recalled Taylor Farms de Mexico iceberg lettuce.
Why it matters A lettuce-linked parasite outbreak has become the largest cyclosporiasis event in US surveillance history, concentrated heavily in Michigan, with two deaths reported so far.
Earnings Aug 18, 2026
Second quarter revenue fell to 55.2 million dollars with a 7.5 million dollar GAAP net loss, while adjusted EBITDA of 14.6 million dollars topped guidance and the company raised its adjusted EPS outlook, pointing to its new Turbo AI platform as a stabilizing factor.
Why it matters A healthcare data analytics company beating its own profit guidance while revenue keeps shrinking shows the difference between cost discipline and growth; watch whether the new Turbo AI product actually reverses the revenue decline.
Rule Aug 18, 2026
U.S. District Judge Amit Mehta was assigned August 17 to a proposed class action five federal employees filed against OPM director Scott Kupor challenging a directive that excluded gender-affirming care from FEHB and PSHB plans starting January 1, 2026.
Why it matters A federal court will now decide whether excluding gender-affirming care from federal employee health plans violates civil rights law, a case that could affect tens of thousands of transgender workers and retirees.
Rule Aug 18, 2026
A final rule effective August 24 strips health care fraud jurisdiction from DOJ's Criminal Division and hands it to the new National Fraud Enforcement Division, which can also prosecute any other crime it uncovers and convene special grand juries nationwide.
Why it matters A new DOJ unit built specifically to chase health care fraud is now law, effective August 24, and it can pursue any crime it finds along the way, not just fraud.
Deal Aug 18, 2026
Under an all-stock deal, pre-merger Fulcrum shareholders will hold about 5 percent of the combined company while Slate's investors hold roughly 95 percent, with Slate simultaneously closing a 245 million dollar private placement to fund migraine drug SLTE-1009 through 2029.
Why it matters A struggling biotech merging with a private company to survive is a sign of how thin the margin is in clinical trials; watch whether Slate's migraine drug clears trials that Fulcrum's own drug failed.
Rule Aug 18, 2026
OPTN's emergency policy, effective August 17, cuts HIV testing from 28 days to 7 and West Nile virus testing from 14 days to 7 for all living kidney and liver donors, across all 17 required serology and crossmatch tests.
Why it matters Living kidney and liver donors will now be tested for HIV and West Nile virus much closer to their surgery date, closing a gap that could let an infection go undetected.
Deal Aug 18, 2026
PTC's winning bid of up to 211 million dollars beat Astellas Pharma's original 25 million dollar stalking-horse offer and TerSera Therapeutics after Sangamo filed Chapter 11 in June 2026 following the loss of its Pfizer partnership.
Why it matters A four-times bidding war for a bankrupt biotech's only drug shows how much value gene therapies for rare diseases still command even in distress; watch PTC's FDA filing timeline this quarter.
Deal Aug 18, 2026
Teledyne will pay 18.90 dollars per share in an all-cash deal valued at approximately 1.1 billion dollars for the maker of X-ray detectors used in CT scanners, with both boards approving unanimously and closing expected in early 2027.
Why it matters An 88 percent premium for a company that makes parts inside a huge share of the world's CT scanners signals real appetite for imaging-hardware consolidation; watch whether the deal clears regulatory review given Varex's market position.
Rule Aug 17, 2026
CMS rejected Arkansas's request to renew its 13 year old ARHOME Medicaid expansion waiver under a new prospective budget neutrality policy, putting coverage for roughly 200,000 low income residents at risk when the waiver expires December 31, 2026.
Why it matters This is an early test of a new federal rule that could let Medicaid officials pull back coverage in other expansion states, not just Arkansas. Watch whether Arkansas gets its requested two year bridge or loses coverage outright at year end.
Rule · now Aug 17, 2026
CMS and FDA jointly proposed the RAPID Coverage Pathway, under which eligible Breakthrough-designated devices could get a final national Medicare coverage determination roughly 60 to 90 days after FDA authorization instead of the multi-year gap that exists today, with comments due October 13, 2026.
Why it matters This could meaningfully shorten how long it takes new medical technology to reach Medicare patients, though its real world impact is untested since no device has gone through it yet.
Rule Aug 17, 2026
The DEA proposed reclassifying suvorexant, lemborexant, and daridorexant from Schedule IV to Schedule V after an HHS review found low abuse and dependence potential, with public comment open through September 10, 2026.
Why it matters Easier scheduling could make these newer insomnia drugs simpler to prescribe and fill, an incremental access improvement to watch through the comment period ending September 10.
Alert · now Aug 17, 2026
A federal verification committee is assessing whether ongoing transmission chains, including a Utah outbreak running since June 2025, mean the US has lost the elimination status it has held since 2000, as national case counts reach 2,465, the highest since 1991.
Why it matters Losing elimination status would be a symbolic and public health setback showing sustained domestic measles spread; watch for the WHO regional body's determination in November.
Rule Aug 17, 2026
Three Republican and three Democratic senators introduced the SUSTAIN 340B Act on August 5, 2026, which would codify contract pharmacy use, create a duplicate discount clearinghouse, require patient financial assistance policies, and give HHS new audit and removal authority over covered entities.
Why it matters This is a rare bipartisan attempt to settle the years long fight between drugmakers and hospitals over 340B contract pharmacies; watch whether it gains traction as a standalone bill or gets folded into other legislation.
Enforcement Aug 17, 2026
Maryam Qayum was sentenced to 150 months in federal prison for running a cash-only Kingwood, Texas clinic that prosecutors say issued prescriptions for more than 3 million opioid pills to street-level dealers from 2022 to 2025.
Why it matters This is another example of DOJ and DEA prioritizing pill mill prosecutions; watch for continued enforcement against cash only prescribing operations nationally.
Enforcement Aug 16, 2026
Eldar Zarbavel of Pepper Pike, Ohio pleaded guilty August 14, 2026 to money laundering for laundering about $3.4 million in proceeds from Operation Gold Rush, a $1.42 billion Medicare fraud scheme run through a Florida durable medical equipment company, and faces up to 20 years at sentencing December 16, 2026.
Why it matters This is an update in the largest health care fraud case DOJ has ever prosecuted, a reminder that federal prosecutors are actively working through a 35-person Medicare fraud network with more guilty pleas likely.
Alert · now Aug 16, 2026
HHS Secretary Robert F. Kennedy Jr. declared a public health emergency for six Washington counties on August 7, 2026, and CMS followed August 10 with Medicare and Medicaid flexibilities retroactive to August 1 that speed prescription refills, ease prior authorization and allow alternative care settings, amid wildfires that have burned more than 425,000 acres and destroyed over 800 structures.
Why it matters Washington wildfires triggered a federal public health emergency, which unlocks Medicare and Medicaid flexibilities that let displaced patients keep getting care and medications without normal red tape.
Enforcement Aug 16, 2026
The Justice Department's National Fraud Enforcement Division issued an August 13, 2026 memo naming home health, hospice, telemedicine and Medicare/Medicaid billing schemes top targets and said it will staff up to roughly 500 attorneys and support staff by August 24, 2026.
Why it matters This signals the federal government is putting more investigators and money behind healthcare fraud cases, so expect more audits, subpoenas and prosecutions touching home health, hospice and telehealth billing over the next two years.
Rule · now Aug 16, 2026
FDA finalized a rule moving in situ hybridization test systems used alongside approved oncology drugs from Class III premarket approval to Class II 510(k) clearance, publishing August 17, 2026 and taking effect September 16, 2026, while also proposing related device-classification changes with comments due October 16, 2026.
Why it matters This makes it cheaper and faster for diagnostic makers to bring cancer companion tests to market, which could speed availability of tests that determine which patients qualify for targeted cancer drugs.
Report Aug 16, 2026
HHS released a report August 13, 2026 finding more than 225 hospitals and health systems filed close to $120 million in claims for pediatric gender-transition care using diagnosis codes, including a generic endocrine-disorder code that did not reference gender dysphoria, and referred providers to the Justice Department and its own Inspector General.
Why it matters A federal report accuses hundreds of hospitals of miscoding pediatric gender-care claims and has now been referred for potential investigation, though a referral is not a finding of guilt and the named hospitals have not yet responded in detail.
Deal Aug 15, 2026
American Healthcare REIT agreed to acquire eight Kensington Senior Living communities totaling 745 units across California, Maryland, New York and Virginia for approximately 873 million dollars, including about 56.46 million dollars in assumed debt.
Why it matters This is one of the largest senior living deals of the year so far, a sign of how much investor money is flowing back into senior housing real estate.
Enforcement Aug 15, 2026
Renat Abramov, a former Brooklyn bank branch manager, was sentenced to 18 months in prison for laundering more than 8 million dollars for a Russia based criminal organization that used shell durable medical equipment companies to bill Medicare and private insurers.
Why it matters A bank employee helped a Russia based crime ring launder more than 8 million dollars in stolen Medicare money, showing how fraud proceeds move through ordinary financial institutions.
Deal Aug 15, 2026
Cardinal Health signed two definitive agreements to acquire AdaptHealth Corp's Diabetes Health mail order business for 235 million dollars and Strive Medical, a urology and wound care supply company, for an implied 125 million dollars, together about 360 million dollars in cash.
Why it matters This shows a major drug distributor betting that shipping diabetes and urology supplies straight to patients' homes is a growing business worth paying for.
Report Aug 15, 2026
KFF's analysis of newly mandatory CMS disclosures found 2025 standard-request denial rates averaging 12 percent in Medicare Advantage, 14 percent in Medicaid managed care and 18 percent in ACA marketplace plans, with 67 percent of appealed Medicare Advantage denials overturned.
Why it matters This is the first time you can see how often insurers deny care requests and how often those denials are wrong on appeal, since most denied patients never actually file that appeal.
Report Aug 15, 2026
The International Foundation of Employee Benefit Plans found employers expect a median 10 percent increase in health plan costs next year, with GLP-1 weight loss and diabetes drugs cited by 67 percent as the top specialty drug cost driver.
Why it matters This is the clearest early signal of how much your health premiums or plan costs could rise next year, and weight loss drugs are now the single biggest reason costs are climbing.
Rule Aug 15, 2026
The en banc Fifth Circuit held HHS unlawfully let insurers pad the qualifying payment amount with rates for services never delivered while excluding real bonus pay, vacating those provisions and ordering a new methodology.
Why it matters A federal appeals court just said the benchmark used to settle millions of surprise medical bills was rigged in insurers' favor, which could raise what insurers pay doctors and hospitals for out of network care.
Rule Aug 15, 2026
CMS's proposed rule implementing the 2025 reconciliation law would cap state directed Medicaid managed care payments to hospitals at 100 to 110 percent of Medicare rates, with KFF estimating California, Illinois and Kentucky face the largest losses.
Why it matters A proposed federal rule could cut 60 billion dollars in Medicaid payments that states currently direct to hospitals, with California facing the single largest loss at 7.4 billion dollars.
Enforcement Aug 15, 2026
A Franklin County grand jury indicted six Ohio Medicaid providers, including behavioral health and home care operators, accused of billing a combined 558,383 dollars for services never delivered, marking the state's fourth fraud indictment round since early summer.
Why it matters Ohio charged six more Medicaid providers with stealing over half a million dollars combined by billing for behavioral health and home care services that were never actually provided.
Deadline Aug 15, 2026
Texas regulators confirmed that Baylor Scott & White Health Plan and sister insurer FirstCare will stop accepting Texas Medicaid, STAR and CHIP claims after August 31, 2026, with contracts ending September 1 and 321 jobs cut as the companies also exit ACA marketplace plans.
Why it matters If you or someone you know is on Texas Medicaid, STAR, CHIP or an ACA marketplace plan through Baylor Scott & White or FirstCare, you will need to find new coverage before September 1, 2026.
Report Aug 13, 2026
The American College of Nurse-Midwives' Midwifery Workforce Study finds the U.S. is short 8,200 certified nurse-midwives against the World Health Organization's minimum staffing benchmark, with 56 percent of counties having none.
Why it matters Staffing, not bed capacity, is now the binding constraint on keeping a labor and delivery unit open, and this is the number that quantifies it.
Rule Aug 13, 2026
CMS's proposed CY2027 Medicare Physician Fee Schedule rule would let payers run legacy bundled global maternity codes alongside 15 new unbundled G-codes, with public comments on CMS-1848-P closing September 14, 2026.
Why it matters The rule decides whether OB billing splits into two competing systems in 2027; watch whether CMS finalizes one code set or lets the dual system stand once comments close September 14.
Enforcement Aug 13, 2026
The U.S. Attorney's Office for the District of Colorado announced August 10, 2026 that the federal government intervened in a False Claims Act whistleblower suit alleging Front Range Urgent Care, Comfort Care Family Practice, QwikCareMD and two individuals billed Medicare and Tricare for nearly a decade under one physician's provider number for services he didn't provide or supervise.
Why it matters This is an allegation, not a finding of liability, but government intervention signals prosecutors found the whistleblower's claims credible enough to take over the case.
Report Aug 13, 2026
As of March 2026, 26 states and Washington, D.C. reimburse doula services through Medicaid, but a peer-reviewed study found fewer than 1 percent of Virginia's Medicaid-covered pregnant patients used a covered doula visit from 2022 through 2024.
Why it matters Coverage on paper is not the same as access; provider enrollment and patient awareness, not the coverage decision itself, determine whether a doula benefit does anything.
Alert · now Aug 13, 2026
FDA and CDC are investigating a multistate Salmonella Javiana outbreak traced to Mexican-grown jalapenos distributed by Coast Citrus Distributors, with 345 confirmed cases, 36 hospitalizations and no deaths as of the latest update, and most patients reporting eating at Chipotle or QDOBA beforehand.
Why it matters If you've eaten at Chipotle or QDOBA recently and have gastrointestinal symptoms, this outbreak is worth knowing about; watch for updated case counts and any expansion of the recall.
Enforcement Aug 13, 2026
Herbert Kimble, who fled to the Philippines to dodge sentencing on a $1.2 billion telemedicine and DME fraud scheme, pleaded guilty August 11, 2026 and stipulated to 15 to 20 years in prison plus $208 million in restitution.
Why it matters This closes out one of the largest telehealth and DME fraud cases in recent years and shows federal agencies actively hunting fugitives who flee overseas. Watch whether Kimble actually pays any of the $208 million.
Record Aug 13, 2026
MaineHealth's board voted August 6, 2026 to close Labor and Delivery at Lincoln Hospital's Miles campus in Damariscotta effective December 18, 2026, Maine's 12th maternity unit closure in about a decade.
Why it matters A hospital board closed a unit despite rising birth volume, showing that overall hospital margin, not unit demand, drives closure decisions; watch whether other high-volume-but-losing units follow.
Report Aug 13, 2026
March of Dimes reported on August 11, 2026 that at least 96 U.S. labor and delivery units have closed since January 2024, pushing roughly one in three U.S. counties into maternity care desert status.
Why it matters This is the national pattern behind the Maine closure above; the number to watch is your own county's labor and delivery access as more units close.
Enforcement Aug 13, 2026
Dr. Sanjeev Kumar was sentenced July 8, 2026 to 240 months in federal prison after reusing adulterated single-use surgical devices on more than 15,000 Medicare and Medicaid patients and billing more than 41 million dollars.
Why it matters A single high-volume operator generated criminal exposure on both fraud and patient-safety grounds at once, a reminder that device-reuse schemes reach gynecologic procedure volume, not just general surgery or endoscopy.
Report Aug 13, 2026
Pennsylvania's Department of Human Services said it expects roughly 310,000 residents, including 26,000 in Allegheny County, to lose Medicaid coverage as the state shifts to six-month renewals and adds federal work-documentation requirements, and it is spending $7.8 million on IT to process the change.
Why it matters If you or someone you know is on Pennsylvania Medicaid, expect more frequent renewal paperwork starting late August 2026; watch for a notice and respond promptly since many losses are expected to hit people who remain eligible but miss paperwork.
Enforcement Aug 13, 2026
Aditya Humad, former CFO of Massachusetts spinal implant maker SpineFrontier, was sentenced August 6, 2026 to four months in prison and a $9,500 fine for conspiring to pay surgeons more than $540,000 in sham consulting fees to use the company's implants.
Why it matters This is a reminder that device-company consulting arrangements with prescribing physicians remain a top federal enforcement target, and executives, not just companies, are going to prison over them.
Earnings Aug 12, 2026
American Healthcare REIT reported Q2 2026 revenue of $674.3 million and net operating income of $137.2 million, and raised its full-year FFO and same-store NOI growth guidance on the strength of $1.4 billion in completed 2026 acquisitions.
Why it matters Signals continued institutional capital flowing into senior housing on demographic demand; watch whether the more than $800 million pipeline closes as planned by year end.
Rule Aug 12, 2026
The rule bars federal Medicaid dollars for puberty blockers, hormone therapy and surgeries for children under 18 and CHIP funding for the same care for people under 19, projecting $235 million in savings over ten years.
Why it matters This cuts off federal Medicaid and CHIP payment for gender-transition care in kids, a shift that will change what's available to families who rely on public coverage. Watch whether states backfill the funding with their own dollars.
Rule Aug 12, 2026
HB 26-1195 bars AI systems from independently delivering therapy or generating treatment plans without licensed review, exposing violators to civil penalties up to $20,000 per violation.
Why it matters Colorado now fines AI chatbots that pose as therapists, joining four other states that have moved to restrict this technology this year. Watch whether more states follow with their own laws.
Earnings Aug 12, 2026
CVS Health will offer $29 virtual weight-loss visits and transparent Eli Lilly app pricing for Zepbound and Foundayo across roughly 9,000 pharmacies starting early Q4 2026, alongside a Q2 earnings beat that still sent shares down about 9 percent on 2027 concerns.
Why it matters A major retail pharmacy is pushing GLP-1 access and price transparency; watch adoption once app-based Eli Lilly pricing goes live in the fourth quarter.
Alert · now Aug 12, 2026
Hackers accessed DentaQuest's network in May and stole Social Security numbers, Medicaid and Medicare ID numbers, and treatment records, with an independent researcher estimating the true toll could exceed 23 million.
Why it matters A dental benefits administrator with Medicaid contracts in multiple states is notifying 15 million people their personal and health data was stolen, the largest health breach reported to regulators this year. If you or your dependents have dental coverage through a state Medicaid program, watch for a notification letter.
Deal Aug 12, 2026
Park Dental Partners agreed to acquire the 12-location, 48-doctor Village Family Dental Services Organization in Fayetteville, North Carolina, expanding Park beyond its existing three-state, 87-location footprint on undisclosed terms.
Why it matters Another data point in the ongoing private-equity-backed dental roll-up wave; watch how many more states Park adds this year.
Deal Aug 12, 2026
Sentynl Therapeutics, a Zydus Lifesciences subsidiary, gained an option for U.S. commercial and global manufacturing rights to Mereo's pre-Phase 3 lung disease drug alvelestat in a deal worth up to roughly $475 million plus royalties.
Why it matters A large sum is being paid for a rare-disease drug that has not finished Phase 3 trials yet; watch whether the global Phase 3 study starting as early as 2027 succeeds.
Rule Aug 12, 2026
The executive order directs CDC and ACIP to drop flu, COVID-19, rotavirus, meningococcal, hepatitis A and hepatitis B from the recommended childhood schedule, and insurers have pledged free coverage of those shots only through the end of 2026.
Why it matters Six vaccines are dropping off the government's recommended list for kids, and because free coverage is tied to that list, insurers' pledge to keep covering them at no cost only runs through the end of this year. Watch what happens to coverage in 2027.
Enforcement Aug 12, 2026
Minnesota regulators confirmed UCare will lay off 102 additional remote employees between October 2 and November 2026 as its state Medicaid contracts formally end October 1, with nearly 300,000 members moving to Medica.
Why it matters A 40-year-old nonprofit insurer's collapse is displacing workers and nearly 300,000 Medicaid members; watch whether outstanding hospital bills get paid before 2027 as officials warned they might not.
Enforcement Aug 12, 2026
The Justice Department says Veloxis bribed doctors and pharmacies with resort trips, meals and disguised fees from 2016 through 2023 to boost prescriptions of its kidney transplant drug Envarsus XR.
Why it matters A drugmaker admitted bribing doctors and pharmacies for years to push a transplant drug, a reminder that kickback enforcement remains active even for niche specialty drugs. Watch whether other immunosuppressant makers face similar scrutiny.
Deal Aug 11, 2026
Anthem Blue Cross Blue Shield of Georgia and Northside Radiology Associates, a Georgia affiliate of Radiology Partners, announced a multi-year in-network agreement August 3, 2026, with financial terms undisclosed.
Why it matters A large insurer and a large private-equity-backed radiology group chose to stay in-network rather than fight over rates, a small sign of stability in a market otherwise defined by insurer-radiology billing disputes.
Deal Aug 11, 2026
BWX Technologies agreed to sell its BWXT Medical and Kinectrics stable isotopes units to private equity firm Nordic Capital for up to 800 million dollars while retaining a minority stake and continuing to supply isotope expertise.
Why it matters Private equity is now buying into the fragile supply chain that keeps nuclear medicine scans and new radioactive cancer therapies stocked with isotopes, a niche most people never think about until a shortage delays a scan or treatment. Watch whether Nordic Capital's investment expands isotope production capacity or just extracts returns.
Alert · now Aug 11, 2026
Six U.S. and South Korean agencies jointly warned that the Gunra ransomware group is breaking into healthcare networks through exposed VPNs, firewalls and remote desktop systems to steal and encrypt data for extortion.
Why it matters This is a direct warning that hospitals are an active target for a specific ransomware gang right now, so if you or a family member rely on a local hospital system, it's worth knowing their IT team should be patching this week.
Rule Aug 11, 2026
CMS's procedural notice for the RAPID coverage pathway, which commits the agency to issuing a proposed national coverage determination the same day an FDA-designated breakthrough device wins market authorization, published in the Federal Register today and opened public comment.
Why it matters This is the formal starting gun on a policy that could get breakthrough medical devices covered by Medicare in months instead of a year or more, worth watching if you or a family member might need a new device technology.
Rule Aug 11, 2026
CMS's proposed CY2027 rule cuts the physician conversion factor about 1.68 percent while individual radiology codes move far more, with CT angiography of the chest proposed up 149 percent and CT of the upper extremity down 15 percent, and comments close September 14, 2026.
Why it matters The headline "Medicare cut doctor pay again" hides big winners and losers underneath; if you get imaging done, access to certain scans may shift as practices adjust to code-level reimbursement changes.
Rule · now Aug 11, 2026
The FDA proposed a rule that would end the voluntary Generally Recognized as Safe self-affirmation system and require food and animal-food makers to notify the agency of the safety basis for new ingredients, opening a 120-day comment period.
Why it matters If finalized, this would end the decades-old practice of food companies quietly deciding on their own that a new ingredient is safe, giving FDA visibility it currently lacks into what's actually in the food supply.
Approval Aug 11, 2026
GE HealthCare announced August 3, 2026 that its Invenia ABUS Prime scanner and ABUS StreamVue viewer received FDA clearance and CE marking, with the company citing up to 40 percent faster scans and up to 93 percent sensitivity for dense-breast lesion detection when paired with AI-assisted reading.
Why it matters If you have dense breast tissue, this adds another supplemental-screening option your imaging center may offer alongside or instead of contrast-enhanced mammography or MRI.
Deal Aug 11, 2026
Health Catalyst completed the sale of its Vitalware revenue cycle software unit to Med-Metrix for 147 million dollars in cash and used the proceeds to fully repay roughly 160 million dollars in outstanding debt.
Why it matters A healthcare data analytics company sold off a software unit to pay down debt and refocus on artificial intelligence and analytics, a sign of continued portfolio trimming across health tech as companies prioritize balance sheet health over diversification. Watch whether Med-Metrix integrates Vitalware smoothly into its revenue cycle management offerings.
Deadline Aug 11, 2026
Indiana's Family and Social Services Administration launched text alerts, an online exemption screener and town halls this week to help Healthy Indiana Plan members determine before January 1, 2027 whether they are exempt from new 80-hour monthly work requirements.
Why it matters If you're on Indiana's Medicaid expansion plan, this is your heads-up to check the new online screener now so you're not caught off guard when the 80-hour work requirement starts in 2027.
Deal Aug 11, 2026
Jazz Pharmaceuticals agreed to pay 820 million dollars upfront plus up to 500 million dollars in milestones for Actio Biosciences and its experimental KCNT1 epilepsy drug ABS-1230, which has FDA Fast Track and Orphan Drug status but no approved competitor.
Why it matters A large drugmaker is betting hundreds of millions on a rare seizure disorder that affects only about 2,500 Americans and currently has no approved treatment. Watch whether ABS-1230 clears FDA trials, since approval would create the first therapy for KCNT1-related epilepsy.
Deal Aug 11, 2026
KKR agreed to acquire medical device contract manufacturer Integer Holdings for 127 dollars per share in an all-cash deal, its largest healthcare transaction since the 9.9 billion dollar Envision Healthcare buyout in 2018.
Why it matters One of the largest private equity firms is taking a major device-component maker private, a sign private equity remains willing to write big checks for the medical device supply chain. Watch whether KKR pursues further consolidation or cost cuts across cardiovascular and surgical device manufacturing.
Enforcement Aug 11, 2026
A federal jury trial began today in Los Angeles for hospice operator Oren Shachar and marketer Abraham Shin, accused of billing Medicare $27.7 million by enrolling deceased people as hospice patients using identities bought from a mortuary worker.
Why it matters This trial shows how far Medicare fraud schemes can go, using dead people's identities to fake hospice enrollments, and it's a reminder that program integrity enforcement is active and public.
Enforcement Aug 11, 2026
Class members affected by the January 2025 ransomware attack on Mt. Baker Imaging and Northwest Radiologists have until August 19, 2026 to file a claim in the $3.3 million settlement, with final court approval scheduled August 21, 2026.
Why it matters If you were a patient at these two Washington imaging practices, this is your deadline to file for compensation; more broadly it's a real-dollar benchmark for what a mid-size imaging data breach costs.
Report Aug 11, 2026
The Harvey L. Neiman Health Policy Institute reported August 4, 2026 that median time from outpatient imaging study to final interpretation rose 27 percent between 2023 and 2024, with ultrasound turnaround worsening the most at 49.1 percent, based on 2.9 million Medicare claims.
Why it matters If your imaging report is taking longer to come back, this data confirms it's a real, measurable trend, not just anecdote, and ultrasound and X-ray are degrading fastest right now.
Earnings Aug 11, 2026
RadNet's Q2 2026 SEC filing showed revenue up 25 percent to $622.7 million and a new $250 million credit facility earmarked for imaging center and AI acquisitions.
Why it matters Bigger picture: the largest imaging chain in the country now has more cash and cheaper debt to buy up competitors, a sign of consolidation ahead in local imaging markets. Watch whether more independent groups get bought in your area.
Deal Aug 11, 2026
Supernus Pharmaceuticals and Indivior agreed to combine in an all-stock merger of equals that will trade as Supernus, Inc. on Nasdaq, with Indivior shareholders owning 56.5 percent and receiving a 1 billion dollar special dividend before close.
Why it matters Two mid-size drugmakers are combining to build a bigger central nervous system portfolio anchored by an opioid addiction treatment nearing 1 billion dollars in annual sales. Watch whether the combined company uses its larger scale to expand access to opioid use disorder treatment or simply consolidates costs.
Rule Aug 11, 2026
HHS declared a public health emergency for six Washington counties hit by wildfires and CMS followed with Section 1135 waivers relaxing Medicare, Medicaid and CHIP enrollment, documentation and telehealth rules retroactive to August 1, 2026.
Why it matters If you live in or near Spokane, Stevens, Okanogan, Ferry, Chelan or Yakima counties, this waiver means local hospitals and providers have more flexibility to keep treating patients without normal paperwork getting in the way during the wildfires.
Record Aug 10, 2026
The South Carolina nonprofit system's tenth public update on August 5 gave no restoration date or cost estimate after malware knocked out email, phones, and MyChart starting July 26.
Why it matters Two weeks after a malware attack, a 106-facility hospital system still cannot say when it will be fully restored or what the outage has cost, a real-time look at how long ransomware recovery actually takes. Watch for the eventual cost disclosure.
Deal Aug 10, 2026
The claims-repricing platform bought the dialysis cost-management program, which says it has saved health plans 325 million dollars since 2006, in an undisclosed-terms deal announced August 6, 2026.
Why it matters A dialysis cost-management program with a 325 million dollar savings track record for health plans just found a buyer backed by private equity, a sign consolidation continues in the claims cost-management space. Terms were not disclosed.
Rule Aug 10, 2026
CMS released a procedural notice on August 7, 2026 for its RAPID pathway, committing to issue a proposed national coverage determination the same day an eligible breakthrough device receives FDA market authorization, with the notice publishing in the Federal Register on August 11 and opening a 60-day comment period.
Why it matters This could cut the time between FDA approval and Medicare coverage for breakthrough devices from a year or more down to about two months, a significant change for patient access to new technology.
Enforcement Aug 10, 2026
The Department of Justice announced August 3, 2026 that Complete Health Partners Holdings will pay $14.1 million to settle allegations it pressured coders to submit invalid mental health and substance abuse diagnoses between 2020 and 2023 to inflate Medicare Advantage risk scores.
Why it matters This is another case showing federal prosecutors are actively pursuing Medicare Advantage upcoding, so watch for similar False Claims Act suits against other MA-focused providers.
Rule Aug 10, 2026
The FDA published a proposed rule on August 10, 2026 to move digital breast tomosynthesis systems from Class III to Class II, with public comment open through October 9, 2026.
Why it matters If finalized, this could make new 3D mammography technology reach the market faster and cheaper, similar to what happened with 2D digital mammography systems in the 2010s.
Earnings Aug 10, 2026
The musculoskeletal digital health company reported 213 million dollars in Q2 revenue, turned GAAP operating income positive, raised full year guidance, and confirmed its 105 million dollar Cylinder Health acquisition remains on track to close in Q3.
Why it matters A digital health company's swing to positive operating income and raised guidance shows demand for musculoskeletal virtual care is scaling profitably, not just growing revenue. Watch whether the Cylinder Health deal closes on schedule in Q3.
Enforcement Aug 10, 2026
Texas Attorney General Ken Paxton finalized a settlement in early August 2026 requiring Texas Children's Hospital to pay $10 million, permanently revoke five physicians' privileges, and open the nation's first hospital-run detransition clinic by late October.
Why it matters This settlement shows a state Medicaid billing law can force major operational changes at a hospital years after the underlying law passed, so watch how other states with similar bans pursue their own enforcement.
Record Aug 10, 2026
Board pushed out CEO Mike Dandorph and CFO Andrew DeVoe even after the four-hospital system cut its operating loss from 214 million dollars to 51.6 million dollars in fiscal year 2026, with COO Phil Okala elevated to CEO effective end of September.
Why it matters A hospital system's board pushed out its top two executives even as losses shrank sharply, showing boards now want a faster path to breakeven, not just a smaller loss. Watch who leads the next phase of the turnaround.
Report Aug 10, 2026
The White House Task Force to Eliminate Fraud launched a public dashboard on August 6, 2026 crediting HHS programs with $96 billion of the $230 billion in fraud, waste and improper payments identified across federal programs since January 2025.
Why it matters This is a political claim more than an audited number, so watch whether independent auditors like GAO ever confirm the figures rather than taking the tally at face value.
Earnings Aug 9, 2026
agilon health reported second quarter 2026 net income of 18 million dollars, reversing a 104 million dollar loss a year earlier, even as total platform membership fell to 549,000 from 614,000.
Why it matters A company that helps independent doctors take on financial risk for Medicare patients turned profitable by shedding unprofitable membership rather than growing it, a shift worth watching if your doctor participates in one of its risk contracts.
Earnings Aug 9, 2026
AMN Healthcare reported second quarter 2026 adjusted EBITDA of 73.4 million dollars, up 26 percent, as travel nursing volume grew for a second straight quarter.
Why it matters The largest US healthcare staffing firm says hospital reliance on travel nurses is stabilizing after a two year slide, a signal the post-pandemic staffing crunch is easing.
Record Aug 9, 2026
Registered nurses at Sierra Nevada Memorial Hospital in Grass Valley picketed August 6 against CommonSpirit's plan to cut five Family Birth Center and two cancer infusion positions as the nonprofit system posted a 578 million dollar quarterly operating loss.
Why it matters A major nonprofit hospital system is cutting maternity and cancer infusion staff while posting steep quarterly losses, a pattern worth watching if you or a family member relies on one of its hospitals for these services.
Approval Aug 9, 2026
The FDA granted accelerated approval to Replimune's Tudriqev in combination with nivolumab for advanced melanoma after progression on anti-PD-1 therapy, following two prior rejections, based on a 24.2 percent response rate in a 91-patient trial.
Why it matters This is the first cancer therapy of its kind, a genetically modified virus that attacks tumors directly, cleared for use, and it gives melanoma patients who've run out of standard options a new tool. Watch confirmatory trial data since this is an accelerated approval.
Deal Aug 9, 2026
HealthSnap secured a 25 million dollar senior secured growth financing facility led by Eastward Capital Partners, with health system investors Sentara Health, Tampa General Hospital and UnityPoint Health participating.
Why it matters A vendor running AI-powered remote monitoring programs for chronically ill patients inside 200 health systems, including AdventHealth and Ascension, raised new financing to expand, a sign hospitals are investing further in remote chronic care monitoring.
Enforcement Aug 9, 2026
Federal reviewers found 28 of 351 examined donation cases where the patient may not yet have been deceased when Network for Hope began preparing them for organ donation, making it only the second OPO decertification in program history.
Why it matters This is only the second time the federal government has ever pulled an organ procurement group's certification, and it centers on whether patients were treated as deceased before they actually were. Watch whether Network for Hope's appeal succeeds and whether other OPOs face similar scrutiny.
Rule Aug 9, 2026
Six senators introduced the SUSTAIN 340B Act on August 5, 2026, which would kill HRSA's rebate-based 340B overhaul within one year of enactment and replace it with an independent data clearinghouse, threatening the pilot's August 24 manufacturer opt-in deadline.
Why it matters This bill would unwind a major change to how the 340B drug discount program works before it fully takes effect, adding uncertainty for safety-net hospitals and drug manufacturers already gearing up for an August 24 opt-in deadline. Watch whether the bill gains momentum before that deadline arrives.
Enforcement Aug 9, 2026
A federal jury in Massachusetts awarded Larry and Tammy Patterson $88 million after finding Medtronic's Covidien unit failed to warn that its Symbotex hernia mesh coating could dissolve faster than expected, in the first of more than 2,400 pending cases to reach trial.
Why it matters This is the largest compensatory verdict in 15 years of hernia mesh litigation and the first of thousands of pending cases to go to trial, so it will shape how the remaining 2,400-plus cases are valued and whether Medtronic settles going forward. Watch Medtronic's post-trial motions and appeal.
Rule Aug 9, 2026
The Senate voted 90 to 6 to pass H.R. 6500, a continuing resolution funding federal agencies including WIC through December 11 and delaying a hemp-derived THC product ban, sending it to the House for reconciliation with its own stopgap bill.
Why it matters This averts a government shutdown before the midterms and keeps WIC and other programs funded through December 11, but it still needs House agreement on a bill that differs from what the House already passed. Watch whether the House accepts the Senate version or a standoff develops closer to the new deadline.
Report Aug 8, 2026
VMG Health's survey of 97 ASC leaders found 44 percent expect to pay an anesthesia stipend in 2026, up from 28 percent two years earlier, with 67 percent now ranking anesthesia coverage among their top three financial challenges.
Why it matters Anesthesia has shifted from a negotiable line item to a fixed cost most ASCs now budget for. Watch your own anesthesia contract renewal for stipend demands if you haven't seen one yet.
Enforcement Aug 8, 2026
The Department of Justice's Fraud Section declined to prosecute Campus Eye Management after the company self-disclosed a kickback and unnecessary-testing scheme, marking the first declination for a health care company under the March 2026 Corporate Enforcement and Voluntary Self-Disclosure Policy.
Why it matters This is the first real-world test of DOJ's new corporate leniency policy in health care, showing that self-disclosure and cooperation can spare a company prosecution even as its founder faces criminal charges. Watch whether other companies start self-reporting sooner.
Enforcement Aug 8, 2026
EyePoint Pharmaceuticals agreed to pay the United States $4,657,463.18 to resolve False Claims Act allegations it ran an 'Assurance Program' reimbursing ASCs when insurers paid less than cost for its cataract-surgery drug DEXYCU, and entered a five-year Corporate Integrity Agreement with HHS OIG.
Why it matters This is a reminder that drugmakers offering financial cushions to providers to stock a product carries kickback risk on both sides of the transaction. Watch for more ASC-directed pharma settlements as DOJ works through this cluster of ophthalmology cases.
Deadline Aug 8, 2026
CMS's temporary use of the hospital market-basket index to set ASCs' annual Medicare payment update expires after 2026, and companion bills to make it permanent, H.R.8091 and S.4963, remain stuck in committee.
Why it matters If Congress does nothing, ASCs get a smaller inflation-based raise starting in 2027, a real-dollar cut from what they'd get under the current formula. Watch whether H.R.8091/S.4963 move before the trial lapses.
Deal Aug 8, 2026
Surgery Partners signed binding agreements to sell its ownership interests in Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health for roughly $795 million, sharpening its focus on its ASC portfolio a year after its board rejected Bain Capital's take-private offer.
Why it matters Surgery Partners is signaling it wants to grow as a standalone, ASC-focused public company rather than sell out, a year after turning down a $3.2 billion take-private bid. Watch the Hart-Scott-Rodino review and physician/board approvals for close timing.
Rule Aug 8, 2026
CMS's FY2027 Hospital IPPS final rule adds three new severity-based DRGs for spinal fusion and refines episode attribution under the mandatory TEAM bundled-payment model, while leaving open, via an earlier RFI, whether to bring ASCs directly into TEAM's financial accountability.
Why it matters About 740 hospitals move to downside financial risk under TEAM starting January 1, 2027, which sharpens their incentive to push joint and spine cases into ASCs, procedures ASCs today capture without sharing that risk. Watch whether CMS acts on ASC inclusion in a future rule.
Deal Aug 7, 2026
Addus HomeCare said its May 2026 acquisition of HomeCourt Home Care, its entry into Indiana, has slightly outperformed expectations and a second Indiana acquisition is already lined up.
Why it matters A consolidator's first deal in a new state beating projections is a signal other operators watch when deciding whether to expand into that market.
Enforcement Aug 7, 2026
California's attorney general settled with Carbon Health Technologies for a 4.4 million dollar corporate penalty plus a first of its kind 100,000 dollar personal penalty against co-founder Eren Bali, following a similar settlement with Aspen Dental, both under a law effective January 1, 2026.
Why it matters California is actively enforcing a new law against management companies that control physician and dentist clinical decisions, including the state's first ever personal fine against a company executive.
Rule Aug 7, 2026
The DEA's July 6 Federal Register notice said it would not issue its order temporarily placing concentrated 7-hydroxymitragynine into Schedule I before August 5, and that date has now passed, meaning a nationwide ban on products above 0.05 percent concentration could take effect any day.
Why it matters A concentrated kratom compound sold in some gas-station and vape-shop products could become a federal Schedule I substance any day now, while ordinary kratom leaf stays legal.
Earnings Aug 7, 2026
Doximity reported fiscal first quarter 2027 revenue of 156.6 million dollars and raised full year guidance to 671 to 681 million dollars, driven largely by new AI Search advertising contracts that recognized zero revenue this quarter.
Why it matters A digital health company's stock jumped sharply on earnings, but the guidance raise leans on a new AI advertising product that has not yet booked revenue, so watch whether it delivers.
Rule Aug 7, 2026
The FCC adopted an order August 6 letting Rural Health Care Program participants reuse a prior approved rural rate for funding year 2027 instead of redoing a cost-justification, and opened a Third Further Notice of Proposed Rulemaking seeking comment on cutting administrative burden for roughly 14,000 rural providers.
Why it matters A federal subsidy fund that keeps rural clinics connected to broadband just got a little easier to use, and more paperwork cuts could follow.
Rule Aug 7, 2026
CMS published the FY2027 Hospice Wage Index final rule raising payments 2.3 percent and locking in the Service and Spending Variation Index fraud score for nearly every hospice.
Why it matters CMS just gave itself a systematic way to flag hospices for fraud risk, using the same rule that sets next year's payment rates. Watch how fast these scores turn into audits.
Earnings Aug 7, 2026
GoodRx's core prescription transaction revenue fell 26 percent to 106.4 million dollars while its manufacturer funded Pharma Direct channel grew 76 percent to 61.6 million dollars, prompting a full year guidance raise to 790 to 805 million dollars.
Why it matters A consumer drug discount app's original business is shrinking while a pharma funded channel takes over as its growth engine.
Record Aug 7, 2026
A Supreme Court ruling has cleared the way for Haiti's Temporary Protected Status to expire, putting an estimated 21,000 Haitian nursing assistants and caregivers who work in home health, home care, and PACE at risk of losing work authorization while a House-passed extension bill awaits Senate action.
Why it matters Thousands of caregivers could lose work authorization just as agencies are already reporting staffing gaps, a workforce risk driven by immigration law rather than payment policy.
Deadline Aug 7, 2026
Starting October 1, 2026, hospices must give patients a written addendum within five days of election spelling out uncovered services, while telehealth face-to-face recertification is extended through December 31, 2027.
Why it matters Every hospice patient gets new paperwork explaining exactly what will not be covered, while operators keep a telehealth option they had been bracing to lose.
Enforcement Aug 7, 2026
The Department of Justice's Northeast Health Care Fraud Strike Force expansion into Philadelphia signals that the enrollment-moratorium-era hospice and home care fraud enforcement model built in California, Nevada, Arizona, and Texas is exporting itself to new markets.
Why it matters The enforcement model that has targeted hospice and home care fraud in a handful of Sun Belt states just showed up in the Northeast, meaning operators everywhere should expect a standing task force, not just periodic sweeps.
Deal Aug 7, 2026
iRhythm Technologies agreed to pay 237.5 million dollars in cash plus 50 million dollars in stock for VitalConnect, a maker of cardiac and vital sign monitoring patches running at roughly 65 million dollars in annual revenue.
Why it matters Two makers of wearable heart and vital sign monitors are consolidating into one company.
Record Aug 7, 2026
Lane Regional Medical Center in Zachary, Louisiana eliminated 18 positions and is closing its Allergy, Asthma and Immunology Clinic, citing low patient volume, rising operating costs and lagging reimbursement rates.
Why it matters A small independent community hospital is cutting staff and closing a specialty clinic rather than continuing to subsidize it.
Rule Aug 7, 2026
Minnesota's Medical Assistance Protection Act took effect August 1, creating a Severity Level 8 felony tier with a presumptive 48-month prison sentence for Medicaid theft over $1 million, and Attorney General Keith Ellison says it funded growing the state's Medicaid Fraud Control Unit from 32 to 50 staff.
Why it matters Minnesota just made large-scale Medicaid theft carry real, tiered prison time instead of treating all fraud above $35,000 the same, and added investigators to pursue it.
Report Aug 7, 2026
HHS OIG sampled 100 Medicare sacroiliac joint injection sessions and found 72 violated program rules, extrapolating to an estimated $15.2 million improperly paid across 134,526 sessions nationwide, while CMS rejected the recommendation to fix the underlying billing error.
Why it matters This shows a specific pain-procedure billing pattern that federal auditors flagged but the agency in charge chose not to fully fix, so the error will likely keep recurring.
Rule Aug 7, 2026
Led by Oklahoma's Gentner Drummond, 17 state attorneys general sent an August 4 letter to House and Senate committees backing the STOP FRAUD in Medicaid Act, which would expand state Medicaid Fraud Control Units' authority to investigate recipients as well as providers, citing $4.64 recovered per dollar spent and nearly $2 billion recovered in 2025.
Why it matters State fraud investigators want new legal authority to go after Medicaid recipients directly, not just doctors and hospitals, though neither congressional committee has scheduled a markup yet.
Enforcement Aug 7, 2026
The Department of Justice charged 19 defendants on August 4, 2026 in a roughly $4 million Medicaid and Medicare home care fraud scheme and expanded its Northeast Health Care Fraud Strike Force into Philadelphia.
Why it matters A large fraud case just landed in a city that had not previously had a standing federal fraud task force, a sign enforcement is spreading to new markets.
Report Aug 7, 2026
CMS data show non-hospice Medicare spending on hospice patients reached $2.8 billion in FY2024, with for-profit hospices running about 167 percent higher per-day spending than nonprofits, up from roughly 60 percent in FY2022.
Why it matters This is the exact data gap CMS used to build its new hospice fraud score, so it is now a benchmark every hospice, not just the ones under investigation, will be measured against.
Record Aug 7, 2026
The U.S. Preventive Services Task Force has not convened since March 2025 or issued a new recommendation since August 2025, and HHS pushed its July 2026 meeting to late August to onboard new members, freezing any new no-cost preventive coverage mandates in the meantime.
Why it matters The panel whose ratings decide which preventive screenings and shots insurers must cover for free hasn't met in over a year, so no new services can get that no-cost guarantee until it resumes.
Deal Aug 7, 2026
UMass Memorial Health, an existing clinical partner, co-led the first close of a 10 million dollar Series B for Wellinks, whose FDA cleared COPD remote monitoring program is tied to more than 60 percent lower odds of 30 day readmission.
Why it matters A hospital system is putting its own money behind a remote monitoring vendor it already uses clinically, betting on reduced COPD readmissions.
Report Aug 6, 2026
CMS's new toolkit shows national Medicaid and CHIP ABA spending rose 400 percent from 2021 to 2025 while diagnosed children receiving services grew only 67 percent, with median per-child spending climbing from $8,903 to $21,203 and treatment plans above 16 hours a week now flagged for review.
Why it matters Two numbers to know: Medicaid's autism therapy spending grew 400 percent in four years while the population receiving it grew just 67 percent, a gap regulators are now built to spot.
Enforcement Aug 6, 2026
A federal judge approved the $16,205,774.05 civil judgment against ARC and affiliates Pioneer Health Group and Science Hill Family Care after a whistleblower suit alleged therapy sessions were billed under higher-licensed clinicians than the staff who actually performed them and individual therapy codes were used for group sessions.
Why it matters A whistleblower suit over who actually delivered therapy sessions just cost Kentucky's largest addiction treatment network $16.2 million; watch for similar credential-mismatch claims elsewhere.
Deal Aug 6, 2026
The private equity firm is selling the 30-plus facility, eight-state mental health and sober-living network to nonprofit QCF/I through a non-rated municipal bond issuance underwritten by KeyBanc, delivering about $415 million upfront plus up to $100 million in earnout tied to 2026 EBITDA targets.
Why it matters A private equity firm just found a new way to cash out of a behavioral health platform, tax-exempt municipal bonds instead of a sale to another buyer, and advisors say a dozen similar deals worth $3 billion are in the pipeline.
Earnings Aug 6, 2026
Clover Health reported 743.2 million dollars in second-quarter revenue, 28.0 million dollars in net income versus a 10.6 million dollar loss a year earlier, and raised full-year guidance across revenue, profit and membership.
Why it matters Clover Health's swing to profitability, with membership up 48 percent, is a sign that at least one AI-driven Medicare Advantage insurer is finding a working formula after years of losses.
Report Aug 6, 2026
The toolkit responds to national Medicaid and CHIP ABA spending rising from about $2 billion in 2021 to $10 billion in 2025 while the number of children served grew just 67 percent, and recommends prior authorization thresholds, breaks before extended billing, and flags 40-hour weekly treatment plans as not best practice.
Why it matters CMS wants states to tighten oversight of a Medicaid autism therapy benefit whose cost grew far faster than the number of children it serves; watch which states adopt prior authorization and hour caps first.
Rule Aug 6, 2026
The proposed CY2027 OPPS rule would pay 340B-acquired drugs at average sales price minus 33.4 percent starting January 1, 2027, require new JG, TB, and XX billing modifiers, and remove 637 more procedures from the inpatient-only list, with comments closing August 31, 2026.
Why it matters This CMS rule would cut Medicare payments for hospital-administered outpatient drugs by 4.55 billion dollars next year, with most of the change tied to how the program prices drugs bought through the 340B discount program.
Rule Aug 6, 2026
The FY 2027 IPPS/LTCH final rule raises hospital payments by a net 2.3 percent while embedding the CJR-X model, which puts most acute care hospitals on the hook for the full cost of hip, knee and ankle replacement episodes starting January 1, 2028.
Why it matters This raises what Medicare pays hospitals next year and quietly makes joint replacement surgery a test case for mandatory bundled payment nationwide, a model CMS could extend to other procedures. Watch whether CJR-X becomes the template for future mandatory bundles.
Rule Aug 6, 2026
CMS's final IPF PPS rule lifts the federal per diem base rate from $892.87 to $912.40 and caps outlier payments at 20 percent of total IPF payments, while Colorado cut most Medicaid provider rates 2 percent effective July 1, 2026 and moved its Comprehensive Safety Net Providers to a bundled nine-service payment model.
Why it matters Medicare is paying psychiatric hospitals a bit more next year while Colorado is paying its Medicaid behavioral health clinics a bit less right now; watch how the two systems' funding trajectories diverge.
Deadline Aug 6, 2026
While the January 2025 rule permanently allowing telehealth buprenorphine prescribing for opioid use disorder stands, DEA's broader Schedule II through V telemedicine prescribing extension, last renewed December 31, 2025, runs out at year-end 2026 with no permanent rule yet published.
Why it matters The rule letting doctors prescribe buprenorphine for opioid addiction by video visit is now permanent, but the broader rule covering other controlled substances by telehealth expires again at the end of 2026 unless DEA acts.
Approval Aug 6, 2026
The FDA approved Takeda's Orzeyful (oveporexton) on August 5, 2026 as an oral orexin receptor 2 agonist that restores signaling lost in narcolepsy type 1, though the DEA's controlled substance scheduling decision, expected within 90 days, must come before patients can access it through specialty pharmacy.
Why it matters The FDA approved the first drug that treats narcolepsy type 1 at its underlying cause rather than symptom by symptom, but patients still cannot get it until the DEA decides how tightly to control it, a decision expected within 90 days.
Record Aug 6, 2026
Gateway Regional Medical Center in Granite City, Illinois missed payroll again in early August 2026, the fourth such disruption since January, until founder Mike Sarian personally loaned the hospital 1 million dollars to pay hundreds of employees.
Why it matters A hospital's own founder having to personally loan it a million dollars just to make payroll, for the fourth time since January, is a stark sign of financial distress at a single facility that's worth watching for whether it stabilizes or heads toward closure or sale.
Deal Aug 6, 2026
HCA Healthcare closed its acquisition of the 40-location Texas MedClinic chain and split it among three regional HCA affiliates, rebranding all locations under its CareNow urgent care division, which now runs more than 430 clinics nationwide.
Why it matters HCA Healthcare absorbing 40 Texas urgent care clinics into its own hospital network is part of a broader pattern of hospital systems buying urgent care chains to capture patients and referrals before they reach a competitor's emergency room.
Rule Aug 6, 2026
HRSA's second attempt at a 340B rebate model, after a 2025 version was withdrawn following a hospital lawsuit, requires manufacturers of drugs in Medicare's price negotiation program to file rebate plans by August 24 for approvals expected by September 24 and an effective date of January 1, 2027.
Why it matters Drugmakers now have a firm deadline to decide whether to shift how the 340B discount reaches safety net hospitals, from an upfront price cut to an after-the-sale rebate, reviving a fight hospitals already won once in court.
Enforcement Aug 6, 2026
Federal prosecutors allege Stephen Dubin, M.D. billed Medicare more than $95 million for unnecessary amniotic wound allografts on elderly and hospice patients while taking kickbacks through inflated distributor invoices, with Medicare having paid out more than $54 million before the scheme was stopped.
Why it matters A single Nevada doctor's alleged $95 million wound care fraud scheme, targeting elderly and hospice patients, shows how expensive skin substitute billing schemes have become a top enforcement target. Watch for more indictments in this product category.
Deal Aug 6, 2026
Santiam Hospital and Clinics withdrew its Health Care Market Oversight review and obtained an emergency exemption on July 31, 2026 citing imminent insolvency, leaving only the Oregon Department of Justice's public comment period, open through August 7, as a checkpoint before its affiliation with Salem Health closes.
Why it matters A financially failing rural Oregon hospital's takeover is closing without the state's usual competition review, after regulators found it too close to insolvency to wait, leaving the state attorney general as the only remaining checkpoint before a public comment deadline of August 7.
Earnings Aug 6, 2026
Oscar Health reported 4.88 billion dollars in second-quarter revenue and 361.8 million dollars in net income, but its first-half operating income already exceeds its raised full-year guidance of 500 million to 700 million dollars, implying an operating loss of roughly 393 million to 593 million dollars in the second half.
Why it matters Oscar Health's earnings beat masks a warning sign worth watching: the company's own numbers imply a swing back to a loss in the second half of the year, so the headline growth story is not the full picture.
Earnings Aug 6, 2026
Privia Health, which helps independent physician practices adopt value-based care, reported 632.6 million dollars in second-quarter revenue, 9.0 million dollars in net income up 236.7 percent, and raised full-year guidance to the high end of its prior range.
Why it matters Privia Health's strong quarter shows independent physician practices continuing to move into value-based care arrangements at a steady pace, with revenue up 21 percent and profit more than tripling.
Record Aug 6, 2026
The August 4, 2026 hearing pitted Paragon Health Institute and Foundation for Government Accountability witnesses arguing Medicaid spending is unsustainable and fraud-prone against Georgetown's Andy Schneider defending home and community based services growth, with no bill or markup resulting.
Why it matters Dueling Senate testimony previewed the next fight over Medicaid, the program covering roughly 72 million Americans, with no bill or markup resulting yet.
Record Aug 5, 2026
AON announced July 23, 2026 that it now operates nine active radioligand therapy centers nationwide, up from one in 2023, with five more in development and two new physician leaders.
Why it matters Shows community oncology building out capacity for targeted radiation cancer treatment fast enough to match a consolidating manufacturing supply chain.
Report Aug 5, 2026
CareCloud disclosed that hackers accessed one of its Amazon Web Services environments between March 10 and March 16, 2026, exposing Social Security numbers and, for some patients, full credit card numbers, with at least 270,197 of those affected located in Texas.
Why it matters A cloud EHR vendor spent six days compromised before catching it, exposing Social Security numbers and, for some patients, full credit card data. Watch how many more state attorney general filings raise the disclosed total.
Rule Aug 5, 2026
CMS issued a State Medicaid and CHIP Applied Behavior Analysis Toolkit directing states to tighten billing oversight after ABA therapy spending grew 421 percent from 2021 to 2025.
Why it matters CMS is pushing states to tighten oversight of a fast-growing Medicaid benefit category; watch which states adopt the toolkit's recommendations.
Deal Aug 5, 2026
Curium agreed August 3, 2026 to buy Lantheus Holdings for 102.50 dollars per share cash plus a contingent value right worth up to 12.00 dollars per share, up to 114.50 dollars per share total, in the largest radiopharmaceutical deal ever.
Why it matters Signals that the isotope and imaging-agent supply layer behind targeted cancer treatment is consolidating into fewer large companies, even as clinical use of radiopharmaceuticals grows quickly.
Earnings Aug 5, 2026
CVS Health posted 106.1 billion dollars in second quarter revenue and raised full year 2026 guidance, yet its stock fell more than 6 percent after executives warned of 2027 headwinds from the 340B drug discount program and expected Caremark membership losses.
Why it matters CVS Health's Aetna insurance costs are stabilizing, but Wall Street is more worried about 2027 drug discount and pharmacy benefit headwinds than pleased with this quarter's beat. Watch whether that caution proves right.
Rule Aug 5, 2026
CMS's CY2027 Medicare Physician Fee Schedule proposed rule, released July 14, 2026, would require 340B covered entities to report quarterly Part D claims data starting January 1, 2027 and would raise the G2211 complexity bonus for oncologists in MSSP Advanced or LEAD-track ACOs to 32 percent versus 16 percent for others, with comments closing September 14, 2026.
Why it matters A single Medicare rule combines a new federal 340B reporting requirement with a real financial incentive pushing oncologists toward ACO participation; comments close September 14, 2026.
Enforcement Aug 5, 2026
Federal and state prosecutors charged 19 defendants with billing Pennsylvania Medicaid $5.76 million for home care fraud, including an aide who billed while incarcerated, as DOJ unveiled a new embedded anti-fraud unit.
Why it matters DOJ permanently embedding fraud investigators inside a U.S. Attorney's office signals sustained scrutiny on home health billing; watch whether similar offices open in other cities.
Earnings Aug 5, 2026
Eli Lilly raised its full year 2026 revenue guidance to 85 to 87 billion dollars after Mounjaro sales climbed 91 percent to 9.9 billion dollars and Zepbound sales rose 46 percent to 4.9 billion dollars in the quarter.
Why it matters Eli Lilly's weight loss and diabetes drugs are driving explosive growth, and the company just raised its full year guidance for the second time this year. Watch how long that growth rate holds as competition from Novo Nordisk intensifies.
Alert · now Aug 5, 2026
Medline and Arrow International corrected surgical and spinal-anesthesia convenience kits on August 3, 2026 after a Class I recall of Huons bupivacaine tied to infection and meningitis risk.
Why it matters A supply-chain quality problem is prompting removal of specific anesthetic vials from surgical kits; watch for the FDA's evolving list of affected lot numbers.
Approval Aug 5, 2026
The FDA approved zidesamtinib (Jideytro) July 22, 2026 for previously treated ROS1-positive non-small cell lung cancer, one week after GSK closed its acquisition of Nuvalent, the drug's originator.
Why it matters A new oral option arrives for a genetic subtype of lung cancer, just one week after GSK finished buying the small biotech that invented it.
Record Aug 5, 2026
Henry Ford Health System priced 1.317 billion dollars and Intermountain Health priced 1.118 billion dollars in municipal bonds on August 3, 2026, both moving early to beat a crowded municipal supply calendar and falling Treasury yields.
Why it matters Two major nonprofit hospital systems moved fast to lock in lower borrowing costs this week, a signal of how sensitive health system finances are to interest rate swings and bond market timing.
Report Aug 5, 2026
Missouri lawmakers are debating the value of the state's three private Medicaid managed-care insurers, whose 8.17 percent administrative overhead exceeds the 1 to 3 percent Missouri spends managing complex populations directly, as a 2029 deadline to cut the state's error rate below 3 percent looms.
Why it matters A looming $1 billion federal penalty is fueling a state debate over whether to keep paying private insurers to run Medicaid; watch for legislative action ahead of the 2029 deadline.
Rule Aug 5, 2026
A final rule that took general effect August 3, 2026 cut the per-party fee to file a No Surprises Act billing dispute and revised batching and eligibility rules for the federal arbitration system.
Why it matters Arbitration got cheaper and faster to use; watch whether dispute volume, already over 5.1 million since 2022, rises further now that filing costs less.
Earnings Aug 5, 2026
Novo Nordisk raised its full year 2026 sales outlook after second quarter results, but its oral Wegovy pill sales came in slightly below analyst estimates and its ziltivekimab heart drug trial failed to meet its primary endpoint the same week.
Why it matters Novo Nordisk raised its outlook and still got punished by investors, a sign the market is now judging GLP-1 makers on execution details like pill uptake and pipeline results, not just headline growth.
Approval Aug 4, 2026
Biocon launched Yesafili, an FDA interchangeable biosimilar to Regeneron's Eylea 2 mg, in the United States on August 3, 2026, targeting a US aflibercept market Biocon estimates at roughly $5.89 billion.
Why it matters An interchangeable biosimilar lets pharmacists substitute it for the brand drug without a new prescription, which could speed price competition in a nearly $6 billion eye drug market.
Rule Aug 4, 2026
The CY2027 Medicare Physician Fee Schedule proposed rule projects roughly 1 percent higher overall cardiovascular payment while continuing a 2.5 percent efficiency adjustment and reducing tricuspid valve, coronary IVUS, and left atrial appendage closure values.
Why it matters The 2027 cardiology pay picture is a modest headline gain over a broad efficiency cut, so your exposure depends entirely on service mix. Watch the final rule this fall.
Rule Aug 4, 2026
The CY2027 MPFS proposes a 50 percent reduction to an evaluation and management visit billed the same day as a 0, 10, or 90 day global procedure by the same practice, and replaces 17 remote physiologic and therapeutic monitoring codes with four new G codes.
Why it matters A proposed cut to same-day office visits would touch nearly every cardiology practice that pairs a visit with a device check or echo. Watch whether it survives to the final rule.
Report Aug 4, 2026
MedAxiom's most recent compensation survey put private-equity ownership of cardiology groups at about 50 percent, with integrated median cardiologist compensation crossing 700,000 dollars versus 588,479 dollars in private practice, the widest gap in years.
Why it matters Consolidation has reshaped cardiology ownership, and the buyers have not slowed. For an independent group the question is which of four bids to weigh, not whether to align.
Rule Aug 4, 2026
CMS finalized a 2.3 percent net inpatient payment rate increase worth about $2.1 billion and expanded the Comprehensive Care for Joint Replacement model into a mandatory nationwide bundle called CJR-X starting January 1, 2028.
Why it matters This is the first time Medicare has made a bundled payment model mandatory for every eligible hospital nationwide rather than a voluntary subset, changing how hip, knee and ankle replacements get paid starting in 2028.
Deadline Aug 4, 2026
The CY2027 Hospital Outpatient and Ambulatory Surgical Center proposed rule again defers cardiovascular inpatient-only list removals to 2028 while removing about half of the remaining inpatient-only services in other specialties; public comments are due August 31, 2026.
Why it matters Cardiac procedures keep inpatient-only protection one more year, but the site-of-service migration is scheduled to reach more cardiac codes in 2028. Comments are due August 31.
Record Aug 4, 2026
Dignity Health confirmed 57 permanent layoffs at Bakersfield Memorial Hospital and a notice of 82 proposed layoffs at California Hospital Medical Center in Los Angeles, including that facility's entire pediatric nursing staff.
Why it matters A major nonprofit hospital system is cutting frontline clinical staff, including an entire pediatric nursing unit, even as its parent company markets itself as mid-turnaround, a sign of financial pressure worth watching across the nonprofit hospital sector.
Report Aug 4, 2026
A cross-sectional study in JAMA Network Open of 32 cardiology services across four major insurers found the facility fee for an implantable cardioverter-defibrillator ranged from 6,674 dollars at one insurer to 36,269 dollars at another, a greater than five-fold spread for the same procedure.
Why it matters A more than five-fold spread in facility fees for the same defibrillator implant is the evidence base behind site-neutral payment pressure. Track the facility-fee share of your highest-volume implant.
Deal Aug 4, 2026
KKR agreed to acquire Integer Holdings, the world's largest pure-play medical device contract manufacturer, for $127 per share in cash, a 52 percent premium, with the deal expected to close by year end 2026.
Why it matters A major private equity buyout of a device supply chain company signals PE appetite for medtech manufacturing; watch how new ownership affects device pricing and supply reliability.
Earnings Aug 4, 2026
Pfizer reported second quarter 2026 revenue of $15.03 billion, ahead of the $14.45 billion consensus estimate, and raised full year revenue guidance by $500 million at the midpoint.
Why it matters Pfizer's beat and second guidance raise this year signals its non-COVID product portfolio is offsetting the decline in Comirnaty and Paxlovid sales, a trend worth watching for the broader pharma sector.
Rule Aug 4, 2026
The proposed national coverage determination for transcatheter aortic valve replacement would keep procedural volume expectations for established programs, ease requirements for new centers, end coverage with evidence development for symptomatic severe aortic stenosis, and extend it to asymptomatic severe disease, with a final decision expected around September 13, 2026.
Why it matters The proposed rewrite protects incumbent heart-valve programs while making it easier for new ones to open. A final decision is expected in mid September.
Enforcement Aug 4, 2026
The Department of Justice resolved allegations that a vascular physician and practice performed medically unnecessary dialysis-access and peripheral artery disease interventions, including angioplasty, stenting, and atherectomy, and repeated them every few days or weeks without clinical benefit.
Why it matters Peripheral vascular remains the specialty's top enforcement magnet. The theory is repeat interventions without documented clinical benefit.
Report Aug 3, 2026
CMS's July 9 settlement results credit ACO REACH with $988.3 million in net savings for 2024, while the agency's own third independent evaluation found Medicare's net spending under the model still rose, 0.2 percent in 2024, and CMS has not published which ACOs were accepted into the LEAD Model's 2027 start.
Why it matters CMS's own numbers on its flagship accountable care model contradict each other right as ACOs decide whether to sign a ten-year commitment to its successor; watch for whether CMS ever reconciles the two methodologies.
Earnings Aug 3, 2026
The Medicare Advantage insurer reported adjusted EPS of $0.17 versus a $0.13 consensus, membership of 294,100 up 31 percent year over year, and raised its 2026 membership forecast, yet its stock still fell in after-hours trading.
Why it matters A Medicare Advantage insurer beat every number it promised Wall Street and grew membership fast, yet investors sold the stock anyway, a sign the market is watching profit timing and spending plans, not just top-line growth. Watch whether the company's 2027 growth-over-profit stance changes.
Enforcement Aug 3, 2026
The settlement requires Carbon Health to restructure its management services organization so licensed physicians, not the MSO, control the medical group, and holds co-founder Eren Bali personally liable.
Why it matters California just made an example of a common private-equity-style MSO structure, fining a primary care platform $4.5 million and forcing it to hand clinical control back to its doctors.
Rule Aug 3, 2026
The rule raises Inpatient Rehabilitation Facility Prospective Payment System rates by a net 2.3 percent for fiscal year 2027, effective October 1, 2026, and holds the outlier payment threshold at 3 percent of total payments.
Why it matters Medicare is paying inpatient rehab hospitals more starting in October, a modest rate bump that keeps pace with cost growth but doesn't reshape the sector.
Enforcement Aug 3, 2026
The Medicaid Fraud War Room, launched April 23, 2026, used billing-pattern analytics to identify 50 high-risk providers linked to more than $203 million in Medicaid payments in its first 88 days, per a CMS press release issued July 28, 2026.
Why it matters CMS is using data analytics instead of traditional audits to catch Medicaid fraud faster, and 50 providers have already been flagged in under three months.
Rule Aug 3, 2026
CMS's new risk-based survey process, announced via memo QSO-26-14-NH, gives nursing homes with 5-star ratings, adequate staffing scores, and no recent harm citations a streamlined inspection using fewer surveyors in roughly half the time, starting September 2026.
Why it matters About 12 percent of nursing homes will get faster, lighter federal inspections starting in September, a change patient advocates say could let problems go undetected between visits.
Deal Aug 3, 2026
Curium agreed to pay Lantheus shareholders up to $114.50 a share, $102.50 in cash plus up to $12 in contingent value rights tied to sales milestones through 2030, in a deal expected to close in the first half of 2027.
Why it matters Two of the world's largest makers of radioactive imaging and treatment drugs are combining, a bet that pairing diagnosis and treatment in one company, called theranostics, is the future of nuclear medicine. Watch whether the combined company changes access or pricing for scans used in prostate cancer and heart disease.
Report Aug 3, 2026
Hint Health's 2026 report found DPC membership growth of 837 percent from 2017 to 2025 and projects the market growing from $70.2 billion in 2025 to $75.1 billion in 2026.
Why it matters Direct primary care has quietly shifted from a niche cash-pay option to something employers now buy at scale, funding 60 percent of memberships for the first time.
Earnings Aug 3, 2026
The nation's largest medical-office-building landlord reported total revenue fell to $281.8 million on completed asset sales, posted a wider than expected GAAP loss, but raised its full-year 2026 same-store cash NOI growth guidance to 4.25-5 percent.
Why it matters The country's largest owner of medical office buildings, the outpatient clinics and imaging centers next to hospitals, is shrinking its portfolio through asset sales while the space it keeps is generating more income and staying more occupied. Watch whether this signals durable demand for outpatient care sites even as the REIT trims its footprint.
Enforcement Aug 3, 2026
CMS deferred $867.5 million of California's and $199 million of Minnesota's Medicaid spending on July 21, 2026, pending review of claims tied to high-risk providers, bringing cumulative deferrals to $2.76 billion since February.
Why it matters The federal government is withholding billions in Medicaid funding from two states pending fraud reviews, a dispute over whether delay-first enforcement is fair to states and providers.
Enforcement Aug 3, 2026
HHS's Office for Civil Rights found OSF Healthcare System failed to conduct an accurate risk analysis and did not notify 53,907 affected individuals on time after a 2021 Nephilim ransomware attack, making it OCR's 21st settlement from its ransomware enforcement initiative.
Why it matters A hospital system is paying over half a million dollars because it was slow to report a ransomware breach that exposed nearly 54,000 people's health data.
Rule Aug 3, 2026
ACOs choosing LEAD's Global Risk Option can convert all attributed beneficiaries' Medicare Parts A and B spending into a monthly capitated payment and take on 100 percent of savings or losses for a ten year term, twice MSSP's five year agreement period.
Why it matters Medicare is replacing an annual savings check with monthly capitated payments for accountable care organizations, a structural shift that locks participants in for twice as long as the current model.
Report Aug 3, 2026
Federal auditors found Georgia's Medicaid program overpaid clinical diagnostic laboratories $26.1 million on 648,412 of 13.6 million lab services from 2019 through 2023 and recommended the state refund the $18.5 million federal share.
Why it matters Federal auditors caught a state Medicaid program overpaying lab companies for years, and now want $18.5 million back.
Deal Aug 3, 2026
The $110 million round, $50 million in equity led by Andreessen Horowitz plus a $60 million debt facility led by Trinity Capital, will fund expansion of Pearl Health's AI risk-modeling platform into Medicare Advantage.
Why it matters A software platform that helps ACOs manage Medicare risk just raised the largest venture round in that niche since December, a sign investors still see opportunity even as the REACH-to-LEAD transition adds uncertainty to the payment model itself.
Deal Aug 3, 2026
Indivior shareholders will hold about 56.5 percent of the combined company, named Supernus, Inc., and receive a $1.0 billion cash dividend before closing, in an all-stock deal expected to close in the fourth quarter of 2026.
Why it matters Two central-nervous-system drugmakers, one known for ADHD and epilepsy medicines and the other for opioid-addiction treatment, are combining into an 11-medicine company. Watch whether the combined company changes access, marketing, or pricing for these drugs.
Rule Aug 2, 2026
California, Colorado and 20 other states, joined by Pennsylvania's governor, filed suit July 31, 2026 in federal court in California to block CMS's 2027 Notice of Benefit and Payment Parameters rule, citing HHS's own estimate of 5 million lost marketplace enrollees by 2030.
Why it matters A rule expanding cheaper, skimpier catastrophic plans is now in court, and the government's own numbers say millions could lose standard marketplace coverage if it survives. Watch whether the court blocks the rule before its provisions take effect.
Rule Aug 2, 2026
CMS's CMS-1851-F raises FY2027 hospice payments a net 2.3 percent for an estimated $755 million increase and makes the hospice election-statement addendum, disclosing care Medicare won't cover, mandatory for every patient starting October 1, 2026.
Why it matters Hospices get more money next year, but starting in October every hospice patient's family must get a written list of care Medicare won't pay for, a transparency requirement that used to be available only on request. Watch how hospices handle patient and family reactions to that disclosure.
Rule Aug 2, 2026
CMS's CMS-1849-F raises FY2027 inpatient hospital rates 2.3 percent for an estimated $2.1 billion increase and finalizes CJR-X, a mandatory bundled-payment model for hip, knee and ankle replacements starting January 1, 2028 at nearly every acute-care hospital.
Why it matters Medicare is paying hospitals more next year, but nearly every acute-care hospital will also be required to take on financial risk for hip and knee replacement outcomes starting in 2028. Watch how your hospital's readmission and complication rates translate into bundled-payment risk.
Enforcement Aug 2, 2026
CMS's published audit schedule opens Risk Adjustment Data Validation audits of Medicare Advantage insurers' 2024 payment records this month, ahead of Payment Year 2023 in November 2026 and the still-unaudited Payment Year 2022 in January 2027.
Why it matters Federal auditors are checking whether Medicare Advantage insurers got paid the right amount in 2024, and they're doing it before finishing an older, unaudited 2022 backlog. Watch for expanded audit findings as this rolls out under CMS's 2025 audit-acceleration push.
Deal Aug 2, 2026
Guardian Dentistry Partners announced July 15, 2026 a definitive agreement for a strategic majority acquisition of Select Dental Management, a dental support organization operating 38 locations across eight states and Washington, D.C., with closing targeted before the end of Q3 2026.
Why it matters Dental care consolidation keeps accelerating as private-equity-backed dental support organizations buy up regional networks. Watch whether financial terms surface and whether the deal closes on schedule in Q3.
Deal Aug 2, 2026
Private equity firm Knox Lane closed its all-cash acquisition of travel-nurse staffing company Cross Country Healthcare on July 21, 2026 at $13.25 a share, and carved out the company's locum tenens division to sister portfolio company All Star Healthcare Solutions.
Why it matters One private equity firm now controls two of the largest platforms in healthcare staffing, a sign of accelerating consolidation in the labor-cost side of healthcare. Watch for further roll-ups combining travel nursing, allied health and locum tenens platforms.
Enforcement Aug 2, 2026
HHS's Office of Inspector General updated its Heightened Scrutiny list July 29, 2026, naming 13 companies, including Aetna Inc. and CVS Pharmacy Inc., that settled federal fraud investigations but declined to sign a Corporate Integrity Agreement.
Why it matters Two of the biggest names in health insurance and pharmacy are now flagged on a public federal list for refusing the compliance-monitoring deal regulators normally require after a fraud settlement. Watch whether OIG escalates scrutiny of these companies further.
Report Aug 2, 2026
HHS's Office of Inspector General audited 100 claims from Hospice of the Valley, West covering July 2020 to June 2022, found 15 errors worth $69,184, and extrapolated at least $8.6 million in Medicare overpayments, which the hospice disputes.
Why it matters A federal audit sampled just 100 claims, found errors in 15 of them, and extrapolated that into an $8.6 million overpayment estimate, a reminder of how much weight small samples carry in Medicare audits. Watch whether OIG or CMS pursues collection given the hospice's refusal to concur.
Earnings Aug 2, 2026
Regeneron reported second quarter 2026 revenue of $4.291 billion, up 17 percent year over year, and non-GAAP EPS of $14.29 that beat consensus by more than $4, as Dupixent's global sales rose 38 percent to a record $6.0 billion.
Why it matters Regeneron's blowout quarter shows demand for its immunology and eye drugs keeps climbing, a sign biotech innovation is still commanding premium pricing. Watch whether Dupixent's growth holds as competitors enter the eczema and asthma space.
Record Aug 2, 2026
Wellstar notified employees July 28, 2026 that it is eliminating 761 positions, about 2 percent of its more than 35,000-person workforce, concentrated in corporate, shared-services and select administrative roles while leaving frontline clinical staff untouched.
Why it matters A major nonprofit hospital system trimming corporate staff signals financial pressure even at large, established health systems. Watch whether other Georgia or regional systems follow with similar restructuring.
Report Aug 1, 2026
Congress appropriated $345 million for AHRQ this fiscal year but the agency has spent under $15 million, halted at least 104 grants, and cut staff from about 300 to 74 amid a lawsuit by the Society for General Internal Medicine.
Why it matters This is about whether the federal government keeps funding the research that identifies unsafe hospital practices before more patients get hurt. Watch whether the lawsuit forces AHRQ to resume grant-making.
Deal Aug 1, 2026
The Belgian immunology drugmaker will pay 77 dollars a share in cash, an 86 percent premium, to gain full control of Forte's anti-CD122 antibody FB102 after it posted positive Phase 1b vitiligo data on July 9.
Why it matters A single positive early-stage trial readout turned a strategic minority stake into a full 2.2 billion dollar buyout, illustrating how fast biotech valuations move on clinical data. Watch FB102's progress toward pivotal trials in vitiligo and celiac disease.
Earnings Aug 1, 2026
The company reported 13.0 billion dollars in second-quarter 2026 revenue, up 6 percent and more than a billion dollars ahead of consensus, and raised full-year revenue guidance to 49.0 to 50.0 billion dollars.
Why it matters One of the largest US drugmakers is outgrowing patent losses on older products, a sign the broader branded-pharma sector's newer drug launches are gaining traction. Watch whether the Growth Portfolio keeps outpacing legacy drug declines.
Enforcement Aug 1, 2026
CVS Health's Omnicare unit faces an August 12 bankruptcy court hearing on its July 1 settlement resolving a decade old False Claims Act case in which a jury found more than 3.3 million false claims for prescriptions dispensed without valid orders.
Why it matters This is the closing chapter of a decade old fraud case that tests how the government prices and prosecutes dispensing without a valid prescription claims in long term care pharmacy. Watch the August 12 hearing for final court approval.
Rule Aug 1, 2026
The public comment period on excluding semaglutide, tirzepatide, and liraglutide from the section 503B Bulks List closed July 30, 2026 at 11:59pm ET, with no timeline yet announced for a final rule.
Why it matters The public's last chance to weigh in on permanently banning bulk compounded GLP-1s has passed. Watch for FDA's final rule, which has no announced timeline.
Enforcement Aug 1, 2026
The FTC's July 14, 2026 order bars Caremark from disadvantaging low list price insulin, requires a rebate pass through option, and projects up to 8.5 billion dollars in patient savings over 10 years, leaving Optum Rx as the only Big Three PBM without a final order.
Why it matters This closes one of the biggest PBM antitrust cases in years and signals that low cost insulin access terms are becoming standard practice at major pharmacy benefit managers. Watch whether Optum Rx follows with a final order.
Rule Aug 1, 2026
HRSA's revised 340B Rebate Model Pilot Program grew from about 10 drugs and eight manufacturers to as many as 25 products from 13 companies, days after a federal appeals court ruled Novartis, Johnson and Johnson Health Care Systems, Bristol Myers Squibb and Eli Lilly cannot run their own rebate models without HHS approval.
Why it matters This is about who fronts the cash for a drug discount meant for safety-net providers, the government's own program or drugmakers acting unilaterally; watch whether more manufacturers join HRSA's voluntary pilot.
Report Aug 1, 2026
NCPA's member survey found 96.5 percent of independent pharmacists say Medicare Part D reimbursement threatens their business's viability and 30.3 percent are considering closing within the year, as the industry loses roughly one independent pharmacy a day.
Why it matters Nearly every independent pharmacist says their business is at risk under current Part D reimbursement, and the industry is losing roughly one pharmacy a day. Watch whether this accelerates network consolidation in your area.
Deal Aug 1, 2026
The companies will expand KwikPen injectable-device capacity at Resilience's Cincinnati-region facilities, adding at least 400 jobs, while Resilience relocates its headquarters from San Diego to Blue Ash, Ohio.
Why it matters More US-based manufacturing capacity for GLP-1 injector pens could help ease the supply shortages that have dogged Lilly's diabetes and obesity drugs. Watch whether the early 2027 timeline holds amid continued high demand.
Rule Aug 1, 2026
CMS's interim final rule requiring most Medicaid expansion enrollees to document 80 hours a month of work, school or volunteering took legal effect July 31, 2026, two days after a federal judge denied a preliminary injunction sought by Massachusetts and 25 other states in Commonwealth of Massachusetts et al. v. Oz et al.
Why it matters This changes whether millions of Medicaid expansion enrollees keep coverage based on documenting work or school hours; watch the notification deadline and whether the underlying lawsuit over the medically-frail exemption succeeds.
Enforcement Aug 1, 2026
A report this week found Centers Health Care, a 37-facility New York nursing home chain that paid $45 million in 2024 to settle Medicaid fraud and neglect claims, still in violation of that settlement, including a March 2026 inspection that found residents at risk of hypothermia, as the state's monitoring period closes July 31, 2026.
Why it matters This is about whether a nursing home chain that already admitted to diverting Medicaid funds from resident care is actually fixing conditions, right as state oversight of it is set to end.
Deal Aug 1, 2026
The Swiss plasma-therapeutics maker will invest 1.5 billion dollars and create about 1,500 jobs at Palmetto Research Park after Rock Hill's city council voted 7 to 0 on July 24 to approve the land sale and tax incentive package.
Why it matters A major foreign drugmaker is building its first US factory, adding domestic capacity for plasma-derived medicines used in trauma and critical care. Watch whether the mid-2030s timeline holds and how the local tax fight resolves.
Deadline Aug 1, 2026
CMS's deadline for applicable clinical laboratories to report private-payer rate and volume data for January through June 2025 passed at 11pm Eastern on July 31, 2026, with penalties up to $10,000 per day for noncompliance, and the data will set Medicare lab payment rates for 2027 through 2029.
Why it matters This determines how much Medicare pays for lab tests nationally for three years starting in 2027; watch how many labs actually reported and whether CMS enforces the daily penalty.
Report Aug 1, 2026
Practice management and billing vendor Unlimited Technology Systems began notifying more than 442,000 affected patients on July 21, 2026, nine months after an October 2025 ransomware intrusion exposed health insurance, diagnosis, and Social Security data.
Why it matters A single back-office vendor's ransomware breach exposed data on hundreds of thousands of patients across unrelated practices nationwide, and the nine-month gap before notification highlights how slow breach disclosure can be. Watch whether more state attorneys general disclose additional affected totals.
Deal Aug 1, 2026
A Warburg Pincus led investor group partnered with the Abu Dhabi Investment Authority agreed on July 13, 2026 to acquire a controlling interest in PANTHERx Rare from sellers Nautic Partners, General Atlantic, and the Vistria Group, who will retain minority stakes.
Why it matters Private equity keeps paying premium prices for the infrastructure behind specialty drug distribution rather than the drugs themselves. Watch for regulatory clearance before the deal closes.
Enforcement Jul 31, 2026
Access DX Laboratory, former CEO Michael Stewart and Florida businessman Harold Shatz agreed to pay a combined $36.4 million to settle False Claims Act allegations of kickbacks for referrals, unbundled billing and medically unnecessary genetic testing from January 2018 through January 2020.
Why it matters A genetic-testing lab and two executives are paying $36.4 million after a whistleblower exposed a scheme that paid for referrals and unbundled billing codes for tests patients didn't need. It shows how one tipster can unwind a multi-year fraud scheme and trigger criminal pleas.
Report Jul 31, 2026
CMS's ACO REACH settlement results report $988.3 million in net savings for performance year 2024, while CMS's separately published independent evaluation of performance year 2023 found net Medicare spending rose 0.8 percent under a different comparison methodology.
Why it matters CMS's own numbers disagree with each other on whether its flagship Medicare ACO model actually saves the program money, depending on which measurement method is used.
Rule Jul 31, 2026
CMS finalized its FY2027 hospice rule, publishing named Service and Spending Variation Index scores for 6,673 hospices for the first time and requiring a mandatory written non-hospice-coverage addendum for elections beginning October 1, 2026.
Why it matters Medicare published, for the first time, named risk scores for individual hospices meant to flag which ones shift costs onto other parts of the program, worth watching for how aggressively CMS acts on them.
Rule Jul 31, 2026
CMS finalized CMS-1847-F on July 29, 2026, raising Inpatient Psychiatric Facility PPS rates by a net 2.3 percent for fiscal year 2027 and capping facility-level outlier payments at 20 percent of total payments starting fiscal year 2028.
Why it matters This raises what Medicare pays psychiatric hospitals for patient care next year and adds a new limit on how much a hospital can collect for its most expensive psychiatric admissions starting in 2028. Watch whether the outlier cap changes how hospitals handle high-cost patients.
Rule Jul 31, 2026
CMS finalized a 2.4 percent net FY2027 payment increase for skilled nursing facilities, an estimated $882.74 million aggregate increase, five months after MedPAC recommended a 4 percent cut citing a 24.4 percent industry profit margin.
Why it matters CMS raised Medicare payments to nursing homes even after its own advisers said industry margins were already high, a sign the agency did not follow MedPAC's rate advice this cycle.
Rule Jul 31, 2026
CMS's CY2027 OPPS proposed rule makes the Emergency Care Access and Timeliness measure, which tracks wait times, boarding over four hours, and ED stays over eight hours, voluntary for CY2027 and mandatory for CY2028 with comments due August 31, 2026.
Why it matters This sets a real deadline for hospitals to publicly report ER wait times and boarding, a measure meant to make crowding visible before it becomes tied to Medicare payment in CY2030. Watch the August 31, 2026 comment deadline if you want to weigh in.
Deadline Jul 31, 2026
The D.C. Department of Health Care Finance is automatically reassigning everyone enrolled in Elevance Health's Wellpoint DC Medicaid plan to AmeriHealth Caritas DC effective August 1, 2026, with a continuity period through October 31, 2026 and a window until January 31, 2027 to instead choose MedStar Family Choice DC.
Why it matters Elevance is walking away from its Washington D.C. Medicaid contract because the numbers don't work, and 250,000 enrollees get automatically moved to a new plan starting tomorrow. Watch for Elevance to name more state Medicaid exits over the next 12 to 18 months.
Report Jul 31, 2026
BCC Research reported that decentralized clinical trial platforms, led by Medable's $506.6 million in total funding, have raised more than $650 million as AI tools are pitched to fix low enrollment and costly trial delays in an $8.5 billion market.
Why it matters A corner of the drug-development supply chain, decentralized clinical trials, is drawing AI investment pitches aimed at fixing chronic enrollment failures and costly delays.
Enforcement Jul 31, 2026
Laurent Cassagnol, a VA Community Care Program employee, and Heriberto Rivera, CEO of Family Integrative Medicine of Orlando, pleaded guilty to conspiracy to pay and receive kickbacks after steering VA patients to the clinic for holistic services that billed the VA more than $14 million and were paid more than $11 million.
Why it matters A VA employee and a veterans' clinic CEO admitted to a scheme that billed the VA more than $14 million for holistic care services steered through kickbacks. It's a reminder that VA Community Care referrals face the same fraud scrutiny as Medicare and Medicaid.
Report Jul 31, 2026
LevinPro HC reported 459 healthcare deals in Q2 2026, down 23 percent from 503 a year earlier, while disclosed dollar volume reached $95.3 billion, more than triple the prior-year quarter, driven by 21 deals exceeding $1 billion.
Why it matters Fewer healthcare deals closed last quarter, but far more money changed hands, driven by a jump in billion-dollar-plus transactions, meaning consolidation is concentrating in fewer, larger deals.
Rule Jul 31, 2026
A finalized federal rule cut the No Surprises Act's per party filing fee from $115 to $15 effective June 11, 2026 and allows batching up to 50 line items per dispute, though emergency E/M codes 99281 through 99285 still cannot be batched across patients.
Why it matters The federal dispute process used most by emergency doctors just got cheaper to file into, and analysts expect that to pull in about 30 percent more disputes, which is a volume and staffing issue as much as a policy change. Watch your own IDR filing volume against this projection.
Enforcement Jul 31, 2026
The Maryland Insurance Administration fined Cigna $80,000 on March 13, 2026 for automatically downcoding E/M claims under Policy R49, then extended the ban on unilateral algorithmic downcoding to every insurer in the state on April 7, 2026.
Why it matters This matters because a state regulator forced an insurer to stop quietly cutting doctors' billing codes with an algorithm, and the fix now applies to every insurer in Maryland, not just Cigna. Watch whether other states follow Arkansas, Virginia, and pending New York legislation.
Record Jul 31, 2026
Mount Carmel Health System will close its freestanding Franklinton Emergency Department on August 22, 2026 and open a walk-in primary care clinic two blocks away two days later, leaving Grant Medical Center as the nearest ER about two miles away.
Why it matters This shows a large urban hospital system making the same shrink-the-ER trade that federal rural funding is pushing, on its own balance sheet, which suggests the economics apply beyond rural markets. Watch whether other urban systems follow with similar freestanding ED closures.
Funding Jul 31, 2026
CMS caps direct patient care spending at 15 percent of the $50 billion Rural Health Transformation Program, and at least 25 states are using the money to convert full service EDs into smaller facilities rather than expand emergency care.
Why it matters This affects how rural hospitals near you may change over the next few years, since federal money meant to help them is being used to shrink services like full ERs, maternity, and dialysis rather than expand them. Watch whether your local rural hospital converts to a Rural Emergency Hospital.
Record Jul 31, 2026
The agreement, reached July 31, 2026, preserves in-network access for more than 60,000 UHealth patients across commercial, individual and Florida Medicaid plans, with financial terms undisclosed.
Why it matters The deal avoided a network disruption for tens of thousands of patients, showing how public negotiation pressure can resolve a payer-provider standoff before a deadline.
Report Jul 30, 2026
An AMA Policy Research Perspective found OB/GYN liability premiums for 2025 reached $243,988 in Miami-Dade County and $159,537 in Connecticut, with career-lifetime OB/GYN malpractice claim rates near 60 percent.
Why it matters This shows OB/GYN malpractice insurance costs have now climbed for seven straight years, the longest run since the early 2000s.
Enforcement Jul 30, 2026
DOJ declined to prosecute Campus Eye Management under its self-disclosure policy in exchange for $1 million in restitution while indicting former CEO E. Bruce DiDonato on seven counts tied to about $3.4 million in fraudulent billings and kickbacks to ophthalmologists.
Why it matters A company that caught and reported its own Medicare fraud avoided criminal charges entirely, while its founder was indicted alone, showing self-disclosure can work if you act fast.
Earnings Jul 30, 2026
Cigna reported second quarter 2026 revenue of 71.7 billion dollars, up 7 percent year over year and above analyst estimates, and raised its full year adjusted earnings per share guidance to at least 30.45 dollars.
Why it matters This is the first scorecard on Cigna's new CEO, and the numbers came in strong, but watch the medical care ratio for signs of rising costs across the industry.
Rule Jul 30, 2026
CMS's CY2027 Medicare Physician Fee Schedule proposed rule adds 15 new G-codes to preserve the legacy bundled maternity payment structure alongside the AMA's new unbundled per-visit codes, both set to take effect January 1, 2027, and ACOG and OBHG have formally opposed the dual system.
Why it matters This is about how complicated OB billing will get in 2027, and whether CMS keeps both an old and new coding system running side by side.
Rule Jul 30, 2026
CMS-1843-F raises skilled nursing facility Medicare rates 2.4 percent for an estimated $882.74 million aggregate increase while requiring all SNFs to submit resident assessment data regardless of payer.
Why it matters Medicare is paying skilled nursing facilities more next year, but the tradeoff is that every nursing home, not just Medicare-billing ones, now has to report detailed patient data faster.
Enforcement Jul 30, 2026
The Justice Department's National Fraud Enforcement Division charged 17 cases totaling more than $350 million in intended losses and signed data-sharing agreements covering SNAP, SBA loan and Medicaid records with Alabama, Florida, Georgia, Louisiana, Mississippi, North Carolina and South Carolina.
Why it matters The federal government just made it easier to catch Medicaid and benefits fraud in seven Southeastern states by linking government databases together, and 17 cases are already charged.
Earnings Jul 30, 2026
Grifols reported first half 2026 revenue up 2.6 percent to 3.6 billion euros and net profit up 28.7 percent to 227 million euros, even as it absorbs restructuring costs from closing 29 US donor centers under a new dual operating model that separates its US plasma division from its global structure.
Why it matters The world's largest plasma collector is restructuring its US operations, a supply chain shift worth watching if you or someone you know depends on plasma-derived treatments for immune disorders or rare diseases.
Deal Jul 30, 2026
Included Health announced July 29, 2026 that it struck a deal to acquire virtual-first primary and specialty care practice Firefly Health, with undisclosed terms and an expected close in the third quarter of 2026.
Why it matters Two virtual care companies are combining to offer employers a lower cost alternative to traditional health insurance, a trend worth watching if your employer offers virtual-first health plans.
Deal Jul 30, 2026
Johnson & Johnson completed a 1 billion dollar cash acquisition of oncology biotech Firefly Bio and struck a 785 million dollar initial agreement with an option to acquire Sail Biomedicines for 2.58 billion dollars, cutting its 2026 adjusted earnings per share guidance by about 64 cents.
Why it matters J&J chose to absorb a near term profit hit to buy into next-generation cancer and autoimmune disease technology, a bet that the science pays off later even as this year's numbers take a hit.
Record Jul 30, 2026
MaineHealth's Lincoln Hospital in Damariscotta runs a 5.56 percent operating margin and 43 percent birth-volume growth since 2019, yet its board votes August 5, 2026 on closing Labor and Delivery, with 60 percent of deliveries billed to Medicaid and the nearest alternative 45 minutes away.
Why it matters This shows profitable rural hospitals are still closing maternity units, so watch whether the August 5 board vote confirms it and what happens to your own local options.
Rule Jul 30, 2026
Judge Richard Stearns ruled July 29, 2026 that 26 states and DC failed to show unrecoverable harm since CMS agreed to reimburse 90 percent of implementation costs, leaving the rule on track for January 1, 2027.
Why it matters This keeps Medicaid work requirements on track to start January 1, 2027, so if you or someone you know is on Medicaid, watch for a notice by August 31, 2026 explaining how to comply or claim an exemption.
Enforcement Jul 30, 2026
Dr. Valinda Nwadike agreed to a False Claims Act settlement for signing thousands of prescriptions for compounded drugs and durable medical equipment for patients she never examined between November 2014 and January 2018, claims that Medicare and TRICARE ultimately paid.
Why it matters This shows federal fraud enforcement reaching physicians who sign off on prescriptions arranged by telemarketers without examining patients.
Record Jul 30, 2026
The Senate HELP Committee voted 13 to 10 to advance Erica Schwartz's nomination as CDC director and unanimously advanced the Health Information Privacy Reform Act extending HIPAA-style rules to health apps and wearables.
Why it matters A Senate committee moved forward on both a controversial CDC director pick and a new bill that would bring HIPAA-style privacy protections to health apps and wearables for the first time.
Deal Jul 30, 2026
Organon shareholders approved Sun Pharmaceutical Industries' all-cash acquisition on July 24, 2026, the largest overseas acquisition by an Indian pharmaceutical company in history, with the deal expected to close in early 2027 pending remaining regulatory clearances.
Why it matters This is the largest pharma deal of the year and it puts one of the two dominant global contraceptive makers under new Indian ownership.
Deadline Jul 30, 2026
As of July 30, 2026, UHealth and UnitedHealthcare have not reached a new contract, and if the July 31 deadline passes, UHealth's hospitals, clinics and physicians go out of network for UnitedHealthcare's commercial, ACA exchange and Medicaid plans starting August 1.
Why it matters If you or someone you know is a UnitedHealthcare member who uses UHealth or Bascom Palmer Eye Institute, a missed deadline tomorrow could mean losing in-network access starting August 1.
Earnings Jul 30, 2026
Ventas reported second quarter 2026 results that beat Wall Street estimates, closed 2.2 billion dollars in senior housing investments during the quarter, and raised its full year 2026 senior housing investment target by 50 percent to more than 4.5 billion dollars.
Why it matters A major healthcare landlord is betting big on senior housing demand outpacing new supply, a trend worth watching if you or a family member may need senior living in the next few years.
Rule Jul 30, 2026
A bipartisan Wisconsin law extending Medicaid postpartum coverage from 60 days to 12 months took effect July 1, 2026, an estimated benefit to more than 16,000 low-income mothers, leaving Arkansas as the only state without a full postpartum year.
Why it matters This closes the gap on postpartum Medicaid coverage nationwide, leaving Arkansas as the only state that still cuts new mothers off at 60 days.
Deadline Jul 30, 2026
Senate Finance Committee Democrats led by Ron Wyden released an 86-page request for information seeking public feedback by October 2, 2026 on proposals to lower premiums and deductibles and simplify enrollment.
Why it matters Senate Democrats want to hear from the public by October 2, 2026 on ideas to lower what people pay for private health insurance, though they cannot force a vote on any resulting bill.
Earnings Jul 29, 2026
Boston Scientific reported Q2 2026 net sales of 5.442 billion dollars, up 7.5 percent, and adjusted EPS of 0.86 dollars beating its own guidance range, but full year adjusted EPS guidance of 3.28 to 3.32 dollars sits just under Wall Street's 3.36 dollar consensus.
Why it matters Boston Scientific topped Wall Street's Q2 estimates and shares rose more than 3 percent, though full-year guidance landed just under consensus. Watch whether device demand holds up in the second half.
Enforcement Jul 29, 2026
CMS said the task force, launched April 23, 2026, has taken coordinated action against 50 high-risk Medicaid providers whose billing totals more than $203 million now facing federal exclusion and state enforcement.
Why it matters A new federal-state data-sharing effort is catching suspect Medicaid billing before payment goes out rather than clawing it back later. Watch for more provider exclusions as the program matures.
Rule Jul 29, 2026
CMS confirmed July 28, 2026 it will discontinue the Part D Premium Stabilization Demonstration at the end of this year, raising the 2027 base beneficiary premium from $38.99 to $41.33.
Why it matters This raises what many Medicare drug plan enrollees pay starting in 2027, though CMS says most will see only modest increases or none at all. Watch your own plan's premium notice this fall.
Deal Jul 29, 2026
A faith coalition and a Weld County resident sued Hudson, Colorado on July 23, 2026, arguing the town let GEO Group skip zoning approval to reopen a shuttered prison as a 1,200-bed immigration detention center.
Why it matters This is a local zoning fight over a large federal detention contract, and the outcome could set precedent for whether federal contracting preempts local zoning nationwide. Watch for a hearing date.
Deal Jul 29, 2026
Doctronic, an AI-assisted telehealth startup that has raised 65 million dollars in under a year, acquired text-based pediatric telehealth service Summer Health for an undisclosed amount to expand into pediatric care.
Why it matters An AI telehealth startup is using nearly a year of rapid fundraising to expand from adult triage into pediatric care by acquiring Summer Health. Watch how AI chatbots handling patient triage scale into new clinical populations.
Rule Jul 29, 2026
The FDA's Oncology Center of Excellence finalized three guidances, announced in the Federal Register July 28, 2026, urging researchers to drop unjustified lab-value cutoffs, washout periods and fitness thresholds that currently screen out otherwise eligible cancer patients.
Why it matters Only 3 to 5 percent of cancer patients enroll in trials today, and this guidance aims to widen who qualifies without changing what's being tested. Watch whether enrollment and trial diversity actually improve, since this is a recommendation, not a mandate.
Earnings Jul 29, 2026
Humana reported Q2 2026 net income of 694 million dollars and adjusted EPS of 7.61 dollars, beating Wall Street's 7.23 dollar estimate, but cut its full year GAAP EPS guidance floor to at least 6.52 dollars from at least 8.36 dollars after its medical benefit ratio rose to 91.2 percent.
Why it matters Humana beat Wall Street's profit estimate but warned the rest of the year could be rougher by cutting its GAAP profit guidance floor. Watch whether Medicare Advantage medical costs keep climbing through the second half.
Report Jul 29, 2026
An estimated 20 million Americans owe roughly 220 billion dollars in medical debt, and market researchers project the healthcare buy now pay later financing segment will grow from 6.14 billion dollars in 2026 to 17.89 billion dollars by 2034.
Why it matters An estimated 20 million Americans carry medical debt totaling roughly 220 billion dollars, and a buy now pay later industry is growing quickly to finance it. Watch whether this financing helps patients or adds new debt burden.
Deadline Jul 29, 2026
The Senate HELP Committee rescheduled its vote on CDC director nominee Erica Schwartz to July 30, 2026, after Senator Lisa Murkowski's absence delayed the original July 23 vote, alongside a bill extending privacy rules to health apps and wearables.
Why it matters A Senate committee is set to vote on who runs the CDC and on a bill that would bring privacy rules to health apps and wearables that HIPAA does not currently cover. Watch the July 30 vote outcome.
Record Jul 29, 2026
As of July 29, 2026, UHealth and UnitedHealthcare have not reached a new contract, and hundreds of thousands of patients face going out of network for commercial, ACA exchange and Medicaid plans starting August 1 if no deal is struck by the July 31 deadline.
Why it matters Miami's academic health system and the nation's largest insurer are two days from a deadline that could push hundreds of thousands of patients out of network. Watch whether a deal is reached by July 31.
Deal Jul 28, 2026
CARPL.ai, whose platform connects radiology groups to more than 300 AI applications from over 100 vendors, closed a $10 million Series A led by the International Finance Corporation with participation from existing investor Stellaris Venture Partners to fund global expansion.
Why it matters Capital is still flowing into radiology AI infrastructure even while Medicare is still working out how to pay for the AI tools themselves. It signals investor confidence in AI adoption broadly, not in any single diagnostic product.
Earnings Jul 28, 2026
Centene's health benefits ratio fell to 89.6 percent from 93.0 percent a year earlier, driving second quarter 2026 revenue to 53.58 billion dollars and adjusted EPS of 2.51 dollars, while Marketplace enrollment under the Ambetter brand dropped to 3.5 million from 5.8 million.
Why it matters Centene is the country's largest Medicaid insurer, so its swing back to profit signals that the industry's 2025 cost spike may be easing, but its own numbers show a shrinking ACA marketplace book as subsidies lapse.
Rule Jul 28, 2026
CMS's CY2027 hospital outpatient proposed rule creates a new Software as a Medical Service billing category covering 36 codes, mostly radiology and cardiac imaging AI, and moves 21 of them onto a temporary New Technology APC track that holds payment near 2026 levels.
Why it matters Medicare is for the first time proposing to pay for AI software as its own billable service, which could reshape how hospitals adopt diagnostic AI tools. Watch whether this new category survives into the final rule this fall.
Rule Jul 28, 2026
CMS's proposed CY2027 physician fee schedule cuts the base conversion factor 1.68 percent for non-APM physicians, but ACR's analysis of the rule's practice-expense changes projects diagnostic radiology and nuclear medicine up 2 percent and interventional radiology and radiation oncology up 3 percent if finalized as proposed.
Why it matters A Medicare rule that looks like a pay cut on its face actually helps most imaging specialties once the underlying cost-allocation math is applied. It is a reminder to read past the headline conversion factor number.
Deal Jul 28, 2026
Erlanger's board has approved a non-binding letter of intent to become a wholly owned subsidiary of Prisma Health, which would invest 2 billion dollars over 15 years while Erlanger keeps a local governing board for up to nine years and two seats on Prisma's 11 member corporate board.
Why it matters A Tennessee safety-net hospital trading independence for capital is part of a broader wave of financially stretched systems seeking well-capitalized nonprofit partners; watch the 120-day due diligence period and required regulatory approvals.
Enforcement Jul 28, 2026
A federal judge sentenced the CEO to 48 months, the medical director to 60 months, and the billing manager to 24 months, and ordered 812,881 dollars in restitution for billing Medicare and Medicaid for opioid-addiction treatment that was never rendered or was billed as more complex than it was.
Why it matters This is a reminder that addiction-treatment billing fraud carries real prison time, not just fines, and that patient records can become evidence in these cases.
Rule Jul 28, 2026
25 states and DC are seeking a preliminary injunction against a June 3 interim final rule that adds a significant impairment standard to the medically frail exemption from Medicaid work requirements taking effect January 1, 2027.
Why it matters This case will decide who gets excused from proving they are working to keep Medicaid, including people in stable addiction recovery; watch for a ruling and whether it gets appealed.
Report Jul 28, 2026
Deal count fell to 51 transactions and disclosed dollar volume dropped to 272.1 million dollars across 13 priced deals, down from 927 million dollars across 34 priced deals in the first quarter, according to LevinPro HC.
Why it matters A slowdown in one of healthcare real estate's steadiest niches signals capital markets caution is spreading even to outpatient building investment, which tracks the broader shift of care away from inpatient hospital settings.
Enforcement Jul 28, 2026
Four men used their company, Brilliant Minds Services LLC, to bill Minnesota Medicaid's Housing Stabilization Services program for services roughly 350 disabled people never received, then used AI chatbots to fake records for investigators.
Why it matters This shows fraud schemes now using AI to generate fake documentation, a pattern the public and investigators should expect to see more of in Medicaid fraud cases.
Enforcement Jul 28, 2026
Mt. Baker Imaging and Northwest Radiologists agreed to a $3.3 million non-reversionary class-action settlement in Whatcom County Superior Court covering roughly 340,184 patients whose data was exposed in a January 2025 ransomware attack, with claims due August 19, 2026.
Why it matters A single ransomware attack on two small imaging practices turned into a multimillion-dollar settlement affecting hundreds of thousands of patients, showing how costly a healthcare data breach can get regardless of the practice's size. Watch the August 21 final approval hearing.
Deal Jul 28, 2026
Novanta paid 1.2 billion dollars in cash plus a 250 million dollar milestone due in early 2027 for Riverpoint Medical's surgical fiber consumables business, a deal that roughly doubles Novanta's recurring medical device revenue to about 300 million dollars.
Why it matters A device maker doubling its recurring medical revenue overnight shows continued consolidation in surgical consumables, a corner of the medical device market tied to elective procedure volume.
Rule Jul 28, 2026
Representatives John Joyce, Greg Murphy, and Kim Schrier introduced the Patients First Act on July 14, 2026, which incorporates the ROOT Act's provisions reviving Medicare's imaging appropriate-use-criteria program through clinical decision support rather than the rescinded claims-reporting requirement.
Why it matters A bill to revive Medicare's shelved imaging-guideline-checking program just got a stronger legislative vehicle, backed by physician co-chairs of both House Doctors Caucuses. Passage timing is still uncertain since the bill has not had a committee vote.
Deal Jul 28, 2026
TerraPower Isotopes is building a $450 million, 250,000-square-foot actinium-225 manufacturing facility in Philadelphia, expected to start production in 2029 and, combined with its Everett, Washington site, grow the company's isotope output twentyfold while a Bristol Myers Squibb trial has already paused enrollment for lack of supply.
Why it matters Theranostics and radiopharmaceutical treatments depend on an isotope that decays within about ten days and cannot be stockpiled, so today's cancer care growth is capped by a supply chain that will not meaningfully expand until 2029. Watch actual production ramp-up, not just the announced capacity target.
Deadline Jul 28, 2026
Without a new agreement by July 31, UHealth's hospitals, clinics and physicians go out of network August 1 for UnitedHealthcare's commercial, ACA exchange and Medicaid plans, though Medicare Advantage members are protected through August 31 under a separate carve out.
Why it matters If the deadline is missed, hundreds of thousands of Miami-area UnitedHealthcare members lose in-network access to UHealth's hospitals and specialists, including the Bascom Palmer Eye Institute, starting August 1.
Rule Jul 27, 2026
The U.S. District Court for the District of Maryland ruled July 16, 2026 to stay eight provisions of CMS's 2027 Notice of Benefit and Payment Parameters final rule, days before they were set to take effect July 20.
Why it matters This pause means the marketplace plans you might buy for 2027 will look more like today's plans for now, since expanded out-of-pocket maximums and looser network rules are on hold while the case proceeds.
Deal Jul 27, 2026
American Industrial Partners paid 25.00 dollars a share in cash to take Avanos Medical, a maker of pain management, respiratory and enteral feeding devices, off the New York Stock Exchange.
Why it matters A well known medical device maker used in hospitals and homes is now privately held, which can mean less public financial disclosure and different investment priorities going forward.
Alert · now Jul 27, 2026
CISA, the NSA, the FBI and the Defense Cyber Crime Center published advisory AA26-194A naming healthcare among the critical infrastructure sectors targeted by Russian Federal Security Service-linked actors exploiting poorly configured or unpatched routers and networking devices.
Why it matters This is a direct federal warning naming healthcare as a target for Russian state-sponsored hacking of network equipment, a different threat than the ransomware attacks hospitals usually hear about.
Rule Jul 27, 2026
The proposed CY2027 ESRD PPS rule would raise the per-treatment base rate to $299.55, a projected 1.1 percent overall payment increase, while retiring the Hypercalcemia quality measure and adding a new post-TDAPA drug payment category.
Why it matters Medicare pays for the vast majority of dialysis treatments, so this rate sets the baseline economics for the whole industry; watch whether the 1.1 percent bump survives to the final rule this fall.
Deal Jul 27, 2026
Dentalcorp, Canada's largest dental service organization, acquired 21-practice Florida group Northstar Dental Partners, marking its entry into the US market and pushing its supported network past 650 practices.
Why it matters Dental care consolidation keeps accelerating, with a major Canadian consolidator now entering the US market for the first time, a trend that affects how much choice patients have among dental providers over time.
Report Jul 27, 2026
USRDS data show the national ratio of dialysis facility openings to closures fell from 8.9 in 2018 to 0.8 in 2024, with closures concentrated among rural, smaller, and dual-eligible-heavy clinics.
Why it matters Access to dialysis care is shrinking in rural and low income areas even as larger, better capitalized facilities expand, a trend worth watching for its effect on patient travel burden and outcomes.
Enforcement Jul 27, 2026
CMS filed a notice of appeal around July 21, 2026 to the Eleventh Circuit challenging a Georgia court's May 29, 2026 ruling that it used unlawful measures in Clover Health's star rating, while Elevance Health, SCAN Health Plan and Alignment Healthcare separately sue over the same recalculation issue seeking a combined 290 million dollars.
Why it matters This is a fight over the formula that generates Medicare Advantage star ratings and bonus payments, and CMS choosing to appeal instead of pay signals a longer legal fight over how those ratings get calculated.
Deal Jul 27, 2026
First Choice Healthcare Solutions and Nasdaq listed Westin Acquisition Corp will combine into Wellgevity 360, Inc., valuing the longevity and regenerative medicine clinic chain at approximately 650 million dollars on a pro forma basis, with closing expected in the fourth quarter of 2026.
Why it matters A chain of longevity and wellness clinics is taking the public markets route through a SPAC merger, a sign of continued investor appetite for consumer facing longevity and wellness care.
Record Jul 27, 2026
CareSource is rescinding a 20 percent reimbursement cut on special-needs therapy services that had been set to take effect May 11, 2026 for some but not all providers in its network.
Why it matters This shows how a Medicaid managed-care rate cut aimed at special-needs therapy providers got partially walked back after pressure, but not evenly, leaving some clinics still facing a cut that could hurt access to care for children who depend on it.
Rule Jul 27, 2026
A meta-analysis of 19 trials found GLP-1 receptor agonists cut kidney function decline by 12 percent and mortality by 14 percent without reducing progression to kidney failure, while Medicare's IOTA model doubled hospitals' maximum transplant incentive to $15,000 in its second performance year starting July 1, 2026.
Why it matters Two separate trends are moving at once: GLP-1s are extending time on dialysis rather than preventing it, and Medicare is now paying hospitals more to do transplants while paying nephrology referral sources less.
Rule Jul 27, 2026
CMMI extended the Kidney Care Choices model through 2027 but eliminated the per-beneficiary transplant bonus, cut quarterly chronic kidney disease capitation payments by 50 percent, and added a 1 percent benchmark discount after the model posted $304 million in net losses.
Why it matters This is a real cut to a Medicare value based kidney care program that lost money; watch how many nephrology practices stay in the model through 2027 versus shifting to MSSP ACOs.
Enforcement Jul 27, 2026
Dr. Feliciano Serrano and his practice agreed to pay $6.73 million to resolve False Claims Act allegations that he performed medically unnecessary stents, atherectomies, and angioplasty on dozens of dialysis and peripheral artery disease patients from 2016 to 2024.
Why it matters This is the latest in a pattern of federal fraud enforcement targeting dialysis vascular access procedures, an area where procedure volume per patient draws close scrutiny.
Deal Jul 27, 2026
Strive Health closed a $550 million Series D round in September 2025, split between equity led by New Enterprise Associates and debt financing, pushing its valuation to $1.8 billion while it works with more than 6,500 providers covering about 145,000 kidney disease patients.
Why it matters This valuation is the reference point for how much capital is flowing into value based kidney care platforms that sit between nephrology practices and Medicare; watch how competitors' valuations compare.
Deadline Jul 27, 2026
UHealth, the University of Miami's health system, and UnitedHealthcare remain without a new contract as of July 27, with UHealth's hospitals, clinics and physicians set to go out of network August 1 for commercial, ACA exchange and Medicaid plans if the July 31 deadline is missed.
Why it matters Hundreds of thousands of Miami area patients could lose in network access to a major academic health system in days if no deal is reached, a reminder that provider payer contract fights can hit patients directly.
Earnings Jul 27, 2026
Universal Health Services cut its full year 2026 adjusted EPS and EBITDA guidance and reported a shrinking free cash flow margin, citing a 72 million dollar Florida Medicaid and reserve hit.
Why it matters This is a snapshot of hospital industry health: a big operator's revenue beat masks weaker profit expectations and cash generation, a signal investors read as a warning about margins ahead.
Record Jul 27, 2026
More than seven months after December 12, 2025 oral argument in U.S. ex rel. Zafirov v. Florida Medical Associates, the Eleventh Circuit has not issued an opinion on whether the False Claims Act's qui tam whistleblower provisions are unconstitutional.
Why it matters If the qui tam provisions are struck down, whistleblowers could lose the ability to sue over Medicare and Medicaid fraud on the government's behalf, which currently drives most federal fraud recovery dollars.
Deal Jul 26, 2026
Private-equity-backed staffing platform Care Career acquired MAS Medical Staffing, pushing combined annualized revenue above $150 million toward a stated goal of exceeding $250 million by the end of 2026.
Why it matters This is part of a broader wave of private-equity-backed consolidation in healthcare staffing as travel-nurse demand normalizes.
Rule Jul 26, 2026
CMS published a Federal Register notice on July 27, 2026 approving a six-year renewal of the National Committee for Quality Assurance's deeming authority to accredit Medicare Advantage HMOs and PPOs in place of direct federal inspection.
Why it matters A private accreditor keeps its power to certify Medicare Advantage plans, the option more than half of Medicare enrollees now choose, without a fresh government re-evaluation of that process for six years.
Enforcement Jul 26, 2026
HHS said July 21, 2026 it is deferring about $867.5 million in Medicaid matching funds from California, largely tied to in-home care programs, and about $199 million from Minnesota across 14 claims categories, pending a fraud and noncompliance review.
Why it matters If you live in California or Minnesota and rely on Medicaid, especially in-home care, watch for payment or service disruptions while the review is underway.
Record Jul 26, 2026
A House Oversight subcommittee roundtable examined why Medicare Part B spending on skin substitutes, which grew from about 200 million dollars in 2019 to more than 14.4 billion dollars in 2025, has not been curbed despite a CMS rule effective January 1, 2026 that set a single payment rate of 127.14 dollars per square centimeter.
Why it matters Medicare spending on wound-care skin substitutes grew 7,100 percent in six years, and lawmakers are questioning whether a rate cut already in effect is enough to stop the fraud; watch for any legislation coming out of this roundtable.
Record Jul 26, 2026
The House Energy and Commerce Committee voted 45-0 for H.R. 9393 and the Senate HELP Committee voted 21-1 for S. 2355, both requiring hospitals, labs, surgery centers, and pharmacy benefit managers to disclose real negotiated prices, but neither has a floor vote scheduled.
Why it matters Two bills forcing real price disclosure from hospitals and PBMs cleared committee within a day of each other, but neither is scheduled for a floor vote yet, so no new transparency rule is imminent.
Report Jul 26, 2026
A Maine jury awarded $17 million over a wrong-organ removal, the fourth verdict against Northern Light Health in 2026, as AMA data shows medical liability premiums rose for a seventh straight year in 2025 and insurers respond by consolidating.
Why it matters This is part of a broader trend of rising malpractice verdicts and insurance costs that can eventually show up in what providers charge and where they choose to practice.
Report Jul 26, 2026
The Massachusetts Division of Insurance renegotiated lower 2027 merged-market rate increases with seven insurers and rejected Fallon Community Health Plan's initial 25.7 percent increase request, saving an estimated 72 million dollars for about 670,000 residents and businesses.
Why it matters State regulators pushed back on insurer rate requests and say they saved residents and small businesses an estimated 72 million dollars, though average premiums are still rising for 2027.
Rule Jul 26, 2026
A federal district court in Massachusetts will hold a July 28, 2026 hearing on a preliminary injunction request from 25 states and D.C. challenging a June 3, 2026 interim final rule that narrows the medically frail exemption from Medicaid work requirements.
Why it matters This fight decides how easily sick or disabled Medicaid enrollees can be exempted from proving they work once new requirements start January 1, 2027. Watch the July 28 hearing outcome for whether the narrower standard survives.
Report Jul 26, 2026
The HHS Office of Inspector General reported that state Medicaid managed care contracts give insurers anywhere from 1 to 270 days, or no deadline at all, to refer suspected provider fraud, and recommended CMS require prompt referrals and specify consequences for noncompliance.
Why it matters A federal watchdog found Medicaid fraud can go unreported for months in some states with no real consequence for insurers that fail to flag it; watch whether CMS acts on the two recommendations it has not yet fully addressed.
Deal Jul 26, 2026
Tempus AI agreed to pay $16.25 per share for Personalis in a deal structured as all-stock with an option to pay up to 50 percent in cash, expanding its molecular residual disease cancer-testing platform.
Why it matters This is a bet that combining two cancer-testing companies' data will improve tests that check whether a patient's cancer has returned after treatment.
Record Jul 26, 2026
University of Miami Health System says it will leave UnitedHealthcare's network for commercial, exchange and Medicaid plans starting August 1, 2026 if no new contract is reached by July 31.
Why it matters If you or a family member is a UnitedHealthcare member in South Florida, watch for an out of network notice, though a deal could still land before July 31.
Report Jul 25, 2026
VMG Health's 2026 Healthcare M&A Report found standard control-level ASC deals cluster around 7 to 8 times EBITDA while select high-growth multi-specialty centers are commanding double-digit multiples.
Why it matters If you are weighing whether to sell or recapitalize a surgery center, this is the current market benchmark to use, not last year's number, and it reflects the same strategic buyers now dominating the sector.
Deal Jul 25, 2026
Ascension closed the acquisition June 4, 2026 after an FTC consent agreement required divesting seven overlapping-market surgery centers, giving the nonprofit system more than 300 ASCs behind only Tenet/USPI and Optum/SCA Health.
Why it matters All three of the largest surgery center platforms now sit inside strategic health systems and insurers rather than private equity, a structural shift in who controls outpatient surgery capacity nationally.
Enforcement Jul 25, 2026
HHS and CMS announced July 21, 2026 they are deferring $867.5 million in federal Medicaid matching funds from California, mostly tied to its In-Home Supportive Services program, and $199 million from Minnesota tied to providers flagged for aberrant billing, pending fraud reviews.
Why it matters Two states just lost access to over a billion dollars in Medicaid funding while the federal government reviews fraud claims, which could squeeze state budgets and the services those programs fund. Watch whether California and Minnesota get the money released or whether the deferral turns into a permanent cut.
Enforcement Jul 25, 2026
Chesapeake Regional Medical Center in Virginia was indicted January 8, 2025 for collecting an estimated $18.5 million from unnecessary and misclassified procedures performed by a former OB-GYN convicted on 52 counts in 2020.
Why it matters DOJ charging the facility itself, not only the individual doctor, is a notable escalation in how healthcare fraud cases get built, and a conviction could end this hospital's ability to operate under Medicare and Medicaid.
Rule Jul 25, 2026
The proposed rule would also strip 637 procedures off the inpatient only list, raise ASC payment rates 2.4 percent to about $9.9 billion, and eliminate the device pass-through pathway starting October 1, 2026.
Why it matters This is the biggest one-year expansion of what Medicare will pay outpatient surgery centers to do, and it also makes it harder for new medical devices to reach the market quickly. Watch whether the code counts and the device pass-through cut survive to the final rule expected in November.
Earnings Jul 25, 2026
Gentherm reported second quarter 2026 product revenue of 416.2 million dollars, up 11 percent year over year, and its board approved a new 400 million dollar stock repurchase program to take effect once its roughly 1 billion dollar combination with Modine's Performance Technologies business closes.
Why it matters This is a routine earnings beat with a bigger stock buyback, not something most patients will notice directly, but it points to steady demand in the medical device supply chain.
Report Jul 25, 2026
Comparitech counted 410 ransomware attacks against healthcare linked organizations in the first half of 2026, with attacks on healthcare businesses and vendors growing nearly 35 percent versus a 3 percent rise in attacks on hospitals and direct care providers.
Why it matters If your health data passes through a hospital's vendors, billing company or device maker, not just the hospital itself, you're increasingly exposed to a ransomware breach; this shift is where health data risk is heading.
Rule Jul 25, 2026
HHS published a final rule in the Federal Register on July 24, 2026, effective immediately, removing 45 CFR Part 80 provisions that let it pursue civil-rights enforcement based on discriminatory effect without proof of intent, skipping notice-and-comment under the grant-rule APA exemption.
Why it matters This changes how HHS enforces civil rights protections at any hospital, clinic, or state program that takes federal money, and it happened with no public input. Watch for how HHS's Office for Civil Rights actually applies the new rule in practice.
Record Jul 25, 2026
Intermountain Health confirmed changes effective July 24, 2026 that eliminate about 93 leadership and staff positions while closing several clinics in Colorado and Montana, citing long-term financial sustainability.
Why it matters If you're a patient at one of the closed clinics, you'll need to find a new care location; the cuts show even a large nonprofit system tightening its footprint.
Enforcement Jul 25, 2026
DOJ announced July 23, 2026 that Magnolia Diagnostics and owners John and Kelly Bains will pay $19.2 million and the lab's passive investors will separately pay $4.8 million, resolving allegations that senior-living communities were required to accept unnecessary respiratory pathogen panels via prepopulated test-order forms from April 2020 through September 2021.
Why it matters A Dallas lab's passive investors, not just its owners, are now on the hook for fraud proceeds even without proof they knew about the scheme, a legal theory DOJ used this way for the first time. Watch whether DOJ applies this investor-liability theory to other health care fraud cases.
Record Jul 25, 2026
Senators Bill Cassidy and Richard Blumenthal introduced S.4963 on July 14, 2026, mirroring a House bill, to switch ASC payment updates to the hospital market basket index and drop a budget-neutrality cut ASCA says has suppressed rates.
Why it matters This is a policy fight the ASC industry has waged since 2021 without success; it explains why surgery centers say their Medicare pay raises lag hospitals, but passage this Congress is unlikely given the bill's history.
Deal Jul 25, 2026
Samsung Biologics announced an all-cash tender offer of 44.31 Swiss francs per share, about 1.81 billion dollars, for 100 percent of PolyPeptide Group, a Swiss contract manufacturer of peptide APIs used in GLP-1 obesity and diabetes drugs.
Why it matters This deal is about who controls manufacturing capacity for the ingredients behind GLP-1 drugs like Ozempic and Zepbound, not something that changes your prescription directly, but it shows how much capital is chasing that supply chain.
Record Jul 25, 2026
Skagit County Public Hospital District No. 304, which operates United General Hospital in Sedro-Woolley, is asking voters in an August 2026 special election to raise its property tax levy from about 9 cents to 50 cents per $1,000 of assessed value, still under the state's 75-cent cap.
Why it matters A rural Washington hospital district wants voters to raise property taxes nearly six-fold just to keep current services running, a sign of how rural hospitals are leaning on local taxpayers as federal and state reimbursement lags. Watch the August special election result.
Record Jul 25, 2026
The Surgery Center of Hackensack became the first US ASC to use the eCential Robotics platform on March 5, 2026, and Distalmotion's compact DEXTER system is gaining commercial momentum, with a January 2026 Medicare payment change projected to push ASC robotic surgery growth to about 16 percent annually through 2031.
Why it matters Robotic surgery is moving out of hospitals and into outpatient surgery centers faster than expected, driven partly by a Medicare payment change; the open question for operators is which procedures justify the capital cost first.
Deadline Jul 25, 2026
As of July 22, 2026, UHealth and UnitedHealthcare have not reached a new contract, and UHealth's hospitals, clinics and physicians go out-of-network for UnitedHealthcare's commercial, ACA exchange and Medicaid plan members on August 1 if no deal is struck by July 31.
Why it matters If you're a UnitedHealthcare member who uses UHealth, watch for an update before August 1: without a deal, your visits there could suddenly cost far more or not be covered.
Enforcement Jul 25, 2026
A federal jury in the Southern District of Florida convicted Olushola Yusuf, 60, on July 23, 2026 of conspiracy and illegal distribution for dispensing at least 326,079 oxycodone pills, cash only and at roughly ten times normal price, through two locked-door Broward County pharmacies, with sentencing set for October 14, 2026.
Why it matters A pharmacist was convicted for running a large-scale oxycodone distribution scheme through locked-door storefronts that ignored repeated DEA and employee warnings. Watch for the October 14 sentencing, where she faces up to 20 years per count.
Report Jul 24, 2026
AM Best raised Delta Dental of California's Financial Strength Rating to A+ from A and its Long-Term Issuer Credit Rating to aa- from a+, both with a stable outlook, effective July 23, 2026.
Why it matters A credit rating upgrade for one of the country's largest nonprofit dental insurers highlights how uneven private equity's push into dental care has been, stronger on the insurance side, more disruptive on the practice ownership side.
Rule Jul 24, 2026
CMS's CY2027 Home Health Prospective Payment System proposed rule pairs a 2.4% aggregate payment increase with a temporary 3% adjustment meant to recoup an estimated 4.9 billion dollars in PDGM overpayments from CY2020 through CY2025.
Why it matters Watch whether the temporary 3% clawback survives to the final rule, since it would offset most of the headline payment increase for home health agencies.
Earnings Jul 24, 2026
HCA Healthcare reported second quarter revenue of 20.23 billion dollars and diluted EPS of 7.62 dollars, with a roughly 400 million dollar hit from ACA exchange coverage losses nearly offset by a 400 million dollar boost from Florida's Medicaid Supplemental Payment Program.
Why it matters The offsetting swing shows how directly a hospital chain's profits can hinge on two policy levers, ACA exchange enrollment and state Medicaid supplemental payment programs, both now under federal scrutiny.
Rule Jul 24, 2026
CMS's acting Center for Program Integrity director said operators will get 60 days notice before any decision to extend the six-month nationwide hospice and home health enrollment moratorium past its November 13, 2026 expiration.
Why it matters The freeze on new hospice and home health Medicare enrollments is scheduled to expire November 13; watch for a 60-day advance notice around mid-September if CMS plans to extend it.
Rule Jul 24, 2026
CMS began posting Hospice Annual Payment Update non-compliance notices in July 2026 warning of a 4% FY2027 payment cut for hospices that missed a 90% timely HOPE assessment submission threshold or lacked an approved CAHPS survey vendor during calendar year 2025.
Why it matters If your hospice submitted 2025 HOPE assessments, check your iQIES My Reports folder now, since a 4% payment cut for FY2027 is at stake and a reconsideration process is available.
Report Jul 24, 2026
CMS is using the 19.1% national hospice live-discharge rate, the share of patients discharged alive rather than dying in care, alongside long length-of-stay patterns as an automated screen for which hospices receive payment-suspension letters, with some suspended California hospices cited at rates in the mid-50s to 64%.
Why it matters If a hospice caring for you or a family member has an unusually high rate of patients being discharged alive, that pattern is now a documented fraud-screening trigger for CMS.
Record Jul 24, 2026
AFSCME Local 3299 members struck for one day on July 22, 2026 over UC San Diego Health's plan to eliminate about 230 positions, while Novant Health separately confirmed cutting 31 revenue cycle jobs system-wide the same day.
Why it matters Hospital layoffs and labor unrest at two different systems in the same week point to continued cost pressure across the hospital sector even as some large chains post strong earnings.
Report Jul 24, 2026
The Private Equity Stakeholder Project found more than 500 US healthcare facilities now operate through joint ventures between private equity owned companies and nonprofit health systems, including 61 percent of Apollo-owned LifePoint Health's hospitals.
Why it matters The report raises the question of whether joint venture structures let private equity firms operate inside nonprofit hospitals without triggering the new state laws written specifically to screen private equity health care transactions.
Deal Jul 24, 2026
General Atlantic completed a roughly 3 billion dollar acquisition of non-medical personal care platform Team Services Group from Alpine Investors, while Kinderhook Industries separately closed a 1.1 billion dollar take-private of Medicare-certified provider Enhabit.
Why it matters The quarter's two biggest deals split between non-medical personal care, which sits outside Medicare's fraud crackdown, and Medicare-certified home health and hospice, which sits directly in its path.
Report Jul 24, 2026
Home health, hospice, and personal care M&A fell to just 16 closed deals in Q2 2026, down from 27 in Q1 2026 and 29 in Q2 2025, according to Mertz Taggart deal data.
Why it matters Fewer deals closing means less consolidation and slower change in who owns your local home health or hospice agency right now.
Earnings Jul 24, 2026
Quest Diagnostics grew adjusted EPS 19.1 percent to 3.12 dollars and revenue 10.2 percent to 3.04 billion dollars in the second quarter, and raised full year 2026 revenue guidance to 11.95 to 12.05 billion dollars.
Why it matters Continued growth at the country's largest independent lab shows outside diagnostic testing volume keeps expanding even as some hospital systems report softer surgical volumes.
Earnings Jul 24, 2026
Tenet posted adjusted EPS of 6.12 dollars versus a 4.26 dollar estimate on revenue of 5.63 billion dollars and raised full year 2026 EPS guidance to 20.30 to 21.69 dollars, sending shares up as much as 15 percent.
Why it matters Strong hospital chain earnings suggest underlying demand for hospital care remains robust despite ongoing cost and coverage pressures elsewhere in the industry.
Rule Jul 23, 2026
The American Association of Orthopaedic Surgeons said July 22, 2026 that CMS should withdraw payment cuts in its Calendar Year 2027 Medicare Physician Fee Schedule proposed rule, which cuts the conversion factor up to 1.68 percent, with comments due September 14, 2026.
Why it matters This is an early skirmish over next year's Medicare doctor pay rates; watch whether CMS revises the proposed cuts before finalizing the rule later this year.
Funding Jul 23, 2026
SAMHSA and CMS announced May 28, 2026 that ten states will start cost based prospective payment rates for community behavioral health clinics between July 2026 and July 2027, even as H.R. 1's Medicaid work reporting requirement takes effect January 1, 2027.
Why it matters More states now offer a Medicaid payment model built to sustain community mental health clinics, but a new work reporting rule could shrink the patient base that funds it starting in 2027.
Earnings Jul 23, 2026
CHS reported Q2 net income of 70 million dollars, down from 282 million dollars a year earlier, as revenue fell 9.8 percent to 2.825 billion dollars, and it now guides to a full-year diluted loss of 1.10 to 1.25 dollars a share after divesting nine hospitals in 2026.
Why it matters A hospital chain that was solidly profitable a year ago now expects to lose money for the full year, a sign of how divestitures, payor mix and cost pressure are squeezing mid-sized hospital operators; watch whether the divestiture pace continues.
Rule Jul 23, 2026
The CY2027 Physician Fee Schedule proposed rule applies the last 19.1 percent work-value increase to tobacco cessation and SBIRT codes and extends the telehealth in-person exception through December 31, 2027.
Why it matters This determines whether your therapist keeps getting paid more for certain services and whether you can keep seeing a psychiatrist by video without an extra in-person visit through 2027.
Deal Jul 23, 2026
Dassault Systemes agreed to buy the AI-native compliance platform ArisGlobal, which processes more than 12 million patient safety reports a year for over 200 life-sciences customers, for about 1.8 billion dollars in cash plus up to 200 million dollars in milestone payments, with the deal expected to close in the second half of 2026.
Why it matters A major software company is betting 1.8 billion dollars that AI-driven drug-safety compliance is a growth market, a signal worth watching as pharmacovigilance software consolidates.
Enforcement Jul 23, 2026
EyePoint disclosed in a July 17, 2026 SEC filing that it will pay $4,678,981.86, including $4,657,463.18 to the federal government, to resolve False Claims Act allegations that it ran a 2019-2023 Assurance Program reimbursing surgery centers when insurers underpaid for its post-cataract drug DEXYCU.
Why it matters This is a reminder that drugmakers offering to backstop insurance shortfalls for surgery centers can trigger federal kickback enforcement; watch for the underlying DOJ press release once accessible.
Alert · now Jul 23, 2026
Michigan health officials reported 7,171 cyclosporiasis cases as of July 22, 2026, a single day jump of 600 cases linked to Taylor Farms de Mexico iceberg lettuce served at Taco Bell, with hospitalizations more than doubling to 102 in the prior week.
Why it matters This is one of the largest foodborne illness outbreaks on record in the US, so if you ate at a Michigan Taco Bell recently and have prolonged diarrhea, watch for cyclosporiasis symptoms and seek testing.
Deal Jul 23, 2026
A federal bankruptcy judge approved a plan for Greenwood and Leflore County to donate the 25-bed hospital to the University of Mississippi Medical Center effective August 1, 2026, resolving a crisis rooted in a 5.5 million dollar Medicaid recoupment demand from June 2025.
Why it matters A rural safety-net hospital that nearly could not make payroll gets a permanent fix instead of a shutdown, a rare outcome worth watching as a model for other struggling rural hospitals.
Record Jul 23, 2026
The House Committee on Oversight and Government Reform marked up and advanced H.R. 6610, the Pharmacists Fight Back Act, on July 22, 2026, imposing new pricing transparency and markup restrictions on pharmacy benefit managers in the Federal Employees Health Benefits Program.
Why it matters This is a step toward more transparency into how PBMs price drugs for the health plan covering federal workers and retirees; watch whether it gets a Senate companion or floor vote.
Report Jul 23, 2026
The tri-agencies' fourth annual MHPAEA report found 76 of 85 requested comparative analyses got insufficiency letters on first submission, while Pennsylvania became the Counseling Compact's 40th state on July 12, 2026 though only 6 states issue interstate practice privileges.
Why it matters Most health plans reviewed could not initially prove their mental health coverage rules matched their medical coverage rules, and even though 40 states allow counselors to practice across state lines on paper, only 6 actually let them do it yet.
Rule Jul 23, 2026
DOL, HHS, and Treasury told a court on March 30, 2026 that they will not defend the 2024 MHPAEA final rule and plan to propose replacement regulations by year end, with enforcement of the rule's new provisions staying frozen and a status update due September 30, 2026.
Why it matters The rule meant to stop insurers from making therapy harder to access than a doctor visit is in limbo, but the underlying parity law is still enforceable.
Earnings Jul 23, 2026
Molina reported adjusted EPS of 1.51 dollars versus estimates near 1.39 to 1.40 dollars and raised its full-year adjusted EPS floor to 5.25 dollars, but held revenue guidance near 42 billion dollars, about 2.28 billion dollars below Wall Street's estimate, sending shares down as much as 9.2 percent in premarket trading.
Why it matters The stock drop shows investors are focused on revenue growth and Medicaid margin trends more than a one-quarter earnings beat, so watch full-year guidance updates rather than single-quarter results.
Deadline Jul 23, 2026
The Senate HELP Committee voted 17 to 5 on July 22, 2026 to advance the INSULIN Act capping monthly insulin costs at $35 for privately insured patients, and returns today to vote on CDC director nominee Erica Schwartz and two other nominations.
Why it matters This is a step toward a federal insulin price cap and a look at who will run the CDC amid vaccine policy tension with HHS Secretary Kennedy. Watch whether the committee actually advances the nominees today and whether the insulin bill gets floor time.
Deal Jul 23, 2026
Talkspace shareholders approved UHS's $835 million all-cash acquisition on May 29, 2026 with a third-quarter close still pending state regulatory approval, while MKH Capital Partners completed its purchase of the 22-location Haven Health Management SUD operator on March 31, 2026.
Why it matters A major psychiatric hospital chain is close to also owning a national virtual therapy platform, and private equity money is still flowing into addiction treatment.
Enforcement Jul 23, 2026
Federal prosecutors charged Mikia Noble of Advancing Communities Everywhere with conspiracy to commit health care fraud for allegedly paying homeless Medicaid beneficiaries for their Medicaid numbers to bill unnecessary crisis stabilization services.
Why it matters This is a reminder that Medicaid fraud enforcement is actively targeting crisis and behavioral health billing, using some of the most vulnerable patients as the vehicle.
Report Jul 23, 2026
Cardinal Health, Cencora and McKesson have collectively spent more than 16 billion dollars acquiring or taking stakes in physician-practice management organizations, concentrated in oncology, gastroenterology, ophthalmology and urology, with Cencora's 4.6 billion dollar full buyout of OneOncology in February 2026 the latest and largest example, according to analyst Drug Channels.
Why it matters The companies that distribute nearly every drug in America increasingly also own the physician practices prescribing those drugs, a vertical-integration trend worth watching for its effect on drug choice and competition.
Enforcement Jul 22, 2026
The Department of Justice agreed on July 21, 2026 to pay the Alaska Native Tribal Health Consortium $400 million, resolving a 2021 lawsuit over unreimbursed contract support costs from 2014 through 2022.
Why it matters This sets a precedent for tribal health organizations nationwide to recover costs the federal government failed to pay them; watch for more tribes filing similar claims after the 2024 Becerra ruling.
Deal Jul 22, 2026
American Industrial Partners is paying $25.00 a share in cash, a 72.1 percent premium to Avanos's pre-announcement price, with the deal expected to close by July 27, 2026.
Why it matters A medtech maker used in hospitals nationwide is leaving public markets at a large premium, a sign of what private equity will pay for undervalued healthcare companies right now.
Deal Jul 22, 2026
CareDx finalized its purchase of Naveris, maker of the only Medicare covered blood test for monitoring HPV associated head, neck and anal cancers, extending its diagnostics business beyond transplant monitoring.
Why it matters A transplant diagnostics company is betting cancer monitoring blood tests are the next growth market, which could mean wider availability of this HPV cancer surveillance test as it scales.
Rule Jul 22, 2026
CMS's CY2027 OPPS/ASC proposed rule would pay hospitals ASP minus 33.4 percent for 340B acquired drugs starting January 1, 2027, replacing the current ASP plus 6 percent rate, while also accelerating repayment of the 7.8 billion dollar 340B remedy.
Why it matters This is a proposal, not final law yet, but if it holds it directly cuts what hospitals earn on discounted cancer drugs, which could change where you get treated as hospitals reassess their infusion programs.
Report Jul 22, 2026
A federal audit posted July 21, 2026 found Colorado failed to verify personal care visits in its electronic visit verification system, recommending an immediate $8 million refund and flagging $45.7 million in additional questioned costs.
Why it matters This exposes a gap in state-level fraud detection through EVV systems that other states may share; watch for similar audits elsewhere and how much CMS ultimately recovers.
Rule Jul 22, 2026
A federal judge in Maryland stayed eight consumer cost provisions of CMS's 2027 Notice of Benefit and Payment Parameters rule on July 16, 2026, days before its July 20, 2026 effective date, in a suit brought by several cities and counties.
Why it matters This keeps consumer protections like network adequacy standards and standardized plan offerings in place while litigation continues; watch for a ruling on the case's merits.
Enforcement Jul 22, 2026
HealthLGX sued MultiPlan (now Claritev) and roughly two dozen insurers on July 9, 2026 in Illinois federal court, alleging a shared pricing methodology suppressed out-of-network reimbursement across a market the complaint says the group controls by 80 to 90 percent of dollar volume.
Why it matters A new antitrust case alleges a shared pricing algorithm quietly held down what out-of-network doctors get paid across most of that market, and its outcome could reset how those rates are set nationwide.
Report Jul 22, 2026
An OIG audit posted July 20, 2026 found Medicare contractor Novitas Solutions improperly paid about $19.5 million for evaluation and management, psychotherapy, podiatry and wound care services to nursing home residents, a 60.7 percent error rate on sampled claims.
Why it matters This shows widespread documentation errors, not fraud, drove nearly two-thirds of sampled claims to be wrong; watch for the promised provider education rollout.
Report Jul 22, 2026
An OIG report posted July 21, 2026 found state Medicaid managed care contracts set fraud referral deadlines ranging from 1 to 270 days, with some states setting no deadline or consequence at all.
Why it matters This reveals inconsistent state rules on how fast Medicaid plans must report suspected provider fraud; watch for CMS follow-up requiring enforceable rules.
Enforcement Jul 22, 2026
DOJ settled a False Claims Act suit alleging Progressive Oncology & Hematology and owner Dr. Mouhamad Bazzi billed Medicare, Medicaid and the VA for chemotherapy drugs obtained free through manufacturer assistance programs and for chemo never administered.
Why it matters This shows federal fraud enforcement is actively targeting small oncology practices over drug billing practices tied to patient assistance programs, not just large health systems.
Report Jul 22, 2026
A peer-reviewed analysis of CMS data from 2018 to 2025 found 13.6 percent of US counties lost radiation oncology treatment sites, with losses concentrated in poorer, more rural counties with fewer primary care physicians.
Why it matters This matters because where you live increasingly determines whether you can get radiation therapy without traveling far, and the gap is widening in poorer, rural areas.
Deal Jul 22, 2026
Sabra will move 22 of the facilities to Cascadia Healthcare and four to an existing tenant, raising combined annualized cash rent to about $53 million from the $41 million Avamere paid, once the transition completes in the second half of 2026.
Why it matters A nursing home operator told its landlord directly it wanted out of the skilled nursing business, and the landlord replaced it across 26 buildings and raised the rent, a sign of ongoing stress and consolidation in post-acute care.
Approval Jul 22, 2026
The FDA approved subcutaneous isatuximab-irfc (Sarclisa Escena) for three multiple myeloma combination regimens, deliverable through the CirCLIQ on-body injector or manual syringe instead of IV infusion.
Why it matters This could mean shorter, simpler treatment visits for multiple myeloma patients who currently sit through hours long infusions.
Deadline Jul 22, 2026
Absent a new agreement, UHealth's hospitals, clinics and physicians become out-of-network on August 1, 2026 for UnitedHealthcare's commercial, ACA exchange and Medicaid plan members, while Medicare Advantage plans are unaffected.
Why it matters Hundreds of thousands of patients in South Florida could lose in-network access to Miami's academic health system, including specialized cancer and eye care, if no deal is struck by July 31.
Rule Jul 21, 2026
The American College of Cardiology's own analysis found that up to 20 percent of physicians CMS selected for the mandatory Ambulatory Specialty Model may be misclassified under the cardiovascular disease specialty code CMS used to build its roughly 8,600 physician roster.
Why it matters A coding error could pull the wrong doctors into a mandatory five year Medicare risk program with payment swings of plus or minus 9 percent starting January 1, 2027. Watch whether CMS corrects its classification before rosters lock.
Report Jul 21, 2026
A JAMA Network Open study of 32 cardiology services across four major insurers found median facility fees for ICD insertion ranging from 6,674 dollars under Aetna to 36,269 dollars under UnitedHealthcare, a difference the authors trace to payer facility negotiating leverage rather than any difference in the procedure.
Why it matters The same cardiac device implant can cost insurers wildly different amounts depending only on which contract is in place, not on anything clinical. Watch for this data feeding into site neutral payment policy debates.
Report Jul 21, 2026
MedAxiom president and CEO Jerry Blackwell said private equity's footprint in cardiology is smaller than commonly portrayed, even as PwC's mid-year 2026 outlook named cardiovascular services one of the two most sought after physician specialties for the rest of 2026.
Why it matters The pitch that private equity already owns cardiology may be overstated, but deal interest in the specialty is not slowing. Watch how this framing affects negotiating leverage in upcoming practice sales.
Rule Jul 21, 2026
The public comment period on CMS-2449-P, which would cap Medicaid managed care state directed payments at 100 to 110 percent of Medicare rates, closed July 21, 2026 with CMS projecting 774.8 billion dollars in savings over 10 years.
Why it matters This rule could reshape how much money flows to hospitals and insurers through Medicaid, one of the country's largest health programs; watch for a final rule and whether the caps survive as proposed.
Alert · now Jul 21, 2026
FDA said Sunday that a lettuce sample it had reported as testing positive for Cyclospora was actually a false positive, but it is keeping the recall of Taylor Farms de Mexico iceberg lettuce in place based on other traceback and epidemiological evidence.
Why it matters Even though a key lab test in this outbreak turned out to be wrong, the recall and underlying case count of over 1,600 illnesses stand, a reminder that outbreak investigations rely on more than a single lab result.
Enforcement Jul 21, 2026
DOJ charged Dr. Jason Finkelstein of Fort Worth with health care fraud for allegedly billing about 89 million dollars for unreviewed cardiovascular tests on student athletes, including one teenager who died of cardiac arrest 24 days after Finkelstein signed off on 63 of the teen's results in about 11 seconds.
Why it matters A doctor allegedly rubber stamped tens of thousands of student athlete heart scans without reviewing them, and a teenager died weeks after one of those scans. Watch this case as part of DOJ's largest ever health care fraud takedown.
Record Jul 21, 2026
AHA, ACC, ESC and WHF published the Second Universal Definition of Heart Failure, replacing rigid ejection fraction cutoffs with three clinical categories and resetting the lower limit of normal left ventricular ejection fraction to about 53 percent for women and 52 percent for men.
Why it matters This redefines who counts as having heart failure, which affects who qualifies for certain treatments and, down the line, which patients fall inside CMS's new mandatory cardiology risk model.
Enforcement Jul 21, 2026
NeoGenomics disclosed in a July 20, 2026 securities filing that it will pay 9,813,260 dollars plus interest to resolve civil False Claims Act allegations tied to consulting and commission arrangements with referring providers.
Why it matters A national lab company is paying millions after admitting it gave doctors' offices financial perks tied to referrals, a reminder that even self-reported violations carry real settlement costs.
Record Jul 21, 2026
A federal judge in Chicago heard oral argument today on Health Care Services Corporation's motion to dismiss a suit by PHI Health accusing the Blue Cross Blue Shield insurer of withholding payment after losing a No Surprises Act arbitration.
Why it matters This case is testing whether the No Surprises Act's arbitration process actually forces insurers to pay when they lose, since the law set a pricing mechanism but no explicit federal payment-enforcement tool.
Rule Jul 21, 2026
AATS, ACC, HFSA, SCAI and STS filed joint comments before CMS's July 15, 2026 deadline opposing a proposal to drop the dual operator requirement for TAVR, with a final CMS decision due by September 13, 2026.
Why it matters This fight decides whether every TAVR patient must be evaluated by both a surgeon and a cardiologist before the procedure, a safeguard CMS is now reconsidering. Watch for CMS's decision memo by September 13.
Funding Jul 21, 2026
Tennessee closed intake July 20, 2026 on its first wave of Rural Health Transformation Program grant opportunities after receiving approximately 206.9 million dollars in Budget Period 1 funding from the federal program.
Why it matters Rural hospitals and clinics in Tennessee now wait to hear which applicants get funded from this state's share of a five-year, 50 billion dollar federal program meant to shore up rural health care nationwide.
Deal Jul 20, 2026
CBRE found first-quarter 2026 US medical outpatient building investment volume rose 78 percent year over year to 2.9 billion dollars as Big Sky Medical closed its third and fourth Fund III acquisitions, the RidgeWood Medical Center campus, on July 9, 2026.
Why it matters Capital is flowing into the outpatient buildings where more care is happening as it shifts out of hospitals, and cap rates below 7 percent for the first time since 2024 signal strong investor demand. Watch whether this pace holds through the rest of 2026.
Rule Jul 20, 2026
The draft guidance, covering the negotiation program's third cycle and its first five Part B drugs including Botox, Cimzia, Orencia and Entyvio, opens a comment period through September 18, 2026 before the negotiated prices take effect January 1, 2028.
Why it matters This is the first test of Medicare's drug price negotiation program on drugs your doctor administers in office rather than ones you pick up at a pharmacy, and the mechanics are still being worked out.
Deal Jul 20, 2026
Stockholders voted 23.4 million shares in favor versus about 12,300 against on July 16, 2026 to approve Knox Lane's $13.25-a-share all-cash offer, clearing the way for the staffing firm to go private and delist from Nasdaq in the third quarter.
Why it matters One of the largest publicly traded travel-nurse staffing firms is going private, meaning less public visibility into its finances and strategy going forward. Watch for the deal to close in Q3 2026 and Cross Country's delisting from Nasdaq.
Rule Jul 20, 2026
The proposed rule would turn the G2211 office-visit complexity add-on into a modifier worth a 16 percent E/M payment bump, add a second ACO-only modifier worth 32 percent, and require remote physiologic and therapeutic monitoring to be furnished by practice employees rather than contractors.
Why it matters Two Medicare payment changes here: a bigger bonus for complex office visits, and a tighter staffing rule for remote monitoring billing that could squeeze practices relying on contracted monitoring staff. Watch whether the RPM staffing requirement holds through the final rule.
Rule Jul 20, 2026
The CY2027 Physician Fee Schedule proposed rule would raise the prior savings adjustment scaling factor from 50 percent to 75 percent, raise the BASIC track's top shared-savings rate from 50 to 60 percent, and cut the ENHANCED track's maximum regional adjustment weight from 50 to 35 percent, with comments closing September 14, 2026.
Why it matters This rewrites how much of an ACO's own savings get folded back into next year's target, the biggest change to ACO benchmarking math in years. Watch whether the ratchet-relief and guardrail provisions survive comment unchanged by September 14.
Rule Jul 20, 2026
The Justice Department published a Federal Register notice stating its 2011 Olmstead enforcement statement, which directed states to move people with disabilities into community care instead of institutions, is no longer enforceable guidance, though the underlying Supreme Court precedent still stands.
Why it matters The Supreme Court ruling that people with disabilities have a right to community based care instead of institutionalization is unchanged, but the government just pulled the practical guidance it used to enforce it.
Record Jul 20, 2026
The two agencies signed a memorandum of understanding July 13, 2026 to coordinate clinical trial research, train providers and collect real world data on psychedelic assisted therapies ahead of any FDA approval for the more than 1 million veterans the agencies say could be affected.
Why it matters No psychedelic drug currently has FDA approval for these uses, so this agreement is about getting the infrastructure ready in case one does, not a change in what you or a veteran you know can be prescribed today.
Rule Jul 20, 2026
More than 20 Democratic state attorneys general told a federal court in California v. HHS that immigration officials shared Medicaid recipients' data with contractor Palantir and, after claiming the data was purged, found six people who still had copies a day later.
Why it matters If you or a family member is on Medicaid, this is part of an ongoing fight over whether that enrollment data can be used for immigration enforcement, and the allegation here is that deletion promises were not kept.
Rule Jul 20, 2026
Governor Hochul signed a budget provision on May 28 extending NP independent-practice authority past its scheduled July 1, 2026 sunset through July 1, 2030, while a separate bill to make it permanent died in committee before the legislature adjourned June 5.
Why it matters New York avoided letting nurse practitioner independence lapse, keeping the state aligned with the 30-plus states that already allow NPs with sufficient practice hours to see patients without a physician collaborative agreement. Watch 2030, when the sunset returns and the permanent-authority bill could resurface.
Enforcement Jul 20, 2026
The audit, running through fiscal year 2028, targets whether CCM patients actually meet the two-or-more-chronic-conditions eligibility standard rather than just whether billed minutes were documented.
Why it matters This is a narrower, harder-to-defend audit target than the usual time-tracking reviews: perfect documentation of minutes won't save a claim if the underlying diagnoses don't support CCM eligibility. Watch for enforcement actions or self-disclosures as the audit progresses through 2028.
Deal Jul 20, 2026
Valspring Capital led the round in the 21-location pediatric primary care platform with existing backer M33 Growth participating, the same week Astrana Health disclosed $120.4 million in 2024 gross shared savings across eight ACOs in MSSP and ACO REACH.
Why it matters Investors are pricing proven value-based primary care performance at a premium now, per FOCUS's estimate of double-digit EBITDA multiples for practices with strong MA or ACO track records versus 6 to 8 times otherwise. Watch which segment, pediatric or adult ACO, draws more capital next.
Report Jul 20, 2026
Rock Health found US digital health startups raised 7.4 billion dollars across 244 deals in H1 2026 while 115 corporate acquisitions closed, 71 of them in the second quarter alone.
Why it matters This is a snapshot of how much money and dealmaking is happening in digital health right now, useful for gauging whether the sector is consolidating. Watch whether acquisitions keep outrunning new funding rounds through the second half of 2026.
Rule Jul 20, 2026
The committee holds an executive session Wednesday on 13 bills including a 35 dollar monthly insulin cap and a hospital price transparency bill, then votes Thursday on three nominees including Dr. Erica Schwartz to lead the CDC.
Why it matters If either bill clears committee, a 35 dollar insulin cap for privately insured patients and new hospital price disclosure rules move a step closer to reality, though both still need floor votes.
Rule Jul 20, 2026
The Ways and Means Committee approved seven Medicare bills July 15, 2026, including one requiring Medicare Advantage insurers to disclose premium spending starting 2029, while a companion hospital and insurer price disclosure bill passed only 25 to 15 along party lines.
Why it matters One bill would force Medicare Advantage insurers to show how much of your premium goes to actual care versus overhead, and it has bipartisan support, but the broader price transparency bill does not.
Deal Jul 20, 2026
XRHealth acquired Swing Therapeutics on July 15, 2026, its sixth acquisition in two years, adding the FDA-authorized Stanza digital treatment and the Swing Care virtual clinic for fibromyalgia.
Why it matters This adds a new treatment option for fibromyalgia, a condition affecting an estimated 10 million Americans, to a platform already covered by Medicare Part B, the VA and commercial insurance. Watch whether XRHealth expands Stanza's reach beyond its current 22-state footprint.
Report Jul 19, 2026
AM Best's Best's Market Segment Report found medical professional liability insurers posted a combined 712 million dollar underwriting loss in 2025, up from 546 million dollars in 2024, even as their direct premiums written grew 3.6 percent to 9.4 billion dollars.
Why it matters The insurers who cover hospitals and doctors against malpractice claims are losing money on that coverage for a second year running, which usually shows up later as higher premiums for the health systems and physician groups who buy it. Watch renewal pricing over the next year.
Rule Jul 19, 2026
Roughly 8,600 cardiologists who treat outpatient Medicare heart failure patients in CMS-selected regions must join the mandatory, five-year Ambulatory Specialty Model starting January 1, 2027, with no opt-out and payment swings of negative 9 percent to positive 9 percent on Part B claims through 2031.
Why it matters If you or a family member sees a cardiologist for heart failure, your doctor's Medicare pay is about to swing up or down based on quality and cost performance, which could affect how care is managed. Watch whether your cardiology practice is in a selected region.
Enforcement Jul 19, 2026
Advanced Pathology Solutions, its management company APS MSO, and three owners agreed to a five year Corporate Integrity Agreement effective June 17, 2026 after DOJ alleged they paid kickbacks to gastroenterology practices and ordered unnecessary biopsy testing from 2015 through July 2022.
Why it matters This shows federal enforcement targeting kickback arrangements embedded inside physician practices, a pattern other labs doing similar business should take note of.
Rule Jul 19, 2026
The 2026 Consolidated Appropriations Act delinks Part D PBM compensation from drug price, a Department of Labor proposed rule would require claim-level pricing disclosure for employer plans, and the FTC's Express Scripts insulin settlement already bars favoring high list price drugs on standard formularies.
Why it matters If you take medication through an employer or Medicare Part D plan, these changes are aimed at stopping pharmacy benefit managers from steering you toward higher-cost drugs for their own profit, including up to 7 billion dollars in projected insulin savings over a decade. Watch whether your out-of-pocket drug costs actually move as these rules phase in.
Rule Jul 19, 2026
The CY2027 Physician Fee Schedule proposed rule (CMS-1848-P) would raise the Shared Savings Program's Basic Level E rate from 50 to 60 percent and add a retroactive spending guardrail for Performance Year 2025 that delays reconciliation payments to November 2026, with comments due September 14, 2026.
Why it matters This reshapes how Medicare's largest accountable care program splits savings, and if finalized it could delay payments many physician organizations were expecting this year.
Rule Jul 19, 2026
The CY2027 Medicare Physician Fee Schedule proposed rule would end traditional MIPS after the CY2028 performance period, making the MIPS Value Pathway framework mandatory starting CY2029, with hospital medicine getting its first dedicated pathway and comments closing September 14, 2026.
Why it matters This is a back-office Medicare billing change for physicians, not something that directly touches patient care, so minimal direct relevance if you're not a clinician. The one thing to watch is whether quality reporting changes affect which doctors are labeled high performers in public data.
Rule Jul 19, 2026
The proposed CY2027 OPPS/ASC rule would pay hospitals only 40 percent of the normal outpatient rate for basic off-campus CT, MRI, and ultrasound studies without contrast, cutting an estimated 260 million dollars in total imaging spending, with comments open through August 31, 2026.
Why it matters If you get imaging done at a hospital-owned outpatient site, this doesn't change what you pay directly, but it changes what hospitals are paid, which can influence whether they keep operating those sites. Watch for hospitals restructuring or closing off-campus imaging locations.
Approval Jul 19, 2026
The FDA approved Celcuity's gedatolisib (Revtorpyk) on July 14, 2026 for use with fulvestrant, with or without palbociclib, after the VIKTORIA-1 trial showed it cut the risk of progression or death by up to 76 percent in HR-positive, HER2-negative breast cancer.
Why it matters This gives patients with a common, hard-to-treat form of metastatic breast cancer a new option, and the trial results are notably strong; watch how quickly insurers cover it.
Deadline Jul 19, 2026
The House Energy and Commerce Committee, chaired by Rep. Brett Guthrie, will vote July 20, 2026 on 29 bills including the Lower Costs, More Transparency Act, the Prior Authorization Accountability Act, and the Expedited Access to Biosimilars Act.
Why it matters This is a legislative step, not law yet; watch which of the 29 bills clear committee since that signals what Congress may act on next.
Deal Jul 19, 2026
A Haifa District Court deadline for InMode and Steel Partners affiliate SP Strategic Holdings to respond passed on July 19 without a public ruling, leaving frozen the special committee's review of Steel's 16.75 dollar per share offer against CEO Moshe Mizrahy's rival 16.20 dollar per share bid.
Why it matters A takeover fight over who buys InMode is stuck in an Israeli court because the company's own CEO is one of the bidders, and the board cannot move on either offer until the conflict of interest question is resolved. Watch for a new hearing date.
Earnings Jul 19, 2026
Intuitive Surgical reported second-quarter 2026 revenue of 2.89 billion dollars, up 19 percent year over year, but its stock fell as much as 11 percent after US da Vinci procedure growth slowed to about 12 percent from 14 percent in the first quarter.
Why it matters This is a case of investors reading between the lines: hard numbers beat expectations but the growth rate for actual surgeries in the US is slowing, which matters more for the stock than the quarter that just closed. Watch whether the slowdown persists into Q3 or proves temporary.
Deal Jul 19, 2026
LTC Properties paid 73 million dollars for two MorningStar-operated senior living communities in Colorado and New Mexico while National Healthcare Properties closed roughly 197 million dollars in acquisitions across 16 communities since late June, together deploying about 270 million dollars into senior housing real estate in under two weeks.
Why it matters Capital keeps flowing into assisted living and memory care real estate even as investment pulls back from hospital campuses, a sign investors expect steady demand for senior housing regardless of broader healthcare volatility. Watch whether cap rates compress further as more capital chases these deals.
Enforcement Jul 19, 2026
Kirtan Patel was sentenced to 30 months and technician Christopher Lugo to 24 months on July 16, 2026 for falsifying audit documents and prescription pickup records to cover up more than $1.1 million in fraudulent Medicare and private insurer billing, with Patel owing $620,000 in restitution plus $620,000 forfeiture.
Why it matters This is a reminder that falsifying records to cover up billing fraud carries prison time, not just fines.
Report Jul 19, 2026
HHS's Office of Inspector General posted Advisory Opinion 26-16 on July 14, 2026, concluding a health center's produce box and grocery voucher program for chronically ill patients would not trigger Anti-Kickback Statute or Civil Monetary Penalties Law sanctions, though the opinion legally binds only the requesting health center.
Why it matters This signals that food as medicine programs tied to patient diagnoses can be structured to avoid kickback law risk, though the opinion only legally protects the requesting health center.
Rule Jul 19, 2026
The same private equity capital that bought into cardiology, orthopedics, radiology, and specialty pharmacy this month is now facing state transaction review laws in California, Rhode Island, and Maine, with Maine's 2027 law giving regulators up to seven months to approve, conditionally approve, or reject a deal.
Why it matters This affects how quickly and quietly private equity firms can buy up local medical practices, which can influence pricing and access in your area over time. Watch whether your state adopts a transaction review law similar to California's or Maine's.
Rule Jul 19, 2026
The FY2027 IPPS proposed rule would add three spinal fusion MS-DRGs to CMS's mandatory Transforming Episode Accountability Model, with a final rule expected around August 2, 2026, ahead of a proposed October 1 start.
Why it matters If you or a family member needs spinal fusion surgery through Medicare, the hospital performing it may soon carry financial risk for your full episode of care, which can affect care coordination after discharge. Watch for the final rule around August 2.
Report Jul 18, 2026
The Association of Organ Procurement Organizations published an eight-measure quality framework, with the first four measures already submitted for federal endorsement, to replace the two-metric system CMS uses to decide decertification.
Why it matters Nearly every US organ procurement organization is proposing new quality measures to head off intensifying CMS decertification enforcement. Watch whether CMS adopts any of the proposed measures.
Rule Jul 18, 2026
The Consolidated Appropriations Act of 2026, a pending Department of Labor disclosure rule, and an active FTC settlement each attack PBM compensation on a different timeline, from a 2028 Part D fee mandate to insulin formulary rules already in force.
Why it matters This is the biggest shake-up in years to how the middlemen managing your prescription drug benefit get paid, though each piece phases in on its own schedule so nothing changes overnight.
Rule Jul 18, 2026
Judge Brendan Hurson ruled July 16, 2026 in Columbus II that CMS likely exceeded its rulemaking authority with provisions set to take effect July 20 that CMS itself estimated could cost up to 2 million people their marketplace coverage.
Why it matters This preserves coverage for up to 2 million people who could have lost ACA marketplace subsidies. Watch whether the government appeals the ruling.
Enforcement Jul 18, 2026
CVS Health will pay the Justice Department $130 million within two weeks of final approval and the remaining $310 million by March 15, 2028, resolving a False Claims Act case a jury had valued near $950 million, contingent on Omnicare's bankruptcy sale and an August 12, 2026 court hearing.
Why it matters A major nursing home pharmacy chain is paying a nine-figure settlement for filling prescriptions without valid orders, a reminder that long-term care dispensing draws close federal scrutiny.
Alert · now Jul 18, 2026
The agencies traced 1,644 illnesses and 94 hospitalizations across Indiana, Kentucky, Michigan, Ohio, and West Virginia to shredded iceberg lettuce from Taylor Farms de Mexico, which is now pulling all central Mexico-sourced lettuce and starting a recall.
Why it matters This is a large, ongoing multi-state foodborne illness outbreak tied to a major fast food chain's supply chain. Watch for the formal recall notice and whether the case count keeps rising.
Rule Jul 18, 2026
FDA's proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List has a comment period closing July 30, 2026, while Arkansas separately appeals the injunction blocking its law banning PBMs from owning in-state pharmacies.
Why it matters If you or someone you know gets a compounded GLP-1 weight-loss or diabetes drug, this rule would close that option once finalized, since both semaglutide and tirzepatide are no longer in official shortage.
Approval Jul 18, 2026
Merck's Lipfendra (enlicitide) cut LDL cholesterol by 56 percent in a 2,904 patient trial and 59 percent in a 303 patient familial hypercholesterolemia trial, matching injectable PCSK9 inhibitors already on the market.
Why it matters This gives people with high cholesterol a once-daily pill alternative to needles for the first time in this drug class. Watch for insurer pricing and coverage decisions.
Report Jul 18, 2026
The Government Accountability Office's spotlight report cites AMA survey data showing the adoption jump over two years and warns that unverified AI errors in medical notes and coding could cause patient harm or over- and under-billing.
Why it matters A government watchdog flags fast-growing clinician use of AI for notes and billing codes, and warns unverified errors could cause harm or billing mistakes. Watch for any future CMS guidance responding to these questions.
Deal Jul 18, 2026
Steel Partners sued in Haifa District Court to block InMode's special committee from reviewing a rival $16.20 a share bid led by CEO Moshe Mizrahy, after offering $16.75 a share in cash worth about $960 million.
Why it matters Watch whether the Haifa court blocks InMode's board from moving forward with a deal led by its own CEO, since the outcome could set a precedent on executive conflicts in buyouts.
Report Jul 18, 2026
Kaufman Hall found 18 hospital and health system deals closed in Q2 2026 versus 8 a year earlier, with transacted revenue rising to $7.7 billion from $1.4 billion and nearly all buyers nonprofit.
Why it matters Watch which nonprofit systems are absorbing smaller hospitals near you, since consolidation is accelerating after a slow 2025.
Deal Jul 18, 2026
Dimerix will pay Mission Therapeutics $5 million upfront and up to $287 million in milestones plus royalties for MTX652, an acute kidney injury drug, so Mission can focus cash on its Phase 1 Parkinson's candidate MTX325.
Why it matters Watch whether Dimerix's faster manufacturing path gets MTX652 to acute kidney injury patients sooner than Mission could have alone.
Enforcement Jul 18, 2026
Ohio's Attorney General charged Roberta Acheampong and Godfred Owusu-Sekyere, former operators of One Community Mental Health, with 12 felony counts for billing Medicaid for refugee counseling never provided, part of eleven fraud cases announced the same day totaling over $9.8 million.
Why it matters A couple fled the country after allegedly stealing $9.3 million from Medicaid by billing for refugee counseling that was never given. Watch for extradition efforts and how the case proceeds.
Deal Jul 18, 2026
Peak Rock Capital completed its acquisition of Asembia LLC on July 2, 2026, the specialty pharmacy industry's dominant technology, distribution, and data services layer, the same month Warburg Pincus is finalizing a deal exceeding $7 billion for rare disease specialty pharmacy PANTHERx Rare.
Why it matters Private equity is buying up the software and distribution infrastructure behind specialty drugs, not the pharmacies themselves, a sign of where the money sees the real leverage point in prescription drug costs.
Report Jul 18, 2026
The state's Independent Fiscal Office says a budget 'cycle roll' pushes two consecutive monthly Medicaid managed care payment cycles, about $1.3 billion each, later than scheduled without setting a fixed repayment date.
Why it matters A budget accounting move delays $2.6 billion in payments to Medicaid managed care plans without fixing Pennsylvania's roughly $5 billion structural deficit. Watch for whether a repayment date ever gets set.
Report Jul 18, 2026
Benefits consultants cited in July 2026 reporting say specialty drugs, GLP-1s foremost, now account for 60 percent or more of total drug spending at many employer health plans, a figure driving this month's wave of specialty pharmacy acquisitions.
Why it matters This is the number explaining why so much deal activity is happening in specialty pharmacy right now, since specialty drugs like GLP-1s have become the majority of what employer health plans spend on medications.
Deal Jul 18, 2026
Thurston Group united its SGA, Gen4 and Modis Dental Partners portfolio companies under the SGA Dental Partners name, creating a platform spanning more than 250 practice locations, 500 dentists and 26 states.
Why it matters Watch this fast-consolidating, lightly scrutinized corner of healthcare, where large dental support platforms already back a meaningful share of practicing US dentists.
Deal Jul 18, 2026
The private equity firm is buying a controlling stake in PANTHERx Rare from Nautic Partners, General Atlantic and Vistria Group, with terms undisclosed and the deal expected to close in coming months.
Why it matters Watch whether new ownership changes how patients access rare and orphan disease drugs through PANTHERx, the largest specialty pharmacy of its kind.
Rule Jul 17, 2026
CMS announced a Risk-Based Survey approach, effective September 8, that lets top-performing nursing homes skip most routine federal inspections so surveyors can focus on lower-rated facilities.
Why it matters Federal regulators will inspect high-performing nursing homes less often starting September 8, concentrating scrutiny on troubled facilities; watch whether reduced oversight affects care quality.
Rule Jul 17, 2026
CMS released its CY2027 Medicare Physician Fee Schedule proposed rule, which includes a payment cut and the first MIPS Value Pathway designed specifically for hospitalists, with comments due September 14.
Why it matters Medicare proposed cutting physician payments again for 2027 while adding a new hospitalist-specific quality-reporting track; watch the comment period and the final conversion factor.
Rule Jul 17, 2026
In the CY2027 Hospital Outpatient PPS proposed rule, CMS proposed letting accredited hospitals have accreditation organizations, rather than only state surveyors, check their EMTALA paperwork compliance, with comments due August 31.
Why it matters CMS proposed letting private accreditors review hospitals' EMTALA emergency-care paperwork; watch whether that eases or weakens oversight of the duty to screen and stabilize patients.
Report Jul 17, 2026
GAO found CMS lacks sufficient controls to verify consumer authorization for agent and broker changes, that confirmed unauthorized-enrollment complaints more than quadrupled since 2023, and that at least 160,000 federal marketplace applications in 2024 had likely unauthorized changes.
Why it matters A federal watchdog says marketplace enrollments can be changed without consumer consent, pointing to tighter enrollment-integrity rules and unwound plan switches ahead.
Rule Jul 17, 2026
The Consolidated Appropriations Act of 2026 extended CMS's Acute Hospital Care at Home waiver for five years, through September 30, 2030, giving hospitals long-term certainty to run inpatient-level care in patients' homes.
Why it matters Congress locked in Medicare's hospital-at-home program through 2030, letting hospitals keep treating inpatient-level patients at home; watch how programs scale with multi-year certainty.
Record Jul 17, 2026
A House Energy and Commerce subcommittee advanced three bills targeting illicit fentanyl pill-press and manufacturing equipment to the full committee.
Why it matters Congress is advancing bills to choke off illicit fentanyl manufacturing equipment; a supply-side enforcement move, not a coverage or payment change.
Rule Jul 17, 2026
The American Hospital Association filed comments disputing HRSA's estimate of the administrative burden that its proposed 340B Rebate Model Pilot Program would place on hospitals.
Why it matters Hospitals are fighting a proposed change that would run 340B drug discounts through rebates instead of upfront discounts, arguing the paperwork burden is far bigger than the government claims; watch whether HRSA revises the pilot.
Rule Jul 17, 2026
CMS reduced the federal No Surprises Act independent dispute resolution administrative fee from $115 to $15 per party, effective June 11, lowering the cost of entering payment disputes over out-of-network bills.
Why it matters The cost to file a federal surprise-billing payment dispute dropped from $115 to $15, making it far cheaper to challenge out-of-network payments; watch for a rise in dispute volume.
Deal Jul 17, 2026
IPG Photonics Corporation made a binding offer to acquire Lumibird Medical for 300 million euros plus an earnout of up to 50 million euros, for total consideration of up to 350 million euros, expanding into ophthalmology and urology lasers.
Why it matters A laser technology company is buying a medical laser maker to move deeper into ophthalmology and urology devices, a bet on medtech growth built on its core laser expertise.
Deal Jul 17, 2026
Jasper Therapeutics agreed to an all-stock merger with Kira Pharmaceuticals to build a complement-focused immune disease pipeline, paired with an approximately $132 million private placement to fund the combined company.
Why it matters Two small biopharma companies are combining and raising about $132 million to push complement therapies for immune disease; watch whether the cash runway is enough to reach clinical milestones.
Deal Jul 17, 2026
Medtronic closed its $650 million all-cash acquisition of SPR Therapeutics, adding SPR's minimally invasive, non-opioid peripheral nerve stimulation technology for chronic and acute pain to its neuromodulation portfolio.
Why it matters A medtech giant is buying its way deeper into non-opioid pain treatment; watch whether wider distribution expands access to drug-free pain devices.
Rule Jul 17, 2026
The National Family Planning and Reproductive Health Association and the ACLU filed for summary judgment seeking to block new HHS screening rules for Title X family planning grants.
Why it matters A family-planning group and the ACLU are asking a court to strike down new eligibility-screening rules for federal family-planning grants; watch the ruling for whether Title X funds keep flowing under the new terms.
Enforcement Jul 17, 2026
The HHS OIG kept active a Work Plan audit of Medicare high-level emergency department E/M billing, tied to an admission-status kickback theory behind recent settlements including Oroville Hospital's $10.25 million deal.
Why it matters Federal auditors are still scrutinizing hospitals that bill the highest-level emergency department visit codes; watch for more settlements as the audit continues.
Record Jul 17, 2026
REGENXBIO priced a $100 million public offering of common stock after its shares sold off on dilution concerns, raising cash that further dilutes existing shareholders.
Why it matters A gene-therapy developer is raising $100 million by issuing new stock, a move that dilutes current holders; watch what the cash funds and how the market reacts.
Deal Jul 17, 2026
Skagit Regional Health switched its hospitalist staffing contract from Sound Physicians to Vituity, and some physicians are leaving over the change.
Why it matters A Washington health system swapped its hospitalist staffing vendor from Sound Physicians to Vituity, prompting some doctor departures; watch for continuity-of-care disruption during the transition.
Enforcement Jul 17, 2026
Tactile Systems Technology agreed to pay $550,959 to resolve False Claims Act allegations that it submitted falsified Medicare claims for compression devices.
Why it matters A medical-device maker is paying $550,959 to settle claims it billed Medicare using falsified compression-device claims; a reminder that device documentation is under enforcement scrutiny.
Deal Jul 16, 2026
Big Sky Asset Management acquired HealthCap Partners, LLC, whose portfolio spans more than 150 healthcare properties across 28 states and more than $2.5 billion in transaction volume over nearly 30 years.
Why it matters A national medical real estate platform just got bigger, reflecting continued investor appetite for medical outpatient buildings as care keeps shifting out of hospitals into ambulatory settings.
Rule Jul 16, 2026
CMS published a Request for Information seeking input on the first major update to Clinical Laboratory Improvement Amendments regulations since 1992, with comments due September 14, 2026.
Why it matters Federal officials are reconsidering the decades-old rules that govern clinical lab quality and oversight, an early step that could reshape how labs are regulated for the first time in over 30 years.
Rule Jul 16, 2026
The DEA closed the evidentiary record on July 15 in its administrative hearing over moving marijuana from Schedule I to Schedule III, after proceedings that began June 29.
Why it matters The formal fact-finding phase of the long-running federal marijuana rescheduling case is now complete, moving the decision closer while leaving the ultimate outcome and timing uncertain.
Enforcement Jul 16, 2026
Forty-eight state attorneys general reached a $29.6 million settlement with Glenmark Pharmaceuticals over generic drug price-fixing, with New York securing more than $29 million of the total.
Why it matters State prosecutors extracted another settlement in the sprawling generic drug price-fixing cases, keeping pressure on manufacturers accused of coordinating to inflate the prices of everyday medicines.
Rule Jul 16, 2026
The House Ways and Means Committee voted 42 to 0 to advance the Improving Seniors' Timely Access to Care Act (H.R. 3514), a Medicare Advantage prior authorization reform bill, as part of a seven-bill health markup on July 15.
Why it matters A prior authorization reform bill aimed at Medicare Advantage cleared committee with unanimous bipartisan support, a strong signal that streamlining MA prior authorization has real momentum in Congress.
Earnings Jul 16, 2026
Johnson & Johnson and Abbott both beat Q2 2026 estimates and raised full-year guidance, with J&J lifting its outlook to about $101.1 billion in sales and Abbott raising adjusted EPS guidance to $5.45 to $5.60.
Why it matters Two of the largest diversified health companies posted strong quarters and raised their forecasts, a signal that demand for drugs and medical devices stayed healthy heading into the second half of 2026.
Enforcement Jul 16, 2026
Laboratory Corporation of America agreed to pay $14.5 million to resolve False Claims Act allegations that it billed federal programs for medically unnecessary urine drug testing.
Why it matters A major national lab settled claims it billed the government for unnecessary urine drug tests, underscoring continued federal scrutiny of high-volume drug-testing billing.
Deal Jul 16, 2026
Eli Lilly agreed to acquire AtaiBeckley Inc. for $6.75 per share in cash, about $2.8 billion upfront, plus a contingent value right of up to $2.50 per share tied to milestones, for total consideration of up to about $3.8 billion.
Why it matters A major pharma company is buying into psychedelic-derived treatments for treatment-resistant depression, a sign that mainstream drugmakers now see this once-fringe category as a serious pipeline bet.
Rule Jul 16, 2026
The Trump administration filed its defense on July 15 against a 26-state lawsuit challenging CMS and HHS's Medicaid work requirement interim final rule and its medically frail exemption, which is set to take effect July 31, 2026.
Why it matters A legal fight is underway over new Medicaid work requirements and how narrowly the medically frail exemption is defined, with 26 states suing to block a rule scheduled to take effect at the end of July.
Earnings Jul 16, 2026
UnitedHealth Group beat Q2 2026 estimates and raised full-year adjusted EPS guidance to $19.50 to $20.00, as its medical care ratio fell to 86.7 percent of premiums from 89.4 percent a year earlier.
Why it matters The largest US health insurer reported a sharp drop in the share of premiums paid out as medical claims and raised its outlook, a closely watched signal about medical cost trends across the industry.
Enforcement Jul 15, 2026
Aesculap Implant Systems agreed to pay 38.5 million dollars and entered a non prosecution agreement to resolve False Claims Act allegations that it failed to disclose an elevated failure rate for its knee implants.
Why it matters A knee implant maker paid 38.5 million dollars over allegations it hid a higher device failure rate, underscoring disclosure duties for implant makers; watch for related patient and provider claims.
Deal Jul 15, 2026
Atrium Health and OrthoCarolina in North Carolina formed a clinical affiliation and ambulatory surgery center joint venture in which Atrium takes no equity stake and OrthoCarolina remains physician-owned.
Why it matters A large health system and an independent orthopedic group are building an ortho destination through affiliation and shared ASCs rather than an outright buyout, a model that keeps physicians independent while moving surgical volume to lower-cost outpatient sites.
Rule Jul 15, 2026
CMS proposed cutting the Medicare physician fee schedule conversion factor for calendar year 2027 in its proposed rule (CMS 1848 P), published July 14, 2026 with comments due September 14 and an ACO Part B waiver provision starting April 2027.
Why it matters Medicare proposed lowering the base rate that sets physician payments for 2027, renewing the annual fight over doctor pay; watch the comment period and any congressional fix.
Earnings Jul 15, 2026
Elevance Health beat second quarter 2026 estimates and raised full year guidance even as its medical loss ratio rose 80 basis points to 89.7 percent and medical membership fell to about 44.9 million, down 469,000 from the prior quarter.
Why it matters A major insurer topped estimates and lifted guidance despite rising medical costs and membership losses, a sign it is pricing higher claims trend while shedding lives; watch whether the MLR keeps climbing.
Rule Jul 15, 2026
The FDA finalized guidance on designing psychedelic drug clinical trials and opened a request for information on care delivery models, with comments due August 13, a registration deadline of August 21, and a hearing set for September 14, 2026.
Why it matters The FDA laid out how it will evaluate psychedelic therapies and is seeking input on how such treatments would be delivered, a step toward possible approvals; watch the September hearing.
Enforcement Jul 15, 2026
The FTC settled its antitrust case against CVS Caremark over rebating practices it said inflated insulin list prices, securing up to 8.5 billion dollars in projected consumer savings over 10 years and a new 25 dollar monthly insulin cap program.
Why it matters A top pharmacy benefit manager settled federal claims that its rebate practices drove up insulin prices, adding a 25 dollar monthly cap and billions in projected savings; watch whether other PBMs face similar pressure.
Enforcement Jul 15, 2026
The FTC fined Edwards Lifesciences 10 million dollars and Genesis MedTech 2 million dollars, 12 million total, for structuring a 2024 heart device deal to fall just under the Hart Scott Rodino premerger notification threshold and avoid antitrust review.
Why it matters Regulators penalized two device makers for engineering a deal to dodge premerger antitrust review, signaling tougher enforcement of filing rules; watch for more merger scrutiny of device deals.
Rule Jul 15, 2026
Hawaii's governor signed Senate Bill 3025 (Act 220), creating a Medical Debt Acquisition and Forgiveness Program that could erase about 91 million dollars in medical debt for roughly 50,000 residents.
Why it matters Hawaii became the latest state to buy and cancel residents' medical debt for pennies on the dollar; watch whether more states copy the model.
Earnings Jul 15, 2026
HCA Healthcare cut its full year 2026 guidance, now estimating a 1.0 billion to 1.2 billion dollar hit from ACA exchange membership shifts, up from a prior 600 million to 900 million dollar estimate.
Why it matters A large hospital operator warned that shrinking ACA exchange enrollment will cost it more than expected, an early read on how coverage losses hit provider revenue; watch other systems' exposure.
Rule Jul 15, 2026
The HHS Administration for Children and Families finalized rescission of the 2024 rule that set designated placement requirements for LGBTQI+ children in Titles IV E and IV B foster care, effective July 14, 2026.
Why it matters The federal government reversed a 2024 rule that had required specific safe placement standards for LGBTQI+ foster youth; watch for legal challenges and state level responses.
Deadline Jul 15, 2026
The House Energy and Commerce Health Subcommittee marked up three bills, the PRESS Act (H.R. 7184), the Fight Illicit Pill Presses Act (H.R. 5880), and the Stop Pills That Kill Act (H.R. 8005), aimed at illicit fentanyl pill press importers and manufacturers.
Why it matters Congress is advancing bills to choke off illicit fentanyl manufacturing equipment, a supply side enforcement move, not a coverage or payment change.
Deal Jul 15, 2026
Indiana's Orthopedic and Balance Therapy Specialists was acquired by an unnamed national rehabilitation platform, in a sector where deals are reported running roughly 8 to 12 times EBITDA.
Why it matters Another independent physical therapy practice was absorbed into a national platform, part of the ongoing roll-up of outpatient rehab into private-equity-backed chains that consolidates local providers under larger owners.
Rule Jul 15, 2026
The HHS Office of Inspector General issued Advisory Opinion 26 16 approving a food as medicine program, finding that providing medically tailored food would not trigger fraud and abuse sanctions.
Why it matters A federal watchdog gave a green light to a program providing medically tailored food, easing anti kickback worries and opening a path for more such initiatives; watch for copycat programs.
Report Jul 15, 2026
AAOS 2026 Annual Meeting research found that prior authorization delayed elective spine surgery without producing payer cost savings, and that 80 percent of the denials examined were reversed on appeal.
Why it matters A first-of-its-kind study says prior authorization on spine surgery mostly delays care rather than saving money, adding clinical evidence to the political push to scale back these controls.
Report Jul 15, 2026
Rock Health reported that US digital health startups raised 7.4 billion dollars across 244 deals in the first half of 2026, with mega deals of 100 million dollars or more taking 45 percent of the capital in 8 percent of deals, and 115 M&A exits concentrated in revenue cycle management and metabolic health.
Why it matters Digital health funding is flowing to fewer, larger deals while consolidation clusters in billing tech and metabolic care; watch whether smaller startups get squeezed out.
Enforcement Jul 15, 2026
SpineFrontier's former CFO Aditya Humad pleaded guilty to conspiring to pay surgeons more than $540,000 in kickbacks disguised as consulting fees, with sentencing set for August 6 in Massachusetts.
Why it matters A spinal device executive admitted to a kickback scheme dressed up as consulting payments, a reminder that sham consulting arrangements between device makers and surgeons remain a top enforcement target.
Rule Jul 15, 2026
In the FY 2027 IPPS proposed rule, CMS proposed adding spinal fusion to the mandatory Transforming Episode Accountability Model bundles, with comments that closed June 9 and a proposed effective date of October 1, 2026.
Why it matters CMS wants to make hospitals financially accountable for the full episode cost of spinal fusion under its mandatory bundled payment model, extending value-based risk into one of the most expensive surgical categories.
Report Jul 14, 2026
Bloomberg Law reported that surgical device maker CONMED is working with advisers on a possible sale after drawing private equity takeover interest, sending shares up about 10 percent; no bidders or formal process have been disclosed and CONMED has not confirmed a sale.
Why it matters A mid-size maker of surgical devices may be up for sale, an early and unconfirmed sign of renewed buyout interest in medtech.
Rule Jul 14, 2026
In the CY2027 Hospital OPPS/ASC proposed rule, CMS proposes a site-neutral cut that would pay off-campus hospital imaging at 40 percent of the standard outpatient rate; comments close August 31, 2026.
Why it matters CMS wants to pay hospital-owned imaging done at off-campus sites far less, aiming to stop patients from being charged more for the same scan based on where it is done.
Rule Jul 14, 2026
The DEA's administrative hearing on moving marijuana from Schedule I to Schedule III closed its evidentiary record on July 14, 2026, a procedural step before the agency issues a decision.
Why it matters The long-running federal effort to loosen marijuana's controlled-substance status cleared a key procedural milestone, moving it closer to a decision that could ease research and taxation.
Approval Jul 14, 2026
The FDA approved the first at-home starting dose for Eisai's Alzheimer's drug Leqembi Iqlik, a lecanemab-irmb subcutaneous injection, for early Alzheimer's disease with mild cognitive impairment or mild dementia.
Why it matters Patients starting the Alzheimer's drug Leqembi can now begin treatment with an at-home injection rather than only in a clinic, a convenience step for early-stage patients and caregivers.
Deal Jul 14, 2026
An Israeli court in Haifa froze an InMode board decision amid a contested takeover fight, as Steel Partners Holdings pursues an unsolicited $16.75-per-share all-cash bid for the aesthetic device maker against a rival CEO-led buyout.
Why it matters A courtroom fight over control of aesthetic-device maker InMode pits an outside cash bidder against management, with a judge freezing a board move.
Report Jul 14, 2026
Kaufman Hall reported hospital M&A had its strongest second quarter since 2018, with 18 transactions and $7.7 billion in transacted revenue, more than five times the $1.4 billion a year earlier, with nearly all buyers being nonprofit systems rather than private equity or for-profit chains.
Why it matters Hospital dealmaking rebounded sharply, with nonprofit systems doing most of the buying, meaning more local hospitals are joining larger networks.
Rule Jul 14, 2026
Missouri Governor Kehoe signed a package of six health care bills, including an expansion of Medicaid coverage for doula services, with most provisions effective August 28, 2026.
Why it matters Missouri added Medicaid coverage for doula support and several other health measures, expanding maternal-care benefits for the state's Medicaid population starting late August.
Enforcement Jul 14, 2026
Mobile PET scan provider Modern Nuclear Inc agreed to pay $8,334,350.71 plus a share of future revenue to settle DOJ False Claims Act allegations that it paid inflated physician supervision fees, an Anti-Kickback Statute violation, to induce referrals for PET scans.
Why it matters A mobile PET imaging company is paying more than $8.3 million to settle claims it disguised kickbacks as inflated physician supervision fees to win scan referrals.
Report Jul 14, 2026
The Neiman Health Policy Institute reported that radiologist practice turnover rose 61 percent from 2013 to 2022, with the likelihood of a job change accelerating around 12,940 annual wRVUs overall, 13,380 for nonacademic and 8,820 for academic radiologists.
Why it matters A decade of data ties radiologist departures to workload, flagging burnout driven turnover as reading volumes climb; watch whether staffing and AI capacity relieve the pressure.
Report Jul 14, 2026
The HHS Office of Inspector General's Spring 2026 semiannual report says it recovered or saved $5.56 billion from Medicare and Medicaid over six months from October 2025 to March 2026, a $12.70 return per dollar spent, built on 604 criminal and civil actions and 1,212 program exclusions.
Why it matters The federal healthcare watchdog reported billions in recoveries and more than a thousand exclusions in six months, signaling aggressive ongoing enforcement across Medicare and Medicaid.
Rule Jul 14, 2026
The HHS Office of Refugee Resettlement published a notice, effective immediately on July 14, 2026, doubling the eligibility period for Refugee Cash Assistance and Refugee Medical Assistance to eight months.
Why it matters Newly arrived refugees can now receive federal cash and medical assistance for eight months instead of a shorter window, extending short-term coverage during resettlement.
Report Jul 14, 2026
An ACR analysis of CMS data found providers win 88 percent of No Surprises Act IDR disputes with 87 percent of awards above the qualifying payment amount, Radiology Partners posted a median prevailing offer of 631 percent of QPA in the first half of 2024, and new batching rules effective May 2026 cut per claim administrative fees.
Why it matters Independent dispute resolution is paying providers far above insurer benchmark rates, undercutting the No Surprises Act goal of restraining out of network costs; watch whether CMS revisits the QPA methodology.
Deal Jul 14, 2026
RadNet agreed to pay up to 270 million dollars for radiology AI firm Gleamer as part of over 340 million dollars in 2026 acquisitions, including 13 Southwest Florida imaging centers and six Indianapolis centers.
Why it matters A large imaging operator is buying AI capability and physical centers at scale, signaling consolidation and vertical integration in radiology; watch how AI ownership reshapes reading productivity.
Deal Jul 14, 2026
ResMed agreed to sell its MatrixCare post-acute health IT business to Frazier Healthcare Partners for $490 million, less than two-thirds of the $750 million ResMed paid for MatrixCare in 2018.
Why it matters ResMed is exiting post-acute care software at a loss versus its 2018 purchase price, handing MatrixCare to a private equity buyer.
Rule Jul 14, 2026
The bipartisan Radiology Outpatient Ordering Transmission (ROOT) Act would revive the Medicare appropriate use criteria program for advanced imaging that CMS shelved when it rescinded AUC claims reporting effective January 2024.
Why it matters Lawmakers want to restart a shelved program requiring doctors to consult appropriate use criteria before ordering advanced imaging; watch whether it clears committee after May 2026 testimony.
Record Jul 13, 2026
A whistleblower lawsuit alleges Alignment Healthcare used accounting maneuvers to manufacture its first profitable year, according to a report on the Kardes complaint.
Why it matters A former insider is accusing a publicly traded Medicare Advantage insurer of dressing up its books to show a profit; the claims are unproven allegations for now.
Rule Jul 13, 2026
CMS finalized the Ambulatory Specialty Model, a mandatory program running January 1, 2027 through December 31, 2031 that puts participating cardiologists and other specialists into two-sided financial risk.
Why it matters Starting in 2027, a mandatory Medicare model will hold certain specialists, including cardiologists, financially accountable for the cost and quality of care, marking a big step in required value-based payment.
Report Jul 13, 2026
Astrana Health disclosed in an 8-K that all eight of its Medicare ACOs, five in the Medicare Shared Savings Program and three in ACO REACH, generated net and gross shared savings totaling about $120.4 million for the 2024 performance year.
Why it matters A value-based care company reported that every one of its eight Medicare ACOs earned savings in 2024, a strong result in a program where many organizations fall short.
Report Jul 13, 2026
MedAxiom's 2024 data show median total compensation for hospital-integrated cardiologists topped $700,000 for the first time while private-practice cardiologists fell to a median of $588,479, opening a $112,475 gap, the widest in more than five years.
Why it matters A pay gap this wide signals that hospital employment keeps pulling cardiologists out of independent practice, which shapes where you can get heart care and at what facility rates.
Report Jul 13, 2026
MedAxiom reports that close to 50 percent of private-practice cardiology groups now carry private equity ownership, up from effectively zero a few years ago, while Humana separately expanded its value-based cardiology partnerships to four platforms for Medicare Advantage members.
Why it matters Independent cardiology has flipped from physician-owned to nearly half private-equity backed in just a few years, changing who controls a large slice of US heart care.
Rule Jul 13, 2026
CMS is taking comment on an OBBBA-driven policy that would cap Medicaid state directed payments at Medicare rates and add a quality metric requirement, with comments due July 21.
Why it matters The federal government wants to limit how much extra states can pay Medicaid providers, capping those payments at Medicare rates; comments are due July 21.
Rule Jul 13, 2026
In the CY2027 Hospital OPPS/ASC proposed rule, CMS proposes removing cardiovascular procedures from the inpatient-only list starting in 2028, which would let them be paid in outpatient and ambulatory settings; comments close August 31, 2026.
Why it matters CMS wants to let more heart procedures be done as outpatient rather than requiring a hospital admission, which could shift where you have cardiac procedures and how much they cost.
Rule Jul 13, 2026
The DEA administrative hearing on rescheduling marijuana from Schedule I to Schedule III is expected to close around July 15, with no deadline set for a final ruling.
Why it matters The federal hearing that could reclassify marijuana is nearly finished, but there is still no set date for an actual decision.
Approval Jul 13, 2026
The FDA approved Sanofi's Sarclisa Escena (isatuximab-irfc), the first on-body injector cancer drug, for newly diagnosed and relapsed or refractory multiple myeloma in combination regimens.
Why it matters The FDA cleared the first cancer drug delivered by a wearable on-body injector, giving multiple myeloma patients a new administration option that could reduce infusion-chair time.
Enforcement Jul 13, 2026
Health Canada placed new operating conditions on 16 Grifols plasma collection centers after citing recurring systemic deficiencies, including donors who should have been deferred over Creutzfeldt-Jakob disease risk, following two donor deaths at a Winnipeg clinic.
Why it matters Canadian regulators tightened oversight of a major plasma company after two donor deaths and repeated safety lapses, raising questions about a large public plasma collection contract.
Enforcement Jul 13, 2026
Louisiana's Medicaid Fraud Control Unit secured sentences against two Camellia Drive Community Home employees for abusing a disabled Medicaid resident, part of a broader sweep that has produced 105 convictions and more than $73 million in ordered restitution.
Why it matters Two care-home workers were sentenced for abusing a disabled Medicaid resident, part of a wider Louisiana crackdown that has racked up 105 convictions and over $73 million in restitution.
Enforcement Jul 13, 2026
A Memphis gynecologist, Sanjeev Kumar, was sentenced to 240 months in prison for adulterating and misbranding medical devices and health care fraud after reusing single-use devices in a scheme that billed more than $41 million and netted over $4.8 million from Medicare and Medicaid.
Why it matters A gynecologist got 20 years for reusing medical devices meant for single use and defrauding federal programs of millions, a rare and severe sentence signaling patient-safety stakes.
Record Jul 13, 2026
Regional One Health is closing its Regional One Extended Care hospital in Memphis and laying off more than 100 employees, cutting 103 jobs.
Why it matters A Memphis health system is shutting an extended-care hospital and cutting 103 jobs, reducing local post-acute capacity.
Deal Jul 13, 2026
The Minnesota Attorney General held a public hearing on Sutter Health's proposed merger with Allina Health, a deal that would create a roughly $26 billion nonprofit system with 39 hospitals and a pledge to invest more than $2 billion in Minnesota and western Wisconsin.
Why it matters A large hospital merger that would form a $26 billion, 39-hospital nonprofit system is getting public scrutiny from Minnesota's attorney general before any approval.
Rule Jul 13, 2026
CMS proposes eliminating the hospital and operator volume minimums in its TAVR national coverage determination, which would let more hospitals start or continue TAVR programs; the comment period closes July 15, 2026, with a final decision expected September 13, 2026.
Why it matters CMS may drop the case-count rules that limit which hospitals can perform the TAVR heart-valve procedure, potentially expanding access to more, including smaller and rural, hospitals.
Enforcement Jul 13, 2026
Tri-City Cardiology and three physicians agreed to pay $4.75 million, with $4,606,247.22 to the federal government and $143,752.78 to Arizona, to resolve DOJ False Claims Act allegations that they billed for medically unnecessary vein ablation procedures.
Why it matters A Phoenix cardiology group is paying $4.75 million to settle claims it performed and billed unnecessary vein procedures, a reminder that medical-necessity billing is under active federal scrutiny.
Report Jul 12, 2026
The Peterson-KFF Health System Tracker finds ACA marketplace insurers are requesting a median 14 percent premium increase for 2027, a second straight double-digit year driven by roughly 10 percent medical trend, GLP-1 utilization, labor costs, and the loss of enhanced premium tax credits.
Why it matters Marketplace insurers want another double-digit premium hike for 2027; watch how much regulators approve and whether higher costs push healthier enrollees to drop coverage.
Enforcement Jul 12, 2026
California secured a court-approved settlement and permanent injunction against First Call Telemedicine, Trinity HealthShare, Aliera, and their operators over a sham health cost-sharing ministry that kept about 84 percent of consumer contributions, with more than 5.1 million dollars in civil penalties partly suspended.
Why it matters California shut down a sham health-sharing ministry that pocketed most of members' money; watch for continued state crackdowns on fake or misleading coverage products.
Record Jul 12, 2026
Centene announced it will exit the Arkansas ARHOME Medicaid expansion program in 2027, dropping the state's private-option coverage line.
Why it matters A major Medicaid insurer is pulling out of Arkansas's expansion program; watch where affected members land and whether other insurers follow in shaky Medicaid markets.
Deal Jul 12, 2026
Clarivate agreed to sell its Life Sciences and Healthcare data segment to private equity firm Altaris for 600 million dollars, structured as 500 million cash at closing plus 25 million deferred and a 75 million dollar seller note.
Why it matters Clarivate is divesting its health data business to a PE buyer for 600 million dollars; watch whether new ownership changes pricing or service for customers of that data.
Rule Jul 12, 2026
CMS proposed a 2.4 percent update to Medicare hospital outpatient and ASC payments for calendar year 2027, worth about $9.5 billion, with comments due August 31, 2026.
Why it matters Medicare is proposing to pay more for outpatient and same-day surgical care in 2027; the exact rate is not final until after the August 31 comment window closes.
Rule Jul 12, 2026
The DEA administrative hearing on moving marijuana from Schedule I to Schedule III is nearing its expected July 15 close, but no deadline has been set for a final ruling.
Why it matters A long-running federal process that could reclassify marijuana is wrapping up its hearing phase, but there is still no timeline for an actual decision.
Deal Jul 12, 2026
IKS Health closed its 557 million dollar acquisition of health IT and revenue cycle company TruBridge at 26.25 dollars a share in cash, completing the deal on July 9, 2026.
Why it matters IKS Health took TruBridge private in a 557 million dollar deal; watch whether the combination reshapes revenue cycle and EHR services for community providers.
Rule Jul 12, 2026
Twenty-six states asked a federal court to rule by July 31 on their challenge to CMS's interim final rule narrowing the medically frail exemption from Medicaid work requirements, which take effect January 1, 2027.
Why it matters States are fighting a federal rule that would make it harder for sick and disabled people to be exempt from Medicaid work requirements; a court ruling is requested by July 31 ahead of a January 2027 effective date.
Record Jul 12, 2026
Memorial Hermann is shutting down its entire commercial health insurance business, ending its role as a payer in that market.
Why it matters A large Texas health system is exiting commercial insurance entirely; watch how members are transitioned and whether more provider-owned plans retreat from the payer business.
Enforcement Jul 12, 2026
A Jersey City office manager, Janet Tadros, pleaded guilty to conspiring to commit health care fraud and violate the Anti-Kickback Statute by taking roughly $3,000 a week in cash to funnel unauthorized prescriptions to pharmacies in a scheme that cost Medicare and Medicaid about $20.7 million.
Why it matters A guilty plea in a $20.6 million New Jersey kickback and prescription-fraud case shows federal prosecutors continuing to target cash-for-prescriptions referral schemes.
Deadline Jul 12, 2026
More than 450,000 New Yorkers in the 200 to 250 percent poverty tier lost Essential Plan eligibility on July 1, 2026 after the One Big Beautiful Bill Act ended premium tax credit eligibility for most lawfully present immigrants, and they have until August 30 to enroll in a Qualified Health Plan with retroactive coverage to avoid a gap.
Why it matters A federal law change dropped hundreds of thousands of New Yorkers from the Essential Plan, and they have an August 30 deadline to pick a new plan or risk a coverage gap.
Deal Jul 11, 2026
Ascension, through Ascension Saint Thomas, agreed to acquire Tennessee's Williamson Health for a 700 million dollar purchase price plus 250 million dollars in additional capital investment over 10 years, a deal valued near 950 million dollars.
Why it matters One of the largest Catholic health systems is buying a Tennessee hospital in a nearly 1 billion dollar deal, continuing hospital consolidation; watch for effects on local prices and competition.
Rule Jul 11, 2026
CMS's proposed CY2027 Home Health Prospective Payment System rule pairs a roughly 420 million dollar net payment increase with new authority to claw back improper payments, with comments open until August 31, 2026.
Why it matters CMS is proposing to raise home health pay while arming itself to recover fraudulent payments; watch the August 31 comment close and how the clawback powers are defined.
Rule Jul 11, 2026
CMS's proposed CY2027 OPPS and ASC rule would cut Medicare payment for 340B-acquired drugs to hospitals by nearly 40 percent, with comments open until August 31, 2026.
Why it matters A federal proposal would sharply reduce what Medicare pays 340B hospitals for drugs; watch the August 31 comment close and whether the cut survives to a final rule.
Enforcement Jul 11, 2026
CVS agreed to pay 36.5 million dollars, including 25.1 million to state and federal Medicaid programs, to settle False Claims Act allegations that it systematically over-dispensed insulin pens to Medicaid patients from 2010 to 2020.
Why it matters CVS is paying 36.5 million dollars to resolve claims it over-dispensed insulin pens to Medicaid; watch for continued state and federal scrutiny of pharmacy dispensing practices.
Rule Jul 11, 2026
The DEA is moving to temporarily place concentrated kratom extract 7-hydroxymitragynine (7-OH) above a set threshold into Schedule I, with comments due July 31, 2026.
Why it matters The DEA wants to make concentrated 7-OH kratom extract a Schedule I substance; watch the July 31 comment close and whether the temporary scheduling is finalized.
Report Jul 11, 2026
Galen Growth reports H1 2026 global digital health funding held flat at 22.6 billion dollars across 608 rounds even as deal count fell 38 percent, with capital concentrating in fewer, larger, more mature companies.
Why it matters Digital health money is holding steady in dollars but flowing to fewer, bigger deals; watch whether early-stage founders get starved as capital concentrates in mature players.
Report Jul 11, 2026
The FTC and DOJ FY2025 Hart-Scott-Rodino report shows 18 merger challenges, 2,006 notified transactions with nearly 32 percent above 1 billion dollars, 41 Second Requests, and healthcare named a priority under the FTC Healthcare Task Force.
Why it matters Antitrust regulators are naming healthcare a priority enforcement sector; watch for longer reviews and more challenges on hospital, insurer, and pharma deals.
Rule Jul 11, 2026
The HHS Office for Civil Rights Section 504 requirement for accessible medical equipment, including exam tables and weight scales, took effect July 8, 2026 under the 2024 disability nondiscrimination final rule.
Why it matters Federally funded providers now must have accessible exam tables and weight scales in place; watch for OCR complaints and enforcement against facilities that fall short.
Deal Jul 11, 2026
Private equity firm Knox Lane cleared the final regulatory hurdle to acquire staffing company Cross Country Healthcare for 437 million dollars, or 13.25 dollars a share.
Why it matters A major healthcare staffing firm is going private in a 437 million dollar deal; watch whether new ownership reshapes contract labor pricing and availability.
Enforcement Jul 11, 2026
Gwendolyn Singleton of Greensboro pleaded guilty to health care fraud for billing North Carolina Medicaid roughly 1.7 million dollars through Joelle's Center of Hope for urine drug tests that were never performed.
Why it matters A North Carolina operator admitted billing Medicaid 1.7 million dollars for drug tests never done; watch continued enforcement focus on urine drug testing fraud.
Deal Jul 11, 2026
Vertex Pharmaceuticals agreed to acquire endocrinology drugmaker Crinetics Pharmaceuticals for about 10 billion dollars, or 85 dollars a share all cash, including 4.5 billion dollars of bridge financing.
Why it matters Vertex is paying roughly 10 billion dollars to move into endocrinology; watch whether it signals more large biopharma dealmaking after a slow stretch.
Deal Jul 10, 2026
The funds completed a sale-leaseback-style acquisition of 12 acute-care hospitals from Spire Healthcare on July 8, 2026, financed by a secured term loan from Standard Chartered, Natixis, and Credit Agricole, with Spire remaining as tenant.
Why it matters This shows US alternative-asset money continuing to move into overseas hospital real estate rather than US assets. Watch whether Blue Owl extends this net-lease strategy to more hospital portfolios, including in the US.
Rule Jul 10, 2026
CMS proposed rule CMS-2449-P would require states to file Medicaid managed-care state-directed payments prospectively, with the comment period closing July 21, 2026.
Why it matters CMS wants tighter, up-front oversight of the state-directed payments that funnel billions of extra Medicaid dollars to providers; a technical but high-stakes change to watch, with comments due July 21.
Enforcement Jul 10, 2026
Done Global founder Ruthia He was sentenced to 72 months and a 1 million dollar fine and clinical president David Brody to 24 months for a 90 million dollar scheme that shipped over 37 million Adderall pills through a telehealth platform.
Why it matters Two executives of a telehealth ADHD startup got prison time for a 90 million dollar scheme that flooded the market with Adderall prescriptions; a landmark case signaling tougher scrutiny of online stimulant prescribing.
Deal Jul 10, 2026
The Taiwan-based long-term care operator signed a Business Combination Agreement with RF Acquisition Corp III on July 9, 2026, targeting a fourth-quarter close pending shareholder and SEC review.
Why it matters This creates one of the only pure-play post-acute listings on a US exchange, giving investors a way to bet directly on long-term care outside Taiwan. Watch for the SEC's review of the Form F-4 and the shareholder vote before the deal is final.
Enforcement Jul 10, 2026
Memphis gynecologist Dr. Sanjeev Kumar was sentenced to 20 years in federal prison for reusing unsterilized biopsy devices and health care fraud, after billing more than 41 million dollars and netting over 4.8 million from Medicare and Medicaid.
Why it matters A gynecologist got 20 years for reusing single-use biopsy devices on patients and defrauding federal programs; an extreme patient-safety and fraud case that underscores device and billing oversight.
Rule Jul 10, 2026
Montana and Arkansas became the first states to launch Medicaid 80-hour-a-month community-engagement work requirements on July 1, 2026, ahead of a January 1, 2027 deadline for all states.
Why it matters Two states switched on Medicaid work requirements, the leading edge of a nationwide mandate arriving by January 2027; watch for coverage losses as enrollees navigate reporting rules.
Enforcement Jul 10, 2026
HHS-OIG denied recertification and suspended about 60 million dollars a year in federal funding for the New York State Medicaid Fraud Control Unit effective July 1, 2026.
Why it matters Federal regulators cut off funding to New York's Medicaid fraud-fighting unit, an unusual move that could weaken oversight of the nation's largest Medicaid program; watch how the state responds.
Deal Jul 10, 2026
The physician-led fertility and longevity provider, backed by Humania Capital and ARTIS Ventures, acquired clinical decision support and patient-intake software maker Levy Health on July 7, 2026, with terms undisclosed, as it expands from the US into the Gulf Cooperation Council.
Why it matters This is a small, undisclosed-terms deal aimed at standardizing fertility workups as Onto expands into the Middle East. Watch for how Onto scales the technology across its growing footprint.
Record Jul 10, 2026
Bloomberg reported that EQT, Advent, and KKR are each studying a possible bid for the 7.85 billion dollar diagnostics maker, sending its shares up more than 10 percent in Frankfurt trading.
Why it matters This is unconfirmed, early-stage takeover chatter, not a deal. Watch for a formal bid or Qiagen confirming it received an offer before treating this as real.
Deal Jul 10, 2026
Peak Rock Capital closed its acquisition of group-purchasing and commercialization firm Asembia on July 2, 2026, while Cigna's Evernorth separately launched a 100 million dollar AI initiative called Pharmacy Forward at its own specialty pharmacy, Accredo.
Why it matters Specialty drugs are now more than 60 percent of drug spending at many health plans, and this is the backdrop for both moves. Watch for more acquisitions in specialty pharmacy as Peak Rock has said it plans further deals.
Rule Jul 9, 2026
CMS finalized a rule barring hospital accrediting organizations from selling consulting services to the same facilities they inspect, effective June 16, 2027.
Why it matters CMS is closing a conflict-of-interest loophole where accreditors both graded and advised hospitals; a governance tightening that could make accreditation surveys tougher and more independent.
Deadline Jul 9, 2026
Colorado's General Assembly Commission on Medicaid opened a formal review of state Medicaid spending, utilization, and administration, with a recommendations report due December 11, 2026.
Why it matters Colorado is formally studying how to rein in Medicaid spending, an early step that could reshape the state's program; watch the December 11 report for the direction of cuts or reforms.
Rule Jul 9, 2026
Elevance sued CMS on July 1, 2026 over its 2026 Medicare Advantage star ratings methodology, with about 115 million dollars in quality bonus payments at stake, following favorable rulings for Clover and BCBS Louisiana.
Why it matters Another big insurer is suing CMS over how star ratings are calculated, part of a wave of legal challenges that has already won for some plans; the outcome affects billions in Medicare Advantage bonus money.
Report Jul 9, 2026
GAO reported that Medicare and Medicaid spent about 12 billion dollars on assisted living in 2024, while Medicaid still cannot cover the room and board that keeps most seniors out of nursing homes.
Why it matters A federal watchdog put a 12 billion dollar price tag on assisted-living spending and flagged that Medicaid's inability to pay room and board pushes seniors toward costlier nursing homes; watch for reform proposals.
Rule Jul 9, 2026
The 8th Circuit on July 1, 2026 upheld Missouri Senate Bill 751, keeping alive the state law that bars drugmakers from restricting 340B discounts through contract pharmacies.
Why it matters A federal appeals court let Missouri's 340B contract-pharmacy protections stand, a win for safety-net providers in the long fight with drug manufacturers over discounts; watch for similar rulings in other circuits.
Enforcement Jul 9, 2026
TRUST LLC, representing NCPA-affiliated pharmacies, filed suit July 2 in federal court in Washington state alleging a 2019 arrangement let Prime Therapeutics adopt Express Scripts' lower reimbursement structure in exchange for network access.
Why it matters This is a major antitrust test of how much coordination is allowed between two of the largest pharmacy benefit managers. Watch how the case proceeds in discovery and whether other PBMs face similar suits.
Deal Jul 9, 2026
NHI completed the related-party sale of 32 skilled nursing facilities and 3 independent-living properties to entities controlled by National HealthCare Corporation on July 1, cutting NHI's skilled-nursing exposure to about 12.2 percent of its portfolio while raising its senior-housing operating share to about 22 percent.
Why it matters This shows a large nursing-home REIT deliberately shrinking its skilled-nursing exposure in favor of senior housing even as SNF occupancy has been rising. Watch whether other REITs follow the same shift.
Deal Jul 9, 2026
The July 6 announced deal gives Novartis Myricx Bio's oncology antibody-drug conjugate pipeline, built on a novel NMTi payload technology, for about 1.1 billion dollars upfront plus development and sales milestones.
Why it matters This is another large pharma bet on next-generation antibody-drug conjugates for cancer treatment. Watch how the NMTi payload technology performs in clinical development versus existing ADC platforms.
Deal Jul 9, 2026
Pacifica Hospital of the Valley Corporation filed for Chapter 11 protection July 4 in Delaware bankruptcy court, listing 100 million to 500 million dollars in debt and citing COVID-era losses, a lender dispute, and seismic-retrofit compliance costs.
Why it matters A safety-net hospital serving the Sun Valley area is now in bankruptcy proceedings. Watch whether the facility keeps operating through the reorganization or faces closure or sale.
Deadline Jul 9, 2026
Moffitt Cancer Center has been out of Humana Medicare Advantage networks since July 1, a UnitedHealthcare dispute is set to drop 1,900 Brown University Health patients in Rhode Island, and University of Miami Health System's UnitedHealthcare contract for commercial and Medicaid lines expires July 31.
Why it matters Patients in Florida and Rhode Island covered by these plans could lose in-network access to major providers within weeks. Watch whether last-minute deals get struck before the deadlines hit.
Alert · now Jul 9, 2026
FDA and CDC linked an E. coli outbreak with 12 cases across Florida and Georgia to GreenWise frozen organic blueberries, which were recalled from Publix.
Why it matters A recalled batch of frozen organic blueberries sold at Publix is behind an E. coli outbreak in Florida and Georgia; a food-safety alert to heed if you have the product at home.
Funding Jul 9, 2026
SAMHSA opened more than 281 million dollars in behavioral health grant funding across 15 programs, including medication-assisted opioid treatment and school mental health, on a rolling application basis.
Why it matters The federal behavioral-health agency is putting 281 million dollars into addiction, overdose, and mental-health programs; a funding opportunity to watch if you run or partner with treatment services.
Enforcement Jul 9, 2026
The hospital's July 8 complaint alleges Lilly's new claims-data-submission requirement for 340B discounts raised its Mounjaro cost per unit from 750.52 dollars to 1,019.74 dollars, a 35.9 percent increase, and violates Florida's consumer protection law.
Why it matters This is the first lawsuit challenging a drugmaker's data-reporting condition on 340B discounts, a fight that could reshape how much safety-net hospitals pay for brand-name drugs. Watch whether other 340B hospitals file similar suits against Lilly or other manufacturers.
Rule Jul 8, 2026
Arizona became the 25th state to sue over the CMS Medicaid Community Engagement Requirement interim final rule, which was published June 3, 2026, closes comment July 31, and requires work or engagement starting January 1, 2027.
Why it matters Half the states are now suing to block Medicaid work requirements before they start in 2027; watch the litigation and the July 31 comment close.
Deadline Jul 8, 2026
CMS reopened its computer matching program with the VA to verify Medicaid applicants' other coverage and opened public comment through August 6, 2026.
Why it matters CMS is restarting data-sharing with the VA to check whether Medicaid applicants have other coverage; watch the August 6 comment deadline and privacy considerations.
Approval Jul 8, 2026
FDA approved the first BAFF/APRIL dual inhibitor to reduce proteinuria in adults with primary IgA nephropathy who are at risk of rapid disease progression.
Why it matters FDA cleared a first-in-class drug for a serious kidney disease; watch adoption and pricing as a new mechanism enters the IgA nephropathy market.
Approval Jul 8, 2026
CMS launched a Medicare GLP-1 Bridge coverage pathway that lets beneficiaries get weight-loss drugs for a flat 50 dollar copay.
Why it matters Medicare is opening a route to cover GLP-1 drugs for obesity at a low fixed copay, a major expansion of who can access these medicines and a signal of rising federal drug spend to watch.
Rule Jul 8, 2026
New York's Nurse Practitioner Modernization Act independent-practice provision sunset on July 1, 2026, so experienced NPs in the state lose the ability to practice without a physician collaboration agreement.
Why it matters New York let its independent nurse-practitioner authority expire, rolling back scope of practice for NPs and adding friction to primary-care access; watch whether the legislature renews it.
Enforcement Jul 8, 2026
CVS Caremark, Express Scripts, and Optum Rx all settled the FTC's insulin-pricing cases, and on July 1, 2026 the 8th Circuit dismissed the PBMs' countersuit against the agency.
Why it matters The three biggest pharmacy-benefit managers settled federal claims that their rebate practices inflated insulin prices, a milestone in the fight over drug-pricing middlemen; watch what the settlements require them to change.
Rule Jul 7, 2026
CMS proposed cutting Medicare outpatient payments for 340B-acquired drugs by nearly 40 percent in the CY 2027 OPPS/ASC rule and would add botulinum toxin prior authorization effective July 1, 2027, with comments due August 31, 2026.
Why it matters CMS wants to sharply reduce what it pays hospitals for discounted 340B drugs; watch the August 31 comment close and the effect on safety-net hospital finances.
Approval Jul 7, 2026
FDA expanded approval of Casgevy (exagamglogene autotemcel) gene therapy for sickle cell disease to patients as young as 2 years old, effective July 1, 2026.
Why it matters FDA cleared a one-time sickle cell gene therapy for young children for the first time; watch access and payment given the multimillion-dollar price of these therapies.
Enforcement Jul 7, 2026
The FTC and four states sued the World Professional Association for Transgender Health, alleging it made deceptive claims about the safety and effectiveness of pediatric gender-transition treatment.
Why it matters Federal and state regulators are challenging a major clinical group's guidance on youth gender care as deceptive; watch how the case affects treatment standards and provider liability.
Rule Jul 7, 2026
CMS's Innovation Center launched the ACCESS Model on July 5, 2026, activating a new Medicare payment code for chronic-care coordination, with application entry dates of August 17 and October 1, 2026.
Why it matters CMS started a new payment model rewarding coordinated chronic-care management; watch the August 17 and October 1 application windows for participants.
Rule Jul 7, 2026
The House Ways and Means Committee advanced the Tax Exempt Hospital Transparency Act (H.R. 9504) by a 25 to 15 vote on July 1, 2026, moving new community-benefit and charity-care reporting requirements for nonprofit hospitals toward the House floor.
Why it matters Congress is advancing a bill to make nonprofit hospitals disclose more about their charity care and tax-exempt community benefit; watch whether it reaches a floor vote.
Rule Jul 7, 2026
Virginia (S.B. 669), California (new PBM licensing), and Ohio (H.B. 229) all tightened pharmacy benefit manager regulation in the same week, with Virginia effective July 1, 2026, California licenses due by January 1, 2027, and Ohio phasing in July 1, 2027.
Why it matters Three states moved at once to rein in pharmacy benefit managers; watch this as part of a broader multistate push to regulate drug-pricing middlemen.
Rule Jul 6, 2026
CMS released its proposed CY 2027 Home Health Prospective Payment System rule, updating home health rates and adding new durable medical equipment supplier enrollment requirements, with comments due August 31, 2026.
Why it matters CMS is setting next year's home health payment and tightening who can bill Medicare for durable medical equipment; watch the comment period closing August 31 for the final rate.
Rule Jul 6, 2026
DEA and HHS issued a fourth temporary extension of the COVID-era telemedicine flexibilities, letting clinicians prescribe controlled substances via telehealth without an in-person visit through December 31, 2026.
Why it matters The rules letting doctors prescribe controlled medications over telehealth stay in place through the end of 2026; watch for whether a permanent rule replaces this fourth stopgap.
Enforcement Jul 6, 2026
DOJ and HHS OIG announced the 2026 National Health Care Fraud Takedown, charging 455 defendants in schemes totaling $6.5 billion, suspending 1,079 providers and revoking 1,403 billing privileges.
Why it matters Federal prosecutors ran their largest annual health care fraud sweep, signaling aggressive enforcement; watch which scheme types, such as telehealth, DME, and genetic testing, drew the charges.
Deadline Jul 6, 2026
Florida opened statewide enrollment in its IDD Comprehensive Managed Care program for iBudget and SMMC long-term care waiver enrollees on July 1, 2026, while 16,996 people remain on the iBudget waitlist.
Why it matters Florida is moving intellectual and developmental disability waiver services into managed care statewide, but nearly 17,000 people still wait for a slot; watch how the transition affects access.
Rule Jul 6, 2026
HHS opened a public comment docket on temporarily placing 7-hydroxymitragynine, a kratom compound, into Schedule I above a specified threshold, with comments due July 31, 2026.
Why it matters Federal health officials are moving toward restricting a potent kratom compound as a Schedule I substance; watch the July 31 comment close and whether DEA follows with scheduling.
Rule Jul 6, 2026
CMS finalized the Contract Year 2027 Medicare Advantage and Part D Rate Announcement, delivering a net payment increase estimated around $13 billion for MA plans.
Why it matters Medicare Advantage insurers are getting a sizable pay raise for 2027; watch how plans translate the increase into benefits, bids, or margins.
Rule Jul 6, 2026
CMS is moving to annual AI-assisted RADV audits of every Medicare Advantage contract while its 2023 rule allowing extrapolated clawbacks remains in litigation after a court vacated extrapolation in September 2025 and HHS appealed.
Why it matters CMS wants to audit every Medicare Advantage plan yearly using AI to recover overpayments, even as courts weigh whether it can extrapolate the findings; watch the appeal outcome.